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A B S T R A C T
Cell adhesion is essential for the formation and functional integrity
of tissues and organs in multicellular organisms. In vertebrates, the
epithelium is a specialized tissue that maintains a protective barrier
around organs. Epithelial cells are attached to the extracellular matrix
and form tight connections with each other via E-cadherin mediated
multiprotein complexes called adherens junctions (AJs).
In this thesis, I present a method for light-induced dissociation
of dimerizer-mediated AJs. This is the first optochemical tool which
allows to control the formation and disassembly of adhesion com-
plexes inside living cells with high spatiotemporal precision. The
applied dimerizers are bifunctional small molecules that combine
ligands of self-labeling protein tags like Halo and SNAP tag, via a
photocleavable linker. These synthetic molecules induce dimeric com-
plexes of proteins expressed as fusion constructs with the respective
self-labelling tag inside living cells. The complexes are efficiently dis-
assembled by cleaving the dimerizers with light.
To utilize photocleavable dimerizers in the context of cell adhesion,
I first established a covalent-covalent binding dimerizer to ensure me-
chanical stability against mechanical forces acting on the induced
protein complexes. I showed the potential to control the formation
of adhesions complexes via retention, recruitment and complementa-
tion approaches for different target proteins. For example, I replaced
the catenin binding sites on E-cadherin with a Halo tag and coex-
pressed them with SNAP-tagged a-catenin that was deficient of the
b-catenin binding site. The dimerizer-mediated E-cadherin-a-catenin
complexes could restore the epithelial phenotype of human epider-
moid carcinoma cells (A431 cells) when induced in a-catenin KOs,
but not in E-cadherin deficient A431D cells. I could show that the
lack of AJ formation in A431D cells is associated with the failure of re-
cruiting b-catenin. In a-catenin KOs -catenin was indirectly recruited
to the dimerizer-mediated E-cadherin-a-catenin complex via lateral
clustering with endogenous E-cadherin. This in turn led to the forma-
tion of AJ complexes, which are the coupling points for the contractile
actomyosin network between epithelial cells. Moreover, the a-catenin
KO phenotype could be restored upon light induced dissociation of
the dimerizer-mediated AJs via exposure to near UV light. When us-
ing a 405 nm laser to cleave the dimerizers, I was able to target the
AJs between two adjacent cells with subcellular precision or to cre-
ate patterns of deactivated cell-cell adhesion in epithelial monolay-
ers. Furthermore, I could prove the mechanical functionality of the
reconstituted AJs by performing a correlation analysis of collective
monolayer migration and traction force microscopy.
v
Herein, I demonstrated the application of photocleavable dimeriz-
ers to study the cellular response to AJ assembly and disassembly at
different scales of space and time. Photocleavable dimerizers present
several advantages for applications in living cells. Since the protein-
protein interaction depends on external addition of the dimerizers
and can be reliably abrogated by breaking the molecule, the setup of-
fers two binary switches for the formation of AJ complexes, virtually
without any basal activity. Furthermore, the system is bioorthogonal
and light is a trigger that allows to dissociate the protein complexes
at subcellular and subsecond resolution. The possibility to combine
it with specialized imaging techniques like traction force microscopy
renders it a powerful tool to study the mechanobiology of AJs and
its contribution to processes in epithelial cell layers like cellular jam-
ming and unjamming, collective migration and stress propagation.
This new method will help to gain new insights in the dynamic reg-
ulation of cell adhesion in fundamental pathophysiological processes
like embryonal development, wound healing or cancer metastasis.
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Z U S A M M E N FA S S U N G
Zelladhäsion ist essentiell für die Herausbildung und funktionale In-
tegrität von Geweben und Organen in multizellulären Organismen.
In Wirbeltieren ist das Epithel ein spezialisiertes Gewebe, dass eine
schützende Barriere um die Organe bildet. Die Epithelzellen sind ei-
nerseits mit der extrazelluären Matrix verbunden und bilden anderer-
seits über E-cadherin vermittelte enge Verknüpfungen miteinander,
sogenannte Adherens Junctions (AJs).
In dieser Doktorarbeit präsentiere ich eine Methode zur lichtindu-
zierten Auflösung von Dimerizer vermittelten AJs. Dies ist das erste
optochemische Werkzeug, dass die Kontrolle über die Bildung und
Degradation von Adhäsionskomplexen in lebenden Zellen mit hoher
raumzeitlicher Präzision ermöglicht. Die verwendeten Dimerizer sind
bifunktionelle kleine Moleküle, in denen die Liganden für sogenannte
selbstmarkierende Protein-Tags (z.B. Halo-Tag und SNAP-Tag) über
eine photospaltbare Gruppe miteinander kombiniert wurden. Diese
synthetischen Moleküle induzieren in lebenden Zellen dimere Kom-
plexe von Proteinen, welche als Fusionskonstrukte mit dem jeweili-
gen selbstmarkierenden Protein-Tag exprimiert werden. Die Komple-
xe können durch Spaltung des Dimerizers mit Licht effizient getrennt
werden.
Für die Anwendung von photospaltbaren Dimerizern im Kontext
der Zelladhäsion habe ich zunächst einen kovalent-kovalent binden-
den Dimerizer etabliert, mit dem die Stabilität der indizierten Pro-
teinkomplexe gegenüber Spannungen- und Zugkräften gewährleis-
tet wird. Das Potential verschiedener Zielproteine für die Heraus-
bildung von Adhäsionskomplexen über konzeptionelle Ansätze zur
Zurückhaltung, Rekrutierung und Vervollständigung von Adhäsions-
proteinen zu kontrollieren wurde evaluiert. Beispielsweise habe ich
die Cateninbindestellen von E-Cadherin mit einem Halo-Tag ersetzt
und diese Proteine mit einem SNAP-Tag fusionierten a-Catenin oh-
ne b-Cateninbindestellen koexprimiert. Die dimerizervermittelten E-
Cadherin-a-Catenin-Komplexe konnten den ursprünglichen epithe-
lialen Phänotyp von humanen Epidermoidkarzinomzellen (A431 Zel-
len) wiederherstellen, wenn sie in a-Catenin knock-out (KO) Zellen
induziert wurden, aber nicht in E-Cadherin defizienten A431D Zel-
len. Ich konnte zeigen, dass das Scheitern der Bildung von AJs in
A431D Zellen mit der ausbleibenden Rekrutierung von b-Catenin as-
soziiert ist. In a-Catenin KO Zellen wurde b-Catenin indirekt über
endogenes E-Cadherin rekrutiert, welches sich zusammen mit den
dimerizervermittelten E-Cadherin-a-Catenin-Komplexen durch late-
rale Interaktionen anhäuft. Dies wiederum führte zur Bildung von
AJ Komplexen, welche die Verknüpfungspunkte für das kontrakti-
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le Aktin-Myosin-Netzwerk in Epithelzellen bilden. Darüber hinaus
konnte durch die lichtinduzierte Zersetzung der dimerizervermittel-
ten AJs nach Bestrahlung mit langwelligem UV-Licht der a-Catenin
KO Phänotyp wiederhergestellt werden. Durch Verwendung eines
405 nm Lasers zur Spaltung der Dimerizer, konnte ich AJs zwischen
zwei aneinandergrenzenden Zellen mit subzellulärer Präzision anvi-
sieren oder Muster von deaktivierten Zell-Zell-Kontakten in epithe-
lialen Monolagen erzeugen. Des Weiteren konnte ich die mechani-
sche Funktionalität der rekonstituierten AJs mittels Durchführung
von Korrelationsanalysen der kollektiven Migration von Zellmono-
lagen und Zugkraft Mikroskopie Messungen (Englisch: traction force
microscopy), nachweisen.
In dieser Arbeit habe ich die Anwendung photospaltbarer Dimeri-
zer zur Untersuchung der zellulären Reaktionen auf die Herausbil-
dung und Zersetzung von AJs in verschiedenen räumlichen und zeit-
lichen Größenordnungen demonstriert. Photospaltbare Dimerizer ha-
ben mehrere Vorteile für die Anwendung in lebenden Zellen. Weil die
Protein-Protein Interaktion von der externen Zugabe des Dimerizers
abhängt und zuverlässig durch die Spaltung des Moleküls aufgeho-
ben werden kann, bietet diese Methode zwei binäre Schalter für die
Herausbildung von AJs, praktisch ohne Basalaktivität. Des Weiteren
ist das System bioorthogonal und Licht als Stimulus erlaubt die Auf-
lösung der Proteinkomplexe mit subzellulärer Auflösung in Bruch-
teilen von Sekunden. Die Möglichkeit zur Kombination mit speziali-
sierten Mikroskopiemethoden wie der Zugkraft Mikroskopie macht
es zu einem leistungsfähigen Instrument zur Untersuchung der Me-
chanobiologie von AJs und deren Auswirkungen auf Vorgänge in epi-
thelialen Zellschichten wie zelluläre Verdichtungsprozesse, kollektive
Zellmigration oder die zellulären Übertragemechanismen von mecha-
nischen Spannungen. Diese neue Methode wird dabei helfen, neue
Erkenntnisse über die dynamische Regulation der Zelladhäsion in
fundamentalen pathophysiologischen Prozessen wie der Embryonal-
entwicklung, der Wundheilung oder der Metastasierung von Krebs
zu erlangen.
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Mötst di nich argern,
Hett keinen Wiert,
Mötst di blot wunnern,
Wat all passiert.
Mötst ümmer denken,
De Lüd sünd nich klook,
Jeder hett Grappen,
Du hest se ok.
Mötst di nich argern,
Hett keinen Sinn,
Ward di blot schaden
Un bringt di nix in,
Ward an di fräten
As Qualm un Rook.
Is’t nahst vergäten,
Büst grad so klook.
Mötst di nich argern,
Is Unrecht di dahn,
Haug mal up’n Disch
Un glieck is’t vergahn.
Kort is dien Leben
Un lang’ büst du dod,
Minsch, blot nich argern,
Ne, lachen deit good!
— Rudolf Tarnow
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Part I
I N T R O D U C T I O N

1
O P T O C H E M I C A L T O O L S F O R B I O L O G Y
1.1 light is a trigger with many advantages
Biological processes inside a living cell are dynamically regulated
with high spatial precision. Synthetic chemistry offers access to a
plethora of small molecules that can specifically interact with biologi-
cal systems for visualization (e.g. fluorescent labelling)[1–3], manipu-
lation (enzyme inhibitors)[1, 4] and analysis (e.g. crosslinking to iden-
tify interaction partners in mass spectrometry analysis)[5]. In this so
called field of chemical biology synthetic molecules that change their
activity on a biological system via exposure to light are summarized
under the term optochemical tool.
Light as a stimulus to trigger biological effect has multiple advan-
tages as it can be applied dynamically with precise regulation in tim-
ing, location and intensity. In modest intensities light is regarded
as non-invasive and non-cytotoxic and it is highly bioorthogonal for
most applications in cell biology except for cellular systems that do
contain light responsive proteins like e.g. photoreceptor cells in the
retina.
The molecules ability to change its bioactivity upon light irradi-
ation is generally facilitated via a reversible conformational change
(e.g. cis-trans isomerization of azobenzene) or photo labile groups in
functional positions of the molecule. In the later case, installation of a
photo labile group at a position that is important for the activity and
binding of the molecule is defined as photo-caging, while integration
in a structural scaffold creates a photo cleavable linker and leads to
disintegration of the molecule after irradiation. Among the grow-
ing variety of photo labile groups that were extensively reviewed in
Brieke et al.[6], those based on nitrophenyl- and coumarinyl- moieties
(figure 1.1) that can be removed with near UV-violet light (l=350-
405 nm) or violet-blue light (l=400-460 nm), respectively, are still the
most widely used.
1.2 photocaging of small molecules and proteins
Photocaging of small molecules is the most common used optochem-
ical tool and was first realized for cAMP by Engels and Schlaeger [7]
and for ATP by Hoffmann and coworkers [8] (figure 1.2 a). The tool-
box of photocaged second messenger molecules and neurotransmit-
ters (e.g. glutamate, GABA, inositol, Ca2+) was constantly enlarged
and applied since after and was extensively reviewed in [6, 9]. Al-
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Figure 1.1: Photo labile caging groups.
a) Most nitrophenyl based caging groups like NPE are stable under ambient
light, but can be cleaved with near UV light (l=350-405 nm). b) Coumatin
based caging groups like Bhc can be cleaved with visible blue light of longer
wavelengths (l=400-460 nm). R denotes the residue coupling site. NPE: 1-
(2-nitrophenyl)ethyl; Bhc: 6-bromo-7-hydroxycoumarin-4-ylmethyl.
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Figure 1.2: Photocaged small molecules can be used to control protein ac-
tivity.
a) The bulky photocaging group prevents NPE-ATP from entering the re-
active binding pocket of ATP dependent enzymes. Energy providing ATP
hydrolysis can occur only after uncaging with light. [9] b) Photocaged un-
natural amino acids like NP-lysine can be used to control enzymatic activity
by blocking their reactive binding pocket. The activity turns in directly after
the caging group is released[10].
though being easily accessible for chemical modifications photocaged
small molecules sufferer from several limitations. First of all they
offer only a single switch for activation or deactivation. Secondly,
the general approach to use photocaged small molecules is limited
to proteins that offer binding sites for the non-caged analogon. Fi-
nally, many second messenger molecules are recognized by multiple
downstream effector proteins and therefore bear the risk of induc-
ing cellular reactions activated by other proteins then the one under
investigation.
Another approach is to install the photocaging group directly at
the protein of interest at an amino acid that is essential for activat-
ing phosphorylation, ATP or ligand binding. This can be done by
direct chemical modification of purified proteins in vitro [11, 12] or
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the ligation of purified proteins with photocaged peptides that were
generated in solid phase synthesis [13]. Applications in living cells
however is fairly limited, because the modified proteins need to be de-
livered into the cells via microinjection or patch clamp dialysis due to
limited cell permeability. A way to generate photocaged proteins in-
side living cells is the incorporation of photocaged unatural amino
acids (UAA) via stop codon suppression as first demonstrated by
Mendel et al. [14]. Reactive tyrosin, lysin, serin and cystein residues
have been blocked by nitrobenzyl or coumarin caging groups (figure
1.2 b). UAA mutagenesis has been used to induce light controlled
nuclear localization of proteins and to create light activated kinases,
proteases, DNA recombinases . These and further applications have
been reviewed recently [15]. Incorporation of photocaged UAA is
highly specific, because it affects solely the modified protein. Never-
theless, its applicability in mammalian cells is still hampered by lim-
ited efficiency due to the need of extensive genetic modifications like
introduction of the amber stop codon mutation in the target protein,
expression of a complementary suppressor tRNA and an engineered
amino-acyl tRNA synthetase that can load the tRNA with the UAA
[16].
1.3 reversible switching of bioactive compounds
Reversible photoswitching between “on” and “off” state can be achieved
with moieties that undergo steric changes via cis-trans isomeric reac-
tions of double bonds like azobenzene, stilbene or hemithioindigo
or they change their conformational flexibility via unimolecular peri-
cyclic reactions as in the case of spiropyran, diarrylethene or fulgide.
Among these potential photoswitches only azobenzene based molecules
have proofen to be capable of inducing functional changes under
live cell conditions, while the others suffer from low solubility or im-
paired switching behavior in aqueous solutions, the need for shorter
UV wavelength or instabilities under standard synthesis conditions
[6]. A big advantage of azobenzenes is that the UV light induced
isomerization from trans to cis is very stable, but can be reversed se-
lectively with visible light (figure 1.3 a). Isostere of azobenzene are
frequently found structural motifs in drugs that are small molecule
inhibitors or activators. Exchange of theses motifs with photoswitch-
able azobenzene (termed “azologization”) often yields comparable
efficiency to the original compound, but light induced isomerization
abrogates its activity. Another approach called “azoextension”, adds
an azobenzene group to a known structure (figure 1.3 b). The pioneer-
ing work of the Trauner lab in this so called field of photopharmacol-
ogy has been extensively reviewed by Broichhagen et al. [17]. Fur-
thermore azobenzenes can be used as light reactive linker between a
ligand and a reactive moiety that conjugates the photoswitchable teth-
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Broichhagen, Acc Chem Res 2015
Figure 1.3: cis-trans isomerization of azobenzene modified ligands can
switch receptor activity.
a) cis-trans isomerization of azobenzene can actively be switched in both
directions with differen wavelenths. b) Azologisation and azoextensions
are two concepts to turn known drugs into photoswitchable compounds. c)
Photoswitchable orthogonal remotely tethered ligand (PORTL) can be fused
to transmembrane receptors like G-protein coupled receptors or receptor
tyrosin kinases to make their activity dependent on light. a,b) Adapted
from [17]. c) Adapted from[19]
ered ligand (PTL) to its target protein [18]. More recently, this concept
has been expanded by photoswitchable orthogonal remotely tethered
ligand (PORTL) (figure 1.3 c)[19] and photoswitchable bioorthogonal
ligand tethering (photo-BOLT) [20] that both increase the specificity
of biconjugation using either the self-labelling protein SNAP tag (see
also subsection 1.4.2) or the incorporation of UAA that can bind the
ligand in a copper free click reaction.
Despite their immense relevance for controlling the activity of a
large number of proteins the application of photocaging or photo-
switchable groups is limited to target proteins with known small
molecule ligands or single key regulatory reactive amino acid residues.
To control proteins that are activated e.g. via complex phosphory-
lation patterns or conformational changes upon protein binding via
large protein-protein interaction sites another concept is necessary,
that will be explained in the next section.
1.4 photoreactive chemical inducers of dimerization
Many processes inside living cells are facilitated via dynamic spa-
tiotemporal sorting of proteins and other reactive agents. Although
this concept of compartmentalization is most obviously manifested
in membrane enclosed organelles, biological activity can be regulated
via local increase of protein concentration at non-enclosed subcellular
compartments by e.g. recruitment to the plasma membrane or protein
clustering. This can increase the availability of diffusible agents or
the chance for activating phospohorylations e.g. by locally increased
concentration of synthetases or kinases, but is particularly relevant
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a) b)
Figure 1.4: Protein activity can be regulated by chemical induced dimer-
ization.
a) Chemical indicers of dimerization (CIDs) like rapamycin can be used to
recruit a target protein to its place of action via dimerization with a localiza-
tion domain. b) Molecular structure of rapamycin.
Adapted from [22]
for proteins that are active only in a multiprotein cluster via direct
protein-protein interaction[21, 22].
Small molecules that induce the direct interaction between two pro-
teins are called chemical inducers of dimerization (CID) or dimerizer
in short. Dimerizer that facilitate binding between proteins of the
same kind are called homodomerizer, whereas dimerizer which bring
two different proteins together are referred to as heterodimerizer. Es-
pecially heterodimerizer can control protein activity e.g. by induced
binding to a localization domain (figure a). A general concept is func-
tional knock down by sequestration at cellular compartments distant
from their place of action or activation by recruitment to their target
site or direct induced interaction with an activating agent[22–26].
Since Schreiber a Crabtree introduced the first dimerizers based on
rapamycin more than 20 years ago [27] the toolbox has been enlarged
constantly with various protein binding small molecules [5, 21, 22].
They have been used in a broad spectrum of live cell applications
ranging from induced gene expression (including pharmacological
screenings in 3-hybrid systems in yeast [28, 29] and mammalian cells
[30]), activation of split kinases [31] and T-cell receptors [27, 32], pro-
tein degradation [33–35], regulation of vesicle transport [36, 37] and to
induce the formation of ruffles and protrusions [38, 39] of the plasma
membrane, to name just a few. The vast variety of (non-photoreactive)
dimerizers and their application have been reviewed in great detail
recently [5, 21, 22, 40, 41].
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Most dimerizer are cell permeable and can be applied to the cell via
the culture medium. Therefore they offer a decent degree of temporal
control, although the the onset rate can be limited by low diffusion
rates through the plasma membrane. Furthermore, they are lacking
the possibility for spatially defined activation. A great potential lies
in the integration of photoreactive moieties in the chemical structures
of CIDs.
1.4.1 Photocaged derivatives of natural dimerizer
1.4.1.1 Rapamycin - a bacterial macrolide
The most widely used dimerizer is rapamycin, a macrolide naturally
produced by the bacterium Streptomyces hygroscopicus. Rapamycin
induces the formation of a ternary complex via binding to FKBP12
(FK506-binding protein) and the FRB (FKBP-rapamycin binding) do-
main of mTOR (mammalian target of rapamycin) with high affinity
(Kd = 12 nM for FKBP-rapamycin-FRB) [42]. The relatively small
proteins FKBP12 (12 kDa) and FRB (11 kDa) can be fused to a large
variety of target proteins as reviewed in [22].
Reasonably, photoreactive derivatives of rapamycin have been used
to improve the spatiotemporal performance of protein dimerization.
Extracellularly trapped caged rapamycin-avidin conjugate (cRb-A) was
applied to recruit the Rac activator Tiam1 to the plasma membrane,
leading to ruffle formation at defined subcellular regions [43]. The
first intracellularly unchangeable dimerizer pRap (figure 1.5 a) was
used to restore activity of focal adhesion kinase (FAK) again lead-
ing to ruffle formation with single cell precision [44]. Despite being
a photo-cleavable rapamycin dimer that could be used for reversibe
homodimerization of FKBP, dRap was used to activate split TEV pro-
tease and split Cre recombinase in HEK293T cells upon rapamycin re-
lease after irradiation [45]. The photo-cleavable FKBP-homodimerizer
PhAP expanded the application to study endosomal dispersion by
deactivating dynein light chain LC8, a motorprotein that transports
intracellular vesicles along microtubule, via dimer formation [46].
Besides its broad pharmacological application as antifungal, an-
tiproliferative and immunosuppressive drug, the physiological activ-
ity of rapamycin on the mTOR pathway limits its usability to study
long term activations in mammalian cells [47].
1.4.1.2 Absicic acid and gibberellic acid - growth hormones in plants
In contrast to rapamycin, the phytohormones absicic acid (ABA) and
gibberellic acid (GA3) have no known activity in mammalian cells.
ABA (figure 1.5 b) binds to PYL protein (pyrabactin resistance 1-like
protein) and the complex is then bound by ABI (ABA insensitive 1).
Crebtree and coworkers have reduced the protein to their minimal
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Figure 1.5: Natural dimerizer can be decorated with caging groups.
a) Rapamycin can be turned into the photoactivatable dimerizer pRap via
ligation of a photocleavable caging group at an exposed hydroxy residue[44].
b) Also the carboxylic acid residue in ABA can be decorated with a caging
group[48]. c) The carboxylic acid residue of GA3is decorated with an ace-
toxymethyl ester to increase cell permeability or can be used to install a
photocleavable caging group[49]. AM: acetoxymethyl. Adapted from [22].
domains necessary to bind ABA (PYLcs: 19.5 kDa, ABIcs: 32.8 kDa)
which can be used to target proteins of interest [50]. Analogously,
the gibberellin metabolite GA3induced conformational changes upon
binding to its receptor GID1 (gibberellin insensitive dwarf1) and the
resulting complex recruits the GAI (gibberellin insensitive). Despite
the large GID1 domain (38.6 kDa) Inoue and colleagues optimized
the system by reducing GAI to its first 92 amino acids (GAI1-92, 10.1
kDa) and improving the cell permeability of GA3by esterfication of
its carboxylic acid with an acetoxymethyl group (GA3-AM) (figure
1.5 c) [51]. Both dimerizer have been shown to work orthogonal to
rapamycin, which offers the possibility of multiplexed dimerization
[50, 51].
The photoactivatable derivatives PA-ABA [48] and PA-GA3[49] have
been synthesized by installation of a photocleavable nitrobenzyl group
at the the respective free carbocylic acid. For GA3Schelke et al pre-
sented also two new caging groups for photoactivation with two
photon laser irradiation [49]. The proof-of-concept studies demon-
strated the potential of these new photoreactive dimerizers via rapid
translocation of fluorescent target proteins to subcellular compart-
ments upon dimerization with distinct localization domains. Fur-
thermore PA-ABA was shown to be applicable for known concepts
of induced gene expression and ruffle formation [48].
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1.4.2 Synthetic photoreactive dimerizer based on self-labelling protein tags
Self-labelling protein tags have been developed for fluorescent la-
belling of proteins inside living cells via binding of small molecule
ligands that can be decorated with synthetic fluorophores. The com-
bination of these ligands via a flexible linker of appropriate length
leads to another class of small molecule dimerizer. The combina-
tion of two different ligands creates hetero bifunctional dimerizer that
can be used in experiments analogous to those described for natural
dimerizer systems ( see section 1.4.1). A big advantage is the modular
architecture of these dimerizer that can be easily exchanged or sup-
plemented with functional moieties. Furthermore, self-labelling pro-
tein tags are a well established tool for live cell labelling experiments
and many fusion proteins that are potential targets for a dimerization
approach are already on hand.
The most widely used self-labelling tags that have been also ap-
plied in the context of protein dimerization are SNAP tag, Halo tag
and TMP tag. The SNAP tag is based on the DNA repair enzyme
human O6-alkylguanine-DNA alkyltransferase (hAGT) that has been
modified to react selectively with benzylguanine (BG) derivatives in-
stead of the endogenous O6-methylguanine-DNA substrate and to
transfer the alkyl group of BG covalently and irreversibly to a re-
active cystein residue[52] (figure 1.6 a). Furthermore Johnsson and
coworkers reduced the size of the protein tag to 20 kDa [2] and im-
proved its binding kinetics to 5.2 x 103 M -1 s-1. Since the Halo tag
(33 kDa) originates from a promiscous dehalogenase (DhaA), an en-
zyme that removes halides from aliphatic carbohydrates in bacteria
of the genus Rhodococcus, it has no cross-reactive substrate in mam-
malian cells. Mutation of a catalytically active histidine into pheny-
lalanine stabilizes the covalent transfer of the aliphatic hydrocarbon
moiety to a reactive aspartate. The apparent second-order rate con-
stant for a tetramethylrhodamin ligand (Ha-TMR) was measured to
be 2.7x106 M-1 s -1 [3] (figure 1.6 b). In contrast to SNAP and Halo
tag, the DHFR tag binds its preferred substrate trimetoprim (TMP)
non-covalently with a dissociation constant of 32 ± 3 nM [53] (figure
1.6 c). The DHFR tag is based on the dihydrofolate reductase (DHFR)
from E. coli which is binding TMP with much higher affinity (KI =
1 nM) than mammalian DHFR (KI = 4 µM) [54], therefore enabling
fluorescent labelling with minimal background in living cells [53].
The first dimerizer based on self-labelling protein tags was pre-
sented by Erhart et al. via combining the chloroalkyl ligands for Halo
tag (Ha) with the SNAP tag ligand BG [55]. In that work they could
show how the length of the linker and incorporation of moieties that
increase cell permeability can improve the efficiency and onset rates
for dimerization of SNAP and Halo tagged GFP fusion proteins in-
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side living cells. The same group also presented the first photo cleav-
able dimerizer by incorporating a photolabil dimethoxynitrobenzyl
(DMNP) moiety in the linker between the Halo tag and the SNAP
tag ligand (Ha-pl-BG) (figure 1.6 d). When cells coexpressing for ex-
ample a Halo tagged giantin fusion protein that is localized at the
Golgi apparatus and a cytosolic SNAP tagged teal fluorescent pro-
tein (SNAP-mTFP1) were treated with the Ha-pl-BG dimerizer the
SNAP-mTFP1 protein could be sequestered at the Golgi vesicles and
could be released with subcelluar precision upon irradiation with a
near UV lasers [56].
The first photoactivatable dimerizer based in on self-labelling pro-
tein tags was developed in a collaborative work by the groups of
Chanoweth and Lampson. They combined a DMNP photocaged TMP
(pcTMP) with the halo ligand Ha (pcTMP-Ha) and could show the
light induced recruitment of cytosolic mCherry-DHFR to various sub-
cellular compartments depending on the localization domain the co-
expressed Halo tag was fuesed to [57]. Because the dimerizer binds
Halo tagged proteins directly after addition to the cells, but DHFR
tag binding is blocked by the caging group, it was also possible to
recruit the cytosolic protein to a single centromer targeted by 405 nm
laser irradiation without recruition to non-targeted centromers in the
same cell. Thus, the pcTMP-Ha dimerizer allows tight spatial control
over the formation of protein-protein complexes. Additionally, due to
the non-covalent binding between TMP and DHFR tag, the dimerizer
could be outcompeted by an excess of free TMP, which gives the pos-
sibility to reverse the dimerization process although without spatial
control [57]. In a follow up publication Zhang et al. enlarged the tool-
box of photoreactive dimerizers with a coumarine caged pcTMP-Ha
that can be activated with much lower light intensities and a pho-
tocleavable derivative TMP-pl-Ha [58]. Taking advantage of the spa-
tiotemporally precise release of Mad1 (a methaphase-anaphase transi-
tion checkpoint protein) that had been recruited to methaphase kine-
tochores via TMP-pl-Ha, they showed that a small fraction of bound
Mad1 is sufficient to halt cells in methaphase. Furthermore, precisely
activated dimerization between the constitutive kinetochore protein
SPC25 and the constitutively active motor domain of kinesin-1 K560
or CENP-E (kinesin-7) proofed findings from in vitro studies in live
cell experiments [58].
Most recently, photoactivatable and photocleavable functionaliza-
tion of DHFR-Halo tag dimerizers have been combined by decorating
the TMP ligand of TMP-pl-Ha dimerizers with a coumarinyl caging
group. These molecules allow two switches with high spatiotemporal
control by inducing dimerization after removing the more sensitive
coumarinyl group with light of l  450 nm wavelenght and dissocia-
tion of the protein complexes upon irradiation with light of l  405
nm wavelenght [59, 60].
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Figure 1.6: The combination of ligands for self-labelling protein tags via
flexible linker leads to a new class of synthetic dimerizers.
a) SNAP-, b) Halo- and c) DHFR-tag and their ligands. d) Chemically
induced dimerization of Halo- and SNAP-tag. BG: benzylguanin, TMP:
trimethoprim
1.5 optogenetics - the ’chemistry-free’ photoswitching
toolbox
Optogenetics applies light reactive proteins that undergo dramatic
sterical rearrangements under illumination that switches their biolog-
ical activity between an “on” and an “off” state. For a long time
optogenetics was mainly restricted to the light gated cation channels
called channelrhodopsins that can be used to create action potentials
in neurons upon illumination and have found a plethora of appli-
cations in neuroscience [61]. During the past years a variety of so
called cellular or non-neuronal optogentic tools were developed and
readily applied in living cells and animals[6, 62–64], but are beyond
the scope of this work. However, the most widely used optogenetic
tools and the basic concepts of how they are used to control cellular
activities will be presented briefly, because of the great overlap with
optochemical tools.
The LOV domain (figure 1.7 a) consists of a b-sheet core, that con-
tains a flavin mononucleotid (FMN) chromophor, and a terminal a-
helix. In the dark, the a-helix is attached to the b-sheet, but under
blue light excitation the FMN binds to a rective cystein residue in the
b-sheet and induced conformational changes that leads to unwinding
of the a-helix[65] (figure 1.7b). Small peptides with signalling, bind-
ing or localization activity can be fused to the a-helix. The peptides
are masked by the protein core in the dark, but readily exposed un-
der illumination and thereby induce signalling events, dimerization
with binding partners or translocation into another cellular compart-
ment[24, 66, 67]. Alternatively, the LOV domain can be fused directly
to the active side of an effector protein where it is sterically blocking
interactions of the effector protein in the dark but not in the lit state
[66]. The approach of controlled presentation of peptide motifs or
1.5 optogenetics - the ’chemistry-free’ photoswitching toolbox 13
a)
d) e)
b)
c)
Figure 1.7: Optogenetic tools can control protein activity.
a) Crystal structure of the LOV domain with FMN cofactor. b) The love
domain can be fused directly to its target protein or c) carry an activating
peptide in the Jahelix. d) CRY2 and CIBN dimerize under blue light. e)
PhyB dimerization with PIF is switchable with red and far red light. Figure
adapted from a,d,e) from [63], and b,c) [74].
blocking of reactive sites offers possibilities for various applications,
but this high flexibility comes at a cost. Many LOV domain based
tools show a substantial dark state activity that can be suppressed
only via introduction of point mutations that have to be tested in te-
dious screenings and usually reduce also the activity of the lit state[24,
67, 68] . Thus, protein activity is rather switched between a “low” and
a “high” rather then an “on” and an “off” state.
The cryptochrome CRY2 forms a heterodimer with the N-terminal
fragment of the transcription factor CIB1 (CIBN) (figure 1.7c). Like
the LOV domain they incorporate a FMN chromophore and are switch-
able with blue light.[69, 70] Similarly phytochrome B (PhyB) binds the
phytochrome interaction factor 3 (PIF3) to form a heterodimeric com-
plex. In contrast to LOV domains and cryptochromes, PhyB reacts
to red light and dimerization is switched “on” with 650-670 nm light
and whereas light of 700-750 nm wavelength induces the “off” state
(figure 1.7d). Phytochrome photoswitching depends on a tetrapyrrole
chromophore like phycocyanobilin (PCB), that has to be supplied ex-
ternally in mammalian systems [71]. Obviously analogous to chem-
ical dimerizes cryptochromes and phytochromes can be used to in-
duce protein-protein interaction of fusion constructs and therefore
can control protein activity by dimerization with effector proteins or
via translocation to or away from their place of action.[61–63, 72, 73]
More recently the optogenetic tool box was complemented with the
photocleabale fluorescent protein PhoCl. Excitation of the amino acid
based chromophore leads to photoconversion and cleaves the protein
backbone. This leads to a loss of fluorescence and the release of a
short N-terminal fragment from the b-barrel core [75] PhoCl can act
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as a photocleavable linker in a fusion protein construct, but for effi-
cient photocleavage irradiation with near UV light for several minutes
was necessary [75], which bears high risk for phototoxicity in live cell
experiments.
The biggest advantage of all optogenetic tools except PhoCl is that
they are reversible switchable and depend on relatively low doses of
visible light, which reduces the risk of phototoxic side effects. Be-
sides PhyB they do not depend on the external addition of molecules,
which means they can be constantly renewed by the cells protein
expression machinery. On the other side, to maintain long term ef-
fects switchable optogenetic systems depend on constant illumina-
tion. Furthermore, the broad absorption of visible light requires care-
ful experimental precautions to prevent exposure to ambient light.
The blue light absorbing LOV domain and cryptochromes prevent
imaging of many of the most common fluorescent proteins from the
blue to the green-yellow emission range (e.g. CFP, GFP, venus, etc.)
[64].
To conclude, optogenetic tools are enlarging the tool box to control
protein activity with light. Since most optogenetic proteins are acti-
vated with visible light they can in principle be used together with
optochemical tools that react to light of l 405 nm wavelength but
are stable under light of longer wavelengths. This spectral multiplex-
ing would offer the chance to control complex dynamic systems with
more precision then what is possible today.
2
E P I T H E L I A L C E L L A D H E S I O N A N D M I G R AT I O N
A cell is the smallest living unit and is confined by the plasma mem-
brane, which contains the cytoplasma and highly specialized com-
partments. The subcellular compartments are called organelles and
can be enclosed by membranes like the nucleus, mitochondria or the
endoplasmatic reticulum (ER) or multiprotein complexes within the
cytosol like ribosomes or proteasomes. In muticellular organisms
cells are organized in tissues and organs that orchestrate the activ-
ity of the containing cells to facilitate complex biological processes
that define life. In animals organs are outlined by the epithelium,
which builds a tightly connected border to hold the inner tissues of
the organ together and shields them from external cues to maintain
its functional integrity. To form this sealed layer, epithelial cells need
adhesive properties and rigidifying structures, but also need to be
able undego dynamic rearrangements to allow processes like the for-
mation of organs during embryonal development or wound healing
in case of damage[76–78].
2.1 the cytoskeleton defines the shape of cells
The rigidifying structures in eucaryotic cells are built out of filamen-
tous protein structures that are summarized as the cytoskeleton in
analogy to the bone skeleton of vertebrates. The main components
of the cytoskeleton are actin filaments (also called microfilaments),
intermediate filaments and microtubules (figure 2.1a).[79] Actin fila-
ments are built out of globular actin (G-actin) monomers, that form
a helical polymer of 8 nm in diameter with a double strand shape
in an ATP and Mg2+ dependent polymerization[81]. Polymerization
and depolymerization of G-actin happens at both ends of the actin
filament (figure 2.1b), while polymerization is kinetically favored at
the barbed end and slower at the point end , because ATP loaded
G-actin hydrolyses the ATP to ADP soon after incorporation into the
filament and ADP bound G-actin has a lower affinity to each other.
This means, when the concentration of free G-actin is high enough
and can constantly exchange ADP with ATP actin filaments are grow-
ing in both directions, but with different polymerization rate until the
G-actin concentration reaches a critical level. In this steady state actin
filaments are growing at the barbed end (therefore also called plus
end) in the same rate as they are schrinking at the point end (also
called minus end), which leads to a constant treadmilling of subunits
in the filament under consumption of ATP[80]. Actin filaments can
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mircotubule
Figure 2.1: Actin filaments, microtubuli and intermediate filaments are the
main structural components of the cytoskeleton.
a) The molecular architecture leads to distinct shapes of the cytoskeletal
networks. b) Actin and myosin are forming filaments via polymerisation.
c) Interaction of F-actin and myosin II fibres leads to contractility. Figure
adapted from a) , b,c)[80].
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be crosslinked into linear bundles, planar networks or 3D gels via a
plethora of actin binding proteins and thereby build a skeletal frame-
work[81].
Myosins are a family of motor proteins that form dimers which
can bind and move along filamentous actin (F-actin). While most
members of the myosin family are responsible for transporting vesi-
cles along the actin fibers, myosin II dimers assemble into bipolar
filaments[82]. Since myosin II binds F-actin in a defined orientation
and moves towards the barbed end, myosin filaments can shift actin
filaments towards each other leading to a contraction. Therefore, in
the analogy to the bone skeleton, the contractile actomyosin network
could be considered the muscles of the cell.
Microtubules (figure 2.1a) are tube like polymers consisting of two
globular proteins a- and b-tubulin, that preassemble in heterodimers.
The tubulin heterodimer polymerizes into protofilaments. A paral-
lel bundle of 13 protofilaments forms the hollow cylindrical shape of
microtubule with a diameter of 25 nm[81]. Like actin, the tubulin
dimers polymerize and depolymerize at both ends of the polymer
in with different kinetics driven by the energy from GTP hydroly-
sis. Microtubules are usually attached to an organelle in the center
of the cells called centromer from which they sprout into the periph-
ery of the cells. Their shape makes them less flexible then e.g. actin
filaments. Therefore, they can act like stabilizing columns and ad-
ditionally function as highways for vesicle trafficking mediated by
processive motor-proteins like kinesins and dyneins that walk along
the protofilaments[79, 81].
Unlike microtubules and actin filaments, intermediate filaments
(figure 2.1a) are made out of various elongated monomers, which
form parallel coiled-coil dimers, that assemble into bipolar tetramers.
These tetramers can interconnect with each other to form fibers of 10
nm diameter which contain 8 tetramers (i.e. 32 coiled-coil dimers)[81].
The composition of the filaments is strongly dependent on the cell
type and can change during differentiation or cancer formation. In
epithelial cells intermediate filaments can span across the whole cell
from one intercellular connection to another, thus supporting the me-
chanical connection of the whole epithelium[83].
2.2 cell adhesion structures - a grip on the outside
world
To allow the formation of a continuous and tight cellular tissue like
the epithelium, the cytoskeleton needs to be anchored to stabilize
the shape and structure of the cells. As shown in figure 2.2 polar-
ized epithelial cells are interconnected via intermediate filaments that
are linked to desmosomes. Desmosomes are multiprotein complexes,
that contain the transmembrane cadherin-family proteins desmoglein
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Figure 2.2: In polarized epithelia adhesion structures connect the cy-
toskeleton to the basal lamina and surrounding cells.
Figure adapted from [81] figure 16-5.
and desmocollin, which form homophilic contacts with the same pro-
teins from the neighboring cell[84]. On the intracellular site thy cy-
tosolic domains of desmoglein and desmocollin are connected to in-
termediate filaments via proteins like plakoglobin, plakophilin, desmo-
plakin and other anchoring and regulating proteins[85, 86]. Hemidesmo-
somes connect intermediate filaments to the basal lamina, a special-
ized extracellular structure composed of matrix proteins, that present
adhesion points for integrins. Integrins are the dimeric transmem-
brane components of cell-matrix adhesion complexes that consist of
various combinations of a- b-monomers dependent on the cell type
and matrix composition. In the case of hemidesmosomes, integrin
a6b4 is linked to the intermediate filaments predominantly via plec-
trin and dystonin[84].
2.2.1 Adherens junctions are mechanoresponsive structures
An actin meshwork is outlining the cell cortex loosely associated with
the plasma membrane, while adherens junctions (AJs) are the an-
chor points of contractile actomyosin network. In epithelial cells E-
cadherin is the prime transmembrane protein that contributes on the
extracellular side to the formation of AJs via homophilic trans dimeri-
sation with E-cadherins from opposing cells and lateral clustering
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Figure 2.3: E-cadherin mediated adherens junctions are the mechanore-
sponsive cell-cell contact anchor points for the actomyosin net-
work in epithelial cells.
The minimal AJ complex is built from E-cadherin, b-catenin and a-catenin
that are linked to the actomyosin network. p120 catenin only indirectly
involved via regulatory pathways. Mechanoresponses of the AJ complex
are b) conformational changes from X- to strand-swapped dimer between
extracellular E-cadherin domains of opposing cells and c) streatching of a-
catenin increases binding to b-catenin and F-actin. Figure adapted from
[94].
via transient cis interactions with E-cadherins within the same mem-
brane[87–89]. The intracellular domain of E-cadherin offers binding
sited for multiple adaptor proteins like b-catenin, which binds to a-
catenin, which in turn can bind actin filaments[90–92] (figure 2.3).
The connection of E-cadherin via b-catenin and a-catenin (also called
CCC-complex) to the contractile actomyosin network, is the minimal
structural unit of AJs that is sufficient to maintain actin associated
cell-cell contacts. In addition, AJ can contain a large variety of regu-
latory signaling or actin binding proteins. For example p120-catenin
is not physically linked to the actomyosin network, but can control
mechanisms to stabilize AJs and increase actomyosin contractility.[93]
AJs are mechanoresponsive adhesion structures that react to me-
chanical cues with structural changes. The two terminal extracellular
domains (EC12) of E-cadherin forms initial trans dimers with oppos-
ing E-cadherins in a so called X-dimer conformation (figure 2.3 b)
that could be confirmed via crystal structure analysis [95]. These X-
dimers are thought to be transient and under force change into a
strand-swap dimer where the tryptophane residue at the second N-
terminal position (W2) of one E-cadherin is flipping outwards into
a binding pocket of the EC domain of the opposing E-cadherin[89,
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90, 95]. This is the prevalent conformation in mature AJ complexes.
On the intracellular site, a-catenin is binding very weakly to F-actin in
the resting state, but strengthens its binding under tension. This catch
bond behavior is facilitated by a tension induced conformational tran-
sition that exposes the tail domain which contains the actin binding
domain (figure 2.3 c) [96–98]. Indeed the binding between the CCC
complex and F-actin is so week without force that it is not possible to
pull down actin via full length a-catenin in an in vitro cosedimentation
assay[99], while the c-terminal tail domain does bind actin efficiently
[96]. More recently, the force dependency could be confirmed in vitro
via an optical trap based assay, that was used to slide an actin filament
over an immobilized CCC complex [100].
2.2.2 The E-cadherin is a key protein in adherens junction complexes
E-cadherin consists of an extracellular part, that is structured into
five homologous domains (EC1-5) (figure 2.4), which are connected
via flexible hinge regions. Acidic amino acid residues in these hinge
regions can form complexes with three Ca2+ per hinge[84]. This leads
to a stiffening of the extracellular domains into a rod like shape. This
stiffening is essential for the formation of trans dimers[101]. The extra-
cellular domains also maintain the subtype specific binding between
cadherins. While the epithelial E-cadherin binds to E-cadherin, N-
cadherin, which is found in neurons and mesenchymal cells (e.g. fi-
broblasts), binds to N-cadherin. This homophilic binding behavior
leads to a clustering of cells that express the same set of cadherins
and is essential for the separation of different tissues[102]. Experi-
ments with chimeric proteins that contained different numbers of the
extracellular domain of E-cadherin fused with the rest of N-cadherin
showed that the EC12 domain is sufficient to facilitate binding to full
length E-cadherin.
Furthermore, the switch between E-cadherin and N-cadherin is a
hallmark of the epithelial to mesenchymal transition (EMT). During
EMT epithelial cells loose their stable cell-cell connections and turn
into a more motile mesenchymal state. The reverse process called
mesenchymal to epithelial transition (MET) as well as intermediated
transition states also occurs and both are dynamically regulated in
physiological processes during embryonal development and wound
healing, but can also lead to fibrosis or cancer metastasis[76, 103].
Since E-cadherin is a transmembrane protein, it is expressed as a
precursor protein and needs to undergo a maturation process to be-
come fully functional (figure 2.4). The N-terminus of the precursor
E-cadherin, the so called pro-domain, contains a signaling peptide
that ensures correct localization of the future extracellular domain
into the lumen of the ER and integration into its membrane during
protein biosynthesis. The precursor E-cadherin is then transported
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Figure 2.4: E-cadherin domains form extracellular and intracellular con-
nections.
E-cadherin is expressed as a precursor protein and undergoes a maturation
process before being presented aa a transmembrane protein in the plasma
membrane. Figure adapted from [89].
in membrane vesicles via the Golgi apparatus to the plasma mem-
brane. During this transport process, the pro-domain is cleaved off
via furin protease [89] leaving the endogenous N-terminus DWV of
mature E-cadherin. In vitro experiments with recombinantly expres-
sed, unprocessed EC12 domains did show that even a single addi-
tional N-terminal methionin residue (MDWV) dramatically impaired
the formation of EC12 dimers[95].
The C-terminal cytosolic domain of E-cadherin contains distinct
binding sites for p120-catenin and b-catenin. While the p120-catenin
is located close to the transmembrane domain, b-catenin binds close
to the C-terminus. Multiple residues in the b-catenin binding re-
gion can be phosphorylated, which increases the binding affinity of
b-catenin.
2.2.3 The actomyosin network is anchored at the ECM via focal adhesions
Like intermediated filaments, the actomyosin network is not only
linked at cell-cell contacts via adherens junctions, but also via inte-
grin mediated cell-matrix adhesion complexes called focal adhesions
(FAs)[80, 84, 104] (figure 2.5). The initial connection between integrin
dimers and F-actin is mediated by talin, a rod shaped protein with
multiple actin binding sites and a globular head domain[105]. The
head domain binds and activates the b-subunit of integrin dimers,
while the rod domains of two talin proteins can dimerize with each
other, thereby leading to an initial clustering of integrins[106]. Strain
excepted via actomyosin contractility stretches the talin rod domain[107],
which leads to exposure of cryptic actin and vinculin binding sites[108,
109]. The mechanoresponsive protein vinculin itself enables binding
22 epithelial cell adhesion and migration
Figure 2.5: Focal adhesions are multiprotein complexes that anchor acto-
myosin bundles to the ECM.
Proteins recruited to FAs can bind directly to actin or activate regularory
pathways for actin polymerization or myosin contraction. Figure adapted
from [82].
to multiple actin filaments via stress induced unfolding of its tail
domain[110]. The attachment of multiple actin filaments leads to
binding of F-actin crosslinking proteins like a-actinin and Arp2/3[82],
which drives the formation of interconnected bundles of F-actin and
myosin II filaments called stress fibers thereby increasing the effi-
ciency of actomyosin contractility. Another protein that can bind
b-integrin and connect it indirectly to F-actin via recruitment of vin-
culin is paxillin. Like talin, paxillin contains binding sites for kinases
like Src and focal adhesion kinase (FAK)[111] that can activate fur-
ther regulatory signaling pathways. Many of these pathways include
GTPases of the Rho protein family, e.g. RhoA and Rac. While Rac
induces the inhibition of myosin phosphorylation which decreases
actomyosin contractility, RhoA activates the Rho-associated protein
kinase ROCK), which phosphorylates myosin and thus increases ac-
tomyosin contractility[81, 82].
2.3 how cells can move - the interplay of adhesion and
contraction
Single cells or cells at the edge of an epithelial cluster tend to form flat
membrane protrusions called lamellipodia. The formation of lamel-
lipodia derives from the constant pushing force of polymerizing actin
filaments, that are cross-linked into a 2-dimensional branching net-
work by the protein complex Arp2/3[81] and anchored to the under-
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lying substrate via nascent adhesions (figure 2.6 a). The progression
of lamellipodia is slower then the extension of F-actin, because the
actin network is constantly dragged backwards creating a retrograde
flow. Interactions of the back-flowing actin network with adhesion
proteins induces shear stresses that activate a maturation into larger
adhesion clusters and bundled attachments of actin filaments. In a
distance of ca. 2-4 µm from the tip of a lamellipodium the architec-
ture of the actin network changes into aligned actomyosin fibers that
are connected to maturing FAs[82, 112], that can resist the increas-
ing force load excepted by myosin contractions. In this region called
lamellum, the retrograde flow of actin is reduced, which leads to a
stabilization of the actomyosin network. The resulting stress fibers
are firmly attached to the ECM via large elongated FAs and sustain
constant pulling forces. The manifestation of FAs allowed further ex-
tension of the lamellipodia (figure 2.6b). Stress fibers can stretch sev-
eral micrometers across the whole cell to a second FA structure. This
double sided anchoring allows them to built up strong traction forces,
that are transmitted via integrins to the ECM[80, 113] (figure 2.7a) The
interconnected structure of the actomyosin network moves the cell
body into the direction of lamellipodia formation and together with
an orchestrated detachment of the adhesion structures at the trailing
edge of the cell, this leads to migration of the cell.
In epithelial cells the tensile forces that are built up at the leading
edge can be transmitted not only to FAs on the trailling edge, but
also to AJs. As described in section 2.2.1 are mechanoresponsive load
bearing structures like FAs, which leads to a ’tug of war’ between
these two actomyosin anchoring structures. Forces from the leading
edge stimulate cells to move away from each other, while the force
exerted on AJs increase cell-cell adhesion. Forces that are transmitted
from the migrating cells at the edge to their neighboring cell can be
propagated further over lengths of several cell diameters. These in-
tercellular force transmission leads to stress at the cell-cell interfaces
and induces tension within the tightly coupled epithelial layer that in-
crease with distance from the leading edge [114]. Consequently, the
mechanical coupling of epithelial cells also influences their migration.
At AJs cells can experience shear stress (oriented along the cell-cell
interface) or normal stress (oriented perpendicular to the cell-cell in-
terface). It had been shown that cells tend to migrate collectively in
directions correlated with high normal stress, which means the reduc-
tion of shear stress and thus, less neighbor exchange [115]. Therefore,
on a short timescale an epithelial cell cluster acts as a solid elastic
layer in which the relative position of the cells towards each other
stays mostly constant. On longer timescales however cellular reorga-
nizations and turbulences induced e.g. by cell death or cell division
take over and the monolayer behavior can be regarded as liquid. [102]
AJs are essential for this coordinated viscoelastic behavior as their dis-
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Figure 2.6: Actin polymerization, cell-matrix adhesionand actomyosin
contractility lead to migration.
a) In lamellipodia polymerisation of the actin meshwork pushes the plasma
membrane forward. FAs form at the interface to the lamellum initiate the
formation of stress fibers. b) FAs built anchoring points that allow the cell
to extend the lamellum and lamellipodia. Figure adapted from a) [82] and
b) [112].
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Figure 2.7: Contractility and migration in single cells and epithelial mono-
layers.
a) In single cells traction forces can be transmited across the cell via stress
fibres that are anchored to the ECM via FAs. b) In epithelial cells forces
excerted by caells at the migration edge can be transmitted into the cell
layer via AJ.
Figure adapted from [113].
ruption leads to uncoordinated migration comparable to single cells,
which also results in a reduced velocity of the layer[113].

3
M O T I VAT I O N
3.1 a need for precise control of adhesion complexes
As described in section 2.2 cell-cell and cell-matrix adhesions need
to be co-regulated and outbalanced to maintain the integrity of ep-
ithelial cells[116]. On the other hand under certain circumstances
e.g. wounding of the epithelial layer, the cell need to be able to
downregulate cell-cell adhesions and become more motile to close
the wound. These events are accompanied by multiple changes in
the gene expression profile and dynamic regulation of biochemical
signaling pathways. These complex processes are summarized under
the term EMT[76]. The mechanisms of EMT can also lead to metas-
tasis during cancer progression. Regarding the clonal origin of most
tumors [117], the adhesive downregulation occurs in a single mutated
cell or a small group of cells within the adhesive tissue. How the me-
chanical aspects of dynamically regulated cell adhesion contribute to
EMT is poorly understood, mainly because methods to control cell ad-
hesion with sufficient spatiotemporal precision but without systemic
side effects are missing.
A general biological approach to study the function of a protein
within a cell is to deplete it and study the occurring effects. This
can be done either by a permanent, genetic knock out or a transient
knock down on the translational level. Although being a very power-
full tool, this method is very limited to study dynamically regulated
processes. Especially, in the context of cell adhesion complexes it is
known that the downregulation of one protein can be compensated
to a certain extend by another similar protein or activation of regula-
tory pathways. For example in epithelial cells the downregulation of
E-cadherin can be compensated by P-cadherin (e.g. in A431 cells) or
cadherin-6 (e.g. in MDCK cells)[118]. To investigate immediate me-
chanical effect of depletion of a target protein or structural complex,
methods with higher spatiotemporal precision are necessary.
Laser ablation can be used to cut stress fibers within a cell [119] or
selectively kill a cell within an epithelial monolayer [120] with very
high spatiotemporal resolution, but this method is highly invasive
and thus can cause dramatic unspecific side effects. Unwanted side
effects are also an issue for the disruption of cadherin mediated cell-
cell contacts via Ca2+ depletion (ref), since Ca2+ is a second messenger
molecule that is involved in various processes inside a cell. Acto-
myosin contractility can be inhibited or stimulated with blebbistatin,
but like Ca2+ depletion they act systemically on all cells within the
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Figure 3.1: Photocleavable and non-cleavable dimerizer for self-labelling
protein tags taht will be applied in this study.
culture dish and additionally blebbistatin is highly fluorescent and
strongly interferes with GFP imaging[4].
3.2 mission statement - what the reader can expect
3.2.1 Aim of the study
The aim of this project was to develop a method to control cell ad-
hesion with light. Light was chosen as the intended trigger for the
reasons discussed in section 1.1 like bioorthogonality and high spa-
tiotemporal precision, but also it should be compatible with estab-
lished imaging based methods to study cell migration and contrac-
tility. In a previous project at the Wombacher Lab, I developed a
set of photocleavable and non-cleavable dimerizers (figure 3.1), of
which the dimerizers Ha-TMP and Ha-pl-TMP were proven to be ca-
pable of translocating cytosolic proteins to subcellular compartments
(e.g. sequestration at an intracellular membrane) by inducing protein-
protein interactions between the DHFR tagged target protein and a
Halo tagged localization domain [121].
Please note, that the reports of photoreactive dimerizer based on
self-labelling protein tags discussed in section 1.4.2 were all published
during the course of this PhD thesis project. The presented studies
highlighted the broad potential of this cutting edge technology and
encouraged me to develop the application for optochemically con-
trolled adhesion complex formation presented in this thesis.
In the course of this project I wanted to establish the intracellu-
lar dimerization with the covalent-covalent binding Ha-BG and Ha-
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pl-BG molecules and apply this state-of-the-art optochemical tool to
control the formation or strengthening of cell adhesion complexes.
I focused on the actomyosin connected adhesion structures FAs and
AJs, because they are relatively well studied and known to be actively
mechanoresponsive. Furthermore, some proteins have been previ-
ously identified as key players for the formation and enforcement
of the adhesion complexes, and were therefore chosen as targets for
establishing the method. Finally, I wanted to prove the mechanical
functionality of the light controlled adhesion structures in the context
of epithelial cell migration. Therefore, I applied some state-of-the-art
technologies, that will be briefly explained in the following section.
3.2.2 Selected methods to study epithelial cell migration and contractility
As discussed in section2.3 epithelial cell migration is initiated at the
free edge of a cell cluster via formation of filopodia and subsequent
attachment of stress fibers via FAs. The pulling forces of the lead-
ing edge are counteracted by intercellular forces transmitted via AJs,
which leads to collective migration. Thus, coordinated motion and
collective contraction are measures for functional cell-cell adhesion
[113].
To reduce complexity of the system and improve reproducibility,
a rupture free wound healing assay (figure 3.2 a) can be performed.
Cells are physically confined with a adhesion inert barrier e.g. made
out of polydimethylsiloxane (PDMS). When the barrier is removed,
the cells experience a cell free area along straight edge and start to
migrate. The cell free area can be regarded as a model wound.
The collective migration behavior can be analyzed via particle im-
age velocimetry (PIV) (figure b) a method derived from fluid dynam-
ics to analyze streaming behaviors in gases and fluids by tracing the
displacement of particles within over time. Therefore, two subse-
quent image frames of a time lapse recording are subdivided into
smaller units called interrogation windows, that contain a small frac-
tion of particles. The displacement of particles are compared by shift-
ing each interrogation window in the next frame around its original
position to find the best match according to a mathematically defined
score[122]. The shift at each position is then assigned in a displace-
ment vector field, which can be translated into a velocity vector field
concerning the known time difference between two frames. In the
context of cell migration, PIV can help to analyze the displacements
within a cellular subpopulation, without the need to trace every cell
separately. Spatial correlations and the overall correlation length can
be calculated from the velocity fields, which are a measure collectively
coordinated migration [123, 124].
Traction forces microscopy (TFM) allows to measure the tensile
forces that cells exert on the ECM [125]. In a classical TFM experi-
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Figure 3.2: Methods to study epithelial migration and contractility.
Sketches of a) a rupture free wound-healing assay, b) PIV analysis of cells in
a monolayer and c) traction force microscopy (TFM). Figure adapted from
[113]
ment, small fluorescent beads are incorporated in an elastic gel, which
is functionalized with firmly coupled ECM molecules to allow cell at-
tachment. When the cells adhere to the ECM molecules and start to
exert traction forces, this leads to a deformation of the gel that can
be traced via displacement of the beads directly underneath the gels
surface. For a gel of known elastic modulus, the traction forces can
be calculated by inverting the displacement field [114].
Part II
M AT E R I A L S A N D M E T H O D S

4
M AT E R I A L S
List of company abbreviations used
Company Abbreviation
Acros Organics Acros
Asta Tech Inc. Asta
Bruker Daltronics Bruker
Carl Roth Roth
Eurisotop SAS Eurisotop
GE Healthcare GE
Gold Biotechnology GB
KERN & SOHN K&S
Macherey-Nagel GmbH & Co KG Macherey
MCAT GmbH MCAT
New England Biolabs GmbH NEB
Novabiochem Novab.
Scientific Industries Sci. In.
Sigma-Aldrich Sigma
Thermo Fisher Scientific TF
Vacuubrand GmbH + Co KG Vac.
4.1 chemicals and reagents
Tween-20 Roth
Name Company
1-Chloro-6-iodohexane Sigma
20-Azido-3,6,9,12,15,18-hexaoxaicosan-1-ole MCAT
4-[4-(1-Hydroxyethyl)-2-methoxy-5-nitrophenoxy]butyric acid Sigma
4-Nitrophenyl chloroformiate Sigma
6-((4-(Aminomethyl)benzyl)oxy)-9H-purin-2-amine Asta
Acetic acid Sigma
Acetonitril Roth
Agar-Agar, Kobe I Roth
Calcium chloride dihydrate Merck
Celite® S filter aid, dried, untreated Sigma
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Tween-20 Roth
Chloroform-d Eurisotop
Chloramphenicol AppliChem
Coomassie Brilliant Blue R250 Sigma
D-(+)-Glucose Sigma
Dichloromethane anhydrous, 99.8%,
Sigma
contains 40-150 ppm amylene as stabilizer
N,N-Diisopropylethylamine 99.5%, biotech. grade Sigma
N,N-Dimethylformamide puriss. p.a. Sigma
Dimethyl sulfoxide (DMSO) TF
DL-Dithiothreitol Sigma
DNA Stain Clear G SERVA
dNTP-Mix TF
Ethylene glycol-bis(-aminoethyl ether)
AppliChem
-N,N,N’,N’-tetraacetic acid (EGTA)
Ethylenediaminetetraacetic acid (EDTA, 0.5 M 100x) TF
Ethyl acetate for HPLC, 99.7% Sigma
Hydrogen -
Methanol for HPLC, 99.9% Sigma
Methanol-d4 Eurisotop
Nickel(II) sulfate Sigma
Palladium on activated charcoal (10 % Pd basis) Sigma
Pyruvate TF
Polygram Sil G/UV254 TLC plates Macherey
PyBOP Novab.
Potassium chloride (KCl) Roth
Silica gel technical grade, pore size 60 Å,
Sigma
230-400 mesh particle size, 40-63 µm particle size
Sodium hydride 60 % dispersion in mineral oil Sigma
Sodium Cloride (NaCl) Merck
Sodium phosphate (Na3PO4) Roth
Tetrahydrofuran, anhydrous Sigma
Triethylamine puriss. p.a., 99.5% (GC) Sigma
TRIS hydrochloride Biomol
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4.2 biochemical and microbilogical reagents
Name Cat. No Company
Agarose 11404 Serva
Ampicillin A0166 Sigma
Biotin B4039 Sigma
Albumin fraction V (BSA) 8076 Roth
Fetal bovine serum (FBS) - Sigma
Geneticin 10131027 TF
Kanamycin K-120-25 GB
Penicillin/Streptomycin (Pen/Strep) 15140122 TF
Trypsin 59427C Sigma
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4.3 antibodies
Abbreviations used:
Cat. No = catalog number, Comp. = Company, Appl. = applica-
tion, Fin. conc. = final concentration, IF = immunofluorescence and
WB = western blot
Conj. = Conjugation, A = Alexa Fluor, HRP = horseradish peroxidase,
FITC = Fluorescein isothiocyanate, TRITC = Tetramethylrhodamine
DAPI = 4´,6-diamidino-2-phenylindole
4.3.1 Primary antibodies
Target
Species Cat. No Comp. Appl.
Fin. conc.
protein [µg/ml]
a-catenin
Mouse 610193 BD
IF 1.06
(C-terminal) WB 0.11
a-catenin
Rabbit Ab51032 Abcam
IF 1.06
(N-terminal) WB 0.11
b-actin Mouse A1978 Sigma WB 0.50
b-catenin Mouse 610153 BD
IF 2.50
WB 0.25
Desmo- Guinea
DP-1 Progen IF 1.00
plakin1 pig
E-cadherin
Rabbit Sc-7870 Sc
IF 2.00
(H-108) WB 0.20
E-cadherin Mouse Sc-8426 Sc WB 0.20
GFP Rabbit A-11122 TF WB 0.40
m-Cherry Rat M11217 TF WB 0.40
N-cadherin Mouse 610920 BD WB 0.25
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4.3.2 Secondary antibodies
Target
Species Conj. Cat. No Comp. Appl.
Final conc.
species [µg/ml]
Mouse Goat A350 A-21049 TF IF 10.0
Mouse Goat A405 A-31553 TF IF 2.0
Mouse Donkey A647 A-31571 TF IF 20.0
Rabbit Goat A350 A-21068 TF IF 10.0
Rabbit Goat A647 A-21442 TF IF 20.0
Guinea
Goat A647 A21450 TF IF 2.0
Pig
Mouse Goat HRP SC-2005 Sc WB 0.4
Rabbit Goat HRP SC-2004 Sc WB 0.4
Rat Goat HRP Ab97057 Abcam WB 0.4
4.3.3 Fluorescent Affinity Binders
Name Conj. Cat. No Comp. Appl.
Final conc.
[µg/ml]
DAPI - D9542 Sigma IF 1.0
Phalloidin A647 A22287 TF IF 2.0
Phalloidin FITC P5282 Sigma IF 2.0
Phalloidin TRITC P1951 Sigma IF 2.0
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4.4 dna modifying enzymes and master mixes
All enzymes and master mixes were acquired from NEB.
Restriction enzymes
AflII BmtI-HF NotI-HF
AgeI-HF BsrGI-HF PacI
AsiSI DpnI PmeI
BamHI-HF FseI SacII
Master mixes
Q5 High-Fidelity 2x Master Mix
Gibson Assembly 2x Master Mix
4.5 buffers , solutions and media
4.5.1 Buffer recepies
FACS buffer
FBS 10 %
EDTA 2 mM
in PBS
TBST buffer (pH 7.5)
TrisHCL 50 mM
NaCl 150 mM
Tween-20 0.1 %
in deionized H2O
TEV cut buffer (pH 8.0)
Tris-HCl 50 mM
EDTA 0.5 mM
DTT 1 mM
in deionized H2O
Binding buffer/ buffer A (pH 7.4)
Tris-HCl 50 mM
NaCl 0.3 M
Imidazol 30 mM
in deionized H2O
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Eluition buffer/ buffer B (pH 7.4)
Tris-HCl 50 mM
NaCl 0.3 M
Imidazol 250 mM
in deionized H2O
10x TB buffer (pH 7.4)
Tris-HCl 0.5 M
NaCl 1 M
KCl 0.1 M
BSA 2% (w/v)
in deionized H2O
Strippin-Buffer (pH 7.4)
Na3PO4 20 mM
NaCl 0.5 M
EDTA 50 mM
in deionized H2O
Sodium chloride solution
NaCl 1.5 M
in deionized H2O
Nickel (II) sulfate solution
Nickel (II) sulfate 0.1 M
in deionized H2O
Comassie Staining solution
Comassie Brilliant Blue 0.05 % (w/v)
Isopropyl alcohol 25 % (v/v)
in deionized H2O
Comassie Destaining solution
Methanol 20 % (v/v)
Acetic acid 10 % (v/v)
in deionized H2O
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Ponceau Red Solution
Ponceau S 0.5 % (w/v)
Acetic acid 1 % (v/v)
in deionized H2O
4.5.2 Cell culture media
Name Cat. No Company
Dulbecco’s modified Eagle’s medium (DMEM) 41966-029 TF
+ Phenol Red
incl. Glucose 4.5 g/l
incl. Glutamax 4 mM
incl. Sodium Pyruvate 1 mM
add FBS 10 %
opt. Pen/Strep 1 %
opt. Geneticin 750 g/l
Dulbecco’s modified Eagle’s medium (DMEM) no phenol red 31053-028 TF
- Phenol Red
incl. Glucose 4.5 g/l
incl. Sodium Pyruvate 1 mM
FluoroBrite A1896701 TF
- Phenol Red
incl. Glucose 4.5 g/l
add Glutamax 4 mM
add Sodium Pyruvate 1 mM
add FBS 10 %
opt. Pen/Strep 1 %
opt. Geneticin 750 g/l
Opti-MEM 31985-062 TF
4.6 kits 41
4.5.3 Bacteria media
Lysogeny broth (LB)-Medium LB Agar
LB-Medium (Luria/Miller) 2.5 % (w/v) Agar 2.0 % (w/v)
in sterile H2O in LB-Medium
4.5.4 SDS page and western blot buffers
Name Cat. No Company
RIPA lysis buffer R0278 Sigma
Halt Protease and Phosphatase
78442 TF
Inhibitor Single-Use Cocktail
NuPAGE LSD Sample Buffer NP0007 TF
NuPAGE Sample Reducing Agent NP0009 TF
Novex Sharp Pre-stained Protein Standard LC5800 TF
MOPS SDS running Buffer (20x) NP0001 TF
MES SDS running Buffer (20x) NP0002 TF
Nitrocellulose membrane 88018 TF
NuPAGE Transfer Buffer NP0006 TF
Ponceau Red P3504 Sigma
BSA 8476 Roth
Amersham ECL Prime
- GE
Western Blotting Detection Reagent
4.6 kits
Name Company
Amaxa Cell Line Nucleofector Kit L Lonza
Amaxa Cell Line Nucleofector Kit T Lonza
ECL Primer Western Blotting Detecting Reagents Amersham
QIAquick Gel Extraction Kit Quiagen
QIAquick PCR Purification Kit Quiagen
QIAprep Spin Miniprep Kit Quiagen
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4.7 disposables
Name Company
Cell culture flask 25 cm2 Sarstedt
Cell culture flask 75 cm2 Sarstedt
µ- Slides VI 0.4 Ibidi
12 Well Plate TPP
6 Well Plate TPP
Blotting Filter Paper 2.5 mm TF
Nitro Cellulose Membrane 0.45 Micron TF
4- 12 % Bis- Tris Gel 1.0 mm x10 wells TF
4- 12 % Bis- Tris Gel 1.5 mm x15 wells TF
4.8 cell lines and bacterial strains
4.8.1 Cell lines bought
Name Cat. No. Company
A431 CRL-1555 ATCC
BT549 HTB-122 ATCC
MDA-MB-231 HTB-26 ATCC
MCF 7 HTB-22 ATCC
MDCK.2 00062107 Sigma
4.8.2 Cell lines provided
Name Provider Institute, Country
A431 a-catenin KO Dr. T. Kato Francis Crick Institute, UK
A431 D Dr. R.M. Mège Institut Jacques Monod, France
COS 7 Dr. U. Engel Heidelberg University, Germany
MDCK.2 E-cadherin KO Dr. R.M. Mège Institut Jacques Monod, France
REF 52 Dr. B. Geiger Weizmann Institute of Science, Israel
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4.8.3 Stable cell lines produced
Original Plasmid used
cell line Code Name
A431 D
pDO48 hE-cadherin GFP
pDO52 EcGFP-a(280-906)
pDO56 EcGFP-Halo_IRES_SNAP-mCherry-a(280-906)
A431 pDO23 mEmerald-a-catenin
a-catenin KO pDO52 EcGFP-a(280-906)
pDO56 EcGFP-Halo_IRES_SNAP-mCherry-a(280-906)
MDCK II
pDO68
E-cadherin-D-cyto-Halo_
E-cadherin KO IRES_DHFR-EGFP-cytotail
4.8.4 Bacterial strains
Strain Company
E. coli
DH5a NEB
KRX Promega
4.9 machines and equippment
Name Company
ABJ analytic scale K&S
acuracy weighing machine AX 105
DeltaRange analytic scale
Mettler Toledo
Adventurer analytic scale OHAUS
Agilent 1100 Series HPLC system
Agilent
equipped with diode array and fluorescence
detector
Amersham Imager 600 Amersham
Avanti J-26XP Ultracentrifuge with rotor
JA-10 and JA-25.50
ÄKTA pure 25 M, purifier system GE
B28 plate incubator Binder
Centrifuge 5417 R Eppendorf
Centrifuge 5418 Eppendorf
DNAEngine, Thermocycler Bio-Rad
EMB 1000-2 table scale K&S
Excella E24R Incubator shaker Eppendorf
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Name Company
FACS Melody BD
Gene Pulser Xcell, electroporation system Bio-Rad
Hei-VAP value G6 rotary evaporator Heidolph
Heracell, carbon dioxide incubator Hereaus
Heracell 240, carbon dioxide incubator Hereaus
HisTrap HP 5 ml, IMAC column GE
HisTrap HP 1 ml, IMAC column GE
Lambda 25 UV/Vis spectrometer PerkinElmer
Luna 3u C18(2) 100A, LC Column 100 x 0.3
mm, Ea
Phenomenex Ltd.
Megafuge 1.0 tabletop centrifuge Hereaus
Microcentrifuge 5418 tabletop centrifuge Eppendorf
micrOTOF-Q II high resolution mass
spectrometer
Bruker
Mini-Sub Cell GT Systems agarose gel
electrophorese chamber
Bio-Rad
Minitron Incubator AT73 INFORS
MinUVIS UV handlamp (30 W) DESAGA
ND-1000 NanoDrop spectrometer peqlab
Power Ease 90 W TF
PowerPac Basic Power Supply Bio-Rad
Prism Mini Centrifuge Labnet
ROTINA 380 R tabletop centrifuge with
rotor 1754
Hettich
SHAKER DRS-12 rocket shaker neoLab
T100 Thermal Cycler, thermocycler Bio-Rad
Thermomixer comfort Eppendorf
UV-Transilluminator agarosegel
documentation
peqlab
Vacuum pumping unit VP-2 autovac Vac.
Varian Mercury Plus 300 MHz NMR
spectrometer
Varian
Varian Mercury Plus 500 MHz NMR
spectrometer
Varian
Vortex Genie II Sci. In.
XCell SureLock SDS-electrophoresis system
with power Ease 90W power supply
TF
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Microscopes
Microscope Name Stand Company
DMi8 inverted DMi8 Leica
fluorescence wide-field
Objective Name Company NA Imm.
10 x HC PL FLUOTAR Leica 0.32 dry
63 x HC PL APO CS2 Leica 1.40 oil
Camera Name Company
sCMOS DFC9000GT Leica
Light source Name Power
X-Cite 200DC 200 W
Filter sets Filter Excitation [nm] Emission [nm]
DAPI 350/50 460/50
FITC 480/40 527/30
RHODAMINE 546/10 585/40
Y5 620/60 700/76
QSP-T 365/50; 488/20; 561/20; 638/20
Laser scanner Name Excitation [nm]
Leica infinity scanner 405
Microscope Name Stand Company
Olympus IX inverted DeltaVision Olympus
fluorescence wide-field Elite system
Objective Name Company NA, PH Imm.
10 x Zeiss 0.30, PH1 dry
20 x Zeiss 0.50, PH1 dry
60 x Olympus 1.42 oil
Camera Name Company
CoolSNAP HQ ICX285 Photometrics
Light source Name Power
SPECTRA X 220 W
Filter sets Filter Excitation [nm] Emission [nm]
GFP 475/28 525/48
mCherry 575/25 625/45
DAPI 390/18 435/48
Alexa 594 575/25 625/45
FITC 575/25 625/45
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Microscope Name Stand Company
DM6000B microscope system Leica
Objective Name Company NA Imm.
20 x Leica 0.70 dry
63 x Leica 1.40 oil
Camera Name Company
DFC 365FX Leica
Light source Name Power
EL6000 120 W
Filter sets Filter Excitation [nm] Emission [nm]
DAPI 350/50 455/50
FITC 490/20 525/36
TRITC 555/26 605/52
Cy5 645/30 705/72
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5.1 general remarks
Chemicals were purchased from Sigma-Aldrich, MCAT GmbH, Asta
Tech Inc., novabiochem, abcr GmbH & Co. KG, acros Organics and
used as received. Solvents for nuclear magnet resonance (NMR) were
purchased from euriso-top SAS. Thin layer chromatography (TLC)
was performed with polygram Sil G/UV 254 plates. Spots on TLC
plates were visualized with a UV hand lamp (l=254 nm or 366 nm
wavelength) or stained with ninhydrin, vanillin or potassium perman-
ganate staining solution followed by heat treatment.
NMR spectra were measured on a Varian Mercury Plus 300 MHz
spectrometer or a Varian 500 MHz NMR System. Chemical shifts
were reported relative to solvent peaks according to Fulmer et al.
[126] High resolution (HR) mass spectrometry (MS) was performed
on a Bruker microTOF-QII mass spectrometer using electron spray
ionization (ESI). Flash chromatography (FC) was done using silica gel
with a pore size of 60 Å and a particle size range of 40-63 µm. All com-
pounds were characterized by NMR (1H, 13C) and HR-MS/MS (ESI).
Purity was further determined by RP-HPLC analysis via reinjection
of the purified compound and integration of the UV absorbance sig-
nal at l=280 nm. Analytical RP-HPLC was done on an Agilent 1100
series HPLC system using Phenomenex Luna 3µ C18 reversed-phase
columns with a solvent gradient of 10 - 60 % solvent B over 60 min
(Solvent A: H2O containing 0.1% trifluoroacetic acid (TFA); Solvent B:
MeCN containing 0.1% TFA).
5.2 synthesis of compound 5 ha-peg(7)-n3
O O O O O O O N3Cl
5
20-Azido-3,6,9,12,15,18-hexaoxaicosan-1-ole (411.53 mg, 1.17 mmol,
1.0 eq.) was dissolved in dry THF:DMF 7:1 (10 ml:1.5 ml, 0.1 M)
at RT under Ar. The solution was cooled to 0° C in an ice water
bath with constant stirring. NaH (93.6 mg, 2.34 mmol, 2.0 eq.) was
added in small portions under constant Ar flow and stirring. Stirring
continued at 0° C for 30 min before 1-chloro-6-iodohexane (266.6 µl,
1.76 mmol, 1.5 eq.) was added dropwise. The ice water bath was
removed and the stirring was continued over night under Ar slowly
warming to RT.
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The NaH was quenched with ammonium chloride and the mixture
was poured into water (40 ml). Sodium thiosulfate was added to
reduce iodine and the mixture was extracted with EtOAc (3x 10 ml).
The combined organic fractions were dried over magnesium sulfate
and all volatile components were removed under reduced pressure.
The crude product was purified via FC on silica gel (EtOAc) to yield
190.5 mg (35 %) of compound 5 as a yellow liquide.
1H NMR (300 MHz, CDCl3) d 3.69 – 3.58 (m, 23H), 3.58 – 3.52 (m,
2H), 3.49 (t, J = 6.7 Hz, 2H), 3.42 (t, J = 6.6 Hz, 2H), 3.35 (t, J = 5.6, 4.6
Hz, 2H), 1.82 – 1.68 (m, 2H), 1.62 – 1.49 (m, 2H), 1.47 – 1.29 (m, 4H).
13C NMR (75 MHz, CDCl3) d 71.18, 70.66, 70.63, 70.60, 70.57, 70.55,
70.54, 70.06, 69.99, 50.65, 45.00, 32.51, 29.42, 26.66, 25.38.
HR MS (ESI pso.) m/z: calculated for C20H40ClN3NaO7+ [M+Na]+:
492.2447, measured 492.2449.
5.3 synthesis of compound 6 ha-peg(7)-nh2
6
O O O O O O O NH2Cl
Compound 5 (190.5 mg, 405 µmol, 1.0 eq.) was dissolved in MeOH:EtOAc
5:1 (5 ml:1 ml, 0.07 M) at RT under Ar and stirring. A catalytic
amount of Pd/C (42.9 mg, 40.5 µmol, 0.1 eq.) was added under con-
stant Ar flow. H2 was passed through the miture under constant
stirring for 4 h at RT. The mixture was filtered through celite and
volatile components were removed under reduced pressure. Com-
pound 6 was obtained as a gray oil in a yield of 228.01 mg (>100 %,
probably still containing solvent or Pd/C). Analytics were done from
a previous batch.
1H NMR (300 MHz, CDCl3) d 3.76 – 3.57 (m, 23H), 3.57 – 3.53 (m,
2H), 3.50 (t, J = 6.7 Hz, 2H), 3.42 (t, J = 6.6 Hz, 2H), 2.93 (t, J = 5.1 Hz,
1H), 1.82 – 1.67 (m, 2H), 1.64 – 1.50 (m, 2H), 1.49 – 1.27 (m, 4H).
13C NMR (75 MHz, CDCl3) d 71.33, 71.17, 70.56, 70.54, 70.51, 70.50,
70.47, 70.39, 70.37, 70.36, 70.32, 70.25, 70.13, 70.07, 70.03, 45.01, 41.35,
32.51, 29.41, 26.66, 25.39.
MS (ESI pos.) m/z: calculated for C20H43ClNO7+ [M+H]+: 444.2723,
measured 444.3.
5.4 synthesis of compound 7 ha-peg(7)-pl-oh
OCl N
H7 O
O
O OH
NO2
O
7
4-[4-(1-Hydroxyethyl)-2-methoxy-5- nitrophenoxy]butyric acid (80.9
mg, 270 µmol, 1.2 eq.) and PyBOP (140.5 mg, 270 µmol, 1.2 eq.) were
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dissolved in dry DMF (2 ml, 0.14 M) under Ar in the dark and stirred
for 2 h. Compound 6 (100 mg, 225 µmol, 1.0 eq.) was dissolved in
dry DMF (2 ml, 0.11 M), supplemented with DIPEA (47 µl, 270 µmol,
1.2 eq.) and added dropwise to the mixture. Stirring continued over
night at RT under Ar in the dark. The reaction mixture was poured
into water (50 ml) and brine was added for better phase separation.
Compound 7 was extracted with EtOAc (4x 20 ml). The cpmbined
organic fractions were washed with brine supplemented water (30
ml) and dried over magnesium sulfate. All volatile components were
removed under reduced pressure and a bronish yellow oil remained.
Purification via FC on silica gel (DCM:MeOH 30:1 v/v) resulted in
130.2 mg (yield: 80 %) of a yellow oily residue.
1H NMR (300 MHz, CD3OD) d 7.56 (s, 1H), 7.39 (s, 1H), 5.44 (q, J =
6.2 Hz, 1H), 4.07 (t, J = 6.2 Hz, 2H), 3.79 – 3.67 (m, 1H), 3.67 – 3.50 (m,
21H), 3.46 (t, J = 6.5 Hz, 2H), 3.41 – 3.32 (m, 7H), 3.22 (q, J = 7.3 Hz,
1H), 2.42 (t, J = 7.4 Hz, 2H), 2.16 – 2.06 (m, 2H), 1.79 – 1.70 (m, 2H),
1.62 – 1.52 (m, 2H), 1.46 (d, J = 6.3 Hz, 3H), 1.42 – 1.33 (m, 7H).
13C NMR (75 MHz, CD3OD) d 173.77, 153.85, 146.64, 139.08, 137.43,
108.51, 108.41, 70.50, 69.83, 69.60, 69.48, 69.01, 68.10, 64.56, 54.20, 45.77,
45.71, 44.18, 42.17, 38.89, 38.77, 32.13, 31.83, 28.93, 26.12, 25.79, 25.68,
24.87, 24.84, 23.70, 17.11, 15.68, 11.56.
HR MS (ESI pos.) m/z: calculated for C33H57ClN2NaO13+ [M+Na]+:
747.3441, measured 747.3435.
5.5 synthesis of compound 8 ha-peg(7)-pl-activated
8
OCl N
H7 O
O
O O
NO2
O
O
O NO2
Compound 7 (130.2 mg, 179 µmol, 1.0 eq.) was dissolved in dry
DCM (2 ml, 0.08 M). A solution of pyridine (36,2 µl, 447.5 µmol,
2.5 eq.) and 4-nitrophenyl chloroformiate (36.2 mg, 179 µmol, 1.0
eq.) in dry DCM (2 ml, 0.08 M) was added dropwise under con-
stant stirring and Ar flow in the dark at RT. Stirring continued for 4
h before all volatile components were removed under reduced pres-
sure. The crude product was purified via FC on silica gel (DCM, then
DCM:MeOH 100:1, then 50:1, then 30:1 v/v) and yielded 94.58 mg (59
%) of a bright yellow oil.
1H NMR (300 MHz, CD3OD) d = 8.28 – 8.20 (m, 2H), 7.58 (s, 1H),
7.44 – 7.37 (m, 2H), 7.19 (s, 1H), 6.39 (q, J=6.4, 1H), 4.09 (t, J=6.2, 2H),
3.97 (s, 3H), 3.61 – 3.57 (m, J=5.6, 22H), 3.56 – 3.50 (m, 6H), 3.44 (t,
J=6.5, 2H), 3.36 (d, J=5.5, 2H), 2.40 (t, J=7.4, 2H), 2.15 – 2.05 (m, 2H),
1.78 – 1.68 (m, J=6.3, 5H), 1.60 – 1.50 (m, 2H), 1.49 – 1.35 (m, 4H).
13C NMR (75 MHz, CD3OD) d = 173.73, 155.25, 154.00, 151.44,
147.59, 145.22, 139.80, 130.70, 124.67, 121.65, 108.41, 107.88, 73.17,
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70.49, 69.81, 69.75, 69.70, 69.55, 69.42, 69.02, 68.09, 55.46, 44.15, 38.87,
32.09, 31.78, 31.73, 28.88, 26.09, 24.83, 24.73, 20.34.
HR MS (ESI pos.) m/z: calculated for C40H60ClN2NaO17+ [M+Na]+:
912..3503, measured 912.3469.
5.6 synthesis of compound 9 ha-peg(7)-pl-bg
OCl N
H7 O
O
O O
NO2
O
O N
N N
H
NH2N
O
N
H
9
Ha-peg(7)-pl-BG
Compound 8 (94.58 mg, 106.2 µmol, 1.0 eq.) was dissolved in dry
DMF (2 ml, 0.05 M) under Ar at RT. 6-((4-(Aminomethyl)benzyl)oxy)-
9H-purin-2-amine (31.68 mg, 116.8 µmol, 1.1 eq.) and triethylamine
(29,6 µl, 212.4 µmol, 2 eq.) were mixed in dry DMF (1.5 ml, 0.06 M)
and the homogenous suspension was added dropwise to the solu-
tion of compound 8 and stirring continued over night at RT under Ar
in the dark. All volatile components were removed under reduced
pressure and the crude product was purified via FC on silica gel
(DCM:MeOH 50:1 v/v). 35.93 mg (33 %) of a yellow oil were obtained
from the pooled pure fractions (checked by TLC). Analytic RP-HPLC
revealed 91 % purity (retention time = 25.43 min). The extinction co-
efficient at l=280 nm of Ha-peg(7)-pl-BG (9) was assumed to be the
same as for Ha-pl-BG (1) due to the same functional moieties: Ha-
peg(7)-pl-BG#280= 11.3 mM-1cm-1. Ha-peg(7)-pl-BG was dissolved in
dry DMSO. A serial dilution was used to determine the concentration
of this stock solution by measuring the absorption at l=280 nm.
1H NMR (500 MHz, CD3OD) d 7.85 (s, 1H), 7.61 (s, 1H), 7.44 (d, J =
8.1 Hz, 2H), 7.26 – 7.20 (m, 2H), 7.15 (s, 1H), 6.28 (q, J = 6.4 Hz, 1H),
5.57 – 5.46 (m, 2H), 4.32 – 4.15 (m, 2H), 4.08 (t, J = 6.2 Hz, 2H), 3.85 (s,
3H), 3.62 – 3.59 (m, 18H), 3.59 – 3.54 (m, 6H), 3.54 – 3.51 (m, 4H), 3.45
(t, J = 6.6 Hz, 2H), 3.37 (d, J = 5.4 Hz, 1H), 2.42 (t, J = 7.4 Hz, 2H), 2.11
(p, J = 6.7 Hz, 2H), 1.77 – 1.70 (m, 2H), 1.60 – 1.53 (m, 5H), 1.46 – 1.40
(m, 2H), 1.39 – 1.33 (m, 2H).
13C NMR (126 MHz, CD3OD) d = 173.98, 160.24, 156.53, 154.23,
147.24, 139.59, 139.18, 135.52, 133.99, 128.22, 126.97, 108.82, 107.95,
70.73, 70.10, 70.09, 70.07, 70.04, 69.83, 69.72, 69.17, 68.60, 68.33, 67.22,
55.46, 44.33, 43.71, 39.03, 32.33, 32.06, 29.13, 26.32, 25.08, 25.04, 21.00.
HR MS (ESI pos.) m/z: calculated for C47H69ClN8NaO15+ [M+Na]+:
1043.4463, measured 1043.4434.
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M O L E C U L A R C L O N I N G
6.1 general remarks
Bacteria were cultured in selective LB medium for plasmid amplifi-
cation and protein expression (see section 7.2). Antibiotics were dis-
solved in water (Ampicillin 100 mg/ml, Kanamycin 50 mg/ml) and
stock solutions were stored at -20 °C. LB medium was freshly supple-
mented with antibiotics (final concentration Ampicillin 100 µg/ml,
Kanamycin 50 µg/ml (30 µg/ml for low copy number plasmids).
Plasmids were purchased from Addgene as agar stabs of transformed
bacteria or provided by colleagues and collaboration partners as pu-
rified plasmids in water. pFC20A HaloTag T7 SP6 FlexiVector was
purchased as lyophilized powder from Promega (Promega GmbH,
Mannheim). Single stranded oligonucleotides (primer, see Appendix
XY: Cloning Primer List) were purchased from IDT (Integrated DNA
Technologies, BVBA, Leuven) with standard desalting purification.
DNA modifying enzymes, buffer and master mixes were purchased
from NEB (New England Biolabs GmbH, Frankfurt am Main). Lin-
ear DNA fragments were evaluated via agarose gel electrophoresis
using SERVA DNA Stain Clear G (SERVA Electrophoresis GmbH,
Heidelberg) supplemented agarose gels and visualization on a UV-
Transilluminator (peqlab GmbH, Erlangen). DNA purification was
done with kits purchased from Qiagen (QIAGEN GmbH, Hilden).
Concentration and purity (A260/280) of eluated DNA was measured
with a NanoDrop ND-1000 photo-spectrometer (peqlab). All gener-
ated plasmids were sent to Seqlab (Microsynth Seqlab, Göttingen) to
check correct assembly of all ligation sites via Sanger sequencing us-
ing sequencing primers (see Appendix B.1.2) or standard sequencing
primers provided by Seqlab.
6.2 plasmid preparation and restriction digest
Purified plasmids were transformed into chemocompetent E. coli DH5a
via heat-shock transformation. 49 µl bacteria suspension were mixed
with 1 µl plasmid solution (10-100 ng/µl in water) and incubated for
5 min on ice. Then the mixture was heated to 42 °C for 45 seconds
in a waterbath and directly put back on ice for another 2 min. 1 ml
prewarmed (ca. 37 °C) LB medium was added and the bacteria were
incubated at 37 °C with 300 rpm shaking for 1 h. The bacteria were
plated on selective LB-agar and incubated overnight at 37 °C. A single
colony was picked and used to inoculate 10 ml selective LB medium
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and grown over night at 37 °C, 150 rpm shaking. The overnight cul-
ture was used for preparation of glycerol stocks and plasmid purifi-
cation using the QIAprep Spin Miniprep Kit. Glycerol stocks were
made by mixing 500 µl of the bacteria suspension with 500 µl 80 %
glycerol and kept at -80 °C for long term storage. Overnight cultures
for plasmid purification were innoculated directly from the glycerol
stocks if available.
Enzymes and buffers for restriction digests were used according
to the manufacturers instruction. In case the small fragment was
 50 bp, the linearized plasmid was prurified using the QIAquick
PCR Purification Kit. Otherwise the large fragment was purified via
gelextraction using the QIAquick Gel Extraction Kit.
6.3 polymerase chain reaction
PCRs were set up using Q-5 High Fidelity 2X Master Mix following
the manufacturers instructions. Annealing temperatures were calcu-
lated using the online tool NEB Tm Calculator (v1.9.13). Elongation
times were adjusted according to the expected fragment length and
the polymerase fidelity. If the recommended annealing temperature
was 72 °C, the PCR protocol was set up as a 2-step protocol combining
annealing and elongation as one step with a reaction time of the cal-
culated elongation time plus 10 seconds. After PCR the reaction mix
was supplemented with DpnI and incubated overnight to degrade
template plasmids. PCR fragments were purified using the QIAquick
PCR Purification Kit or via gelextraction using the QIAquick Gel Ex-
traction Kit in case of side product formation.
6.4 gibson assembly, transformation and plasmid purifi-
cation
All plasmids were produced via restriction site independent cloning
according to Gibson et al. [127](so called Gibson Assembly) using
the Gibson Assembly 2X Master Mix following the manufacturers
protocol. 1 µl of the assembly mix was added to 49 µl suspension of
electrocompetent E. coli DH5a on ice. The mixture was transferred
into a prechilled 1 mm electroporation cuvette and shocked with 200
W, 25 µFd and a pulse of 1.8 kV/cm using a Gene Pulser Xcell electro-
porator (BioRad). The cells were immediately provided with 1 ml pre-
warmed LB medium and incubated for 1 h before they were plated
on selective LB agar plates and incubated overnight at 37 °C. The
next day, single colonies were picked for amplification in selective LB
medium and plasmid purification as described in 4.2. Plasmids veri-
fied for the correct sequence were re-transformed into chemocompe-
tent E. coli DH5a for plasmid preparation using the HiSpeed Plasmid
Kit following the manufacturers instructions.
7
P R O T E I N E X P R E S S I O N A N D P R O C E S S I N G
7.1 general remarks
EC12 proteins were expressed with an N-terminal 6xHis tag followed
by a modified TEV-cleavage site for affinity based purification and
subsequent proteolytic processing to obtain the correct N-terminus.
Protein concentrations were measured with a NanoDrop ND-1000
photo-spectrometer (peqlab). Purification and processing were evalu-
ated via SDS-PAGE and Western blot analysis (detailed protocol see
section 8.1 and 8.2). The Äkta HPLC system and IMAC columns were
washed and kept under 20 % ethanol after purifications.
7.2 protein expression
Plasmids pNB01 and pNB02 were transformed into E. coli KRX (Pro-
mega, Mannheim) via the heat-shock protocol described in section
6.2. 10 ml selective LB medium was inoculated as starter culture with
a single colony picked from a selective LB agar plate or directly from
a glycerol stock and incubated overnight at 37 °C with rigorous shak-
ing. The starter culture was used to inoculate a 1 l expression culture
of selective LB medium. The expression culture was incubated at 37
°C with rigorous shaking until it reached an OD600 of 0.8-1 and then
supplemented with 0.1 % w/v rhamnose to induce protein expression
in KRX cells. The bacteria suspension was cultivated for additional
4 h under the before mentioned conditions. The expression culture
was cooled to 0-4 °C on ice and pelleted by centrifugation with 6400
rcf for 10 min at 4 °C. The supernatant was discarded and the pellet
was stored at -80 °C or kept on ice to proceed directly with protein
purification.
7.3 protein purification
The pellet from the protein expression culture was resuspended in 20
ml pre-chilled lysis buffer (Buffer A supplemented with 0.1 M PMSF
protease inhibitor). The bacteria were ruptured with ultrasound us-
ing an Omni Ruptor 400 sonicator with 40 % power and pulser of
50 for 10 min on ice. The lysate was centrifuged with 174200 rcf for
30 min at 4 °C. The supernatant was carefully decanted and filtered
through a 0.45 µm cellulose filter.
The cleared supernatant was loaded onto a 5 ml IMAC column
(HisTrap, GE Healthcare) using the fully automated Äkta HPLC sys-
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tem (Äkta pure 25 M) equipped with a 50 ml superloop, UV-Vis detec-
tor and fraction collector, operated with UNICORN Control Software
v.6.3 ( GE Healthcare). The purification was performed at a constant
flow rate of 3 ml/min with buffer A (loading buffer) and buffer B
(elution buffer) as mobile phase in different mix ratios. Before load-
ing, the column was equilibrated with 4 column volumes (CV) buffer
A. After loading the cleared supernatant, impurities were washed out
with 5 CV buffer A. The liquid phase was changed to 20 % v/v buffer
B in buffer A for 8 CV to wash out unspecifically bound proteins be-
fore running a gradient from 50 % to 100 % v/v buffer B in buffer A
over 5 CV to elute the His tag bound protein. During the elution step,
automated peak fractioning according to the slope change of the ab-
sorption value at l=280 nm was activated. The column was washed
with 6 CV buffer B and equilibrated with 6 CV buffer A for the next
run.
The collected fractions were pooled and the buffer was exchanged
to TEV buffer using Amicon Ultra-15 Centrifugal Filter tubes with a
molecular cut off of 10 kDa (Merck Milipore). Therefore, the protein
solution was reduced to ca. 200 µl and washed with 10 ml TEV buffer
for three times. Finally, the protein was concentrated to 120 µM in
TEV buffer.
7.4 tev protease processing and re-purification
To achieve the correct N-terminus of EC12 proteins the His tag was
removed proteolytic treatment with TEV protease according to a pro-
tocol adapted from Ritterson et al.[128]. 1 µg of the purified EC12-
GFP-Halo protein was diluted in 150 µl TEV buffer and 50 µl TEV
protease (10 U/µl, invitrogen) was added. The reaction mixture was
split in two fractions and incubated for 72 h at 4 °C (fraction 1) or
RT (fraction 2). To remove the processed His tag and the protease
(also carrying a His Tag) samples were purified using the Äkta HPLC
system equipped with a 500 ml sample loop and a 1 ml IMAC col-
umn (both GE Healthcare) operated with a constant flow rate of 1
ml/min. The column was equilibrated with 5 CV buffer A to obtain
a stable baseline signal for the absorption at l=280 nm. When the
sample was loaded onto the column, the flow through was collected
manually until the absorption at l=280 nm reached the baseline in-
tensity again. The column was washed with additional 5 CV buffer A
before running a gradient from 50 % to 100 % v/v buffer B in buffer
A over 5 CV to elute the processed His tag and the protease. The
eluate was collected manually. The column was washed with addi-
tional 5 CV buffer B and equilibrated with buffer A. The collected
flow through was concentrated with Amicon 0.5 Centrifugal Filter
tubes (Merck-Millipore) with a molecular cut off of 10 kDa and the
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eluate was concentrated with the Amicon Ultra-15 Centrifugal Filter
tubes.
In a second approach 200 µg purified EC12-GFP-Halo protein was
incubated with 10 µl TEV protease at RT (sample 1) or 16 °C (sample
2) in a total volume of 40 µl. Additionally two samples were prepared
according to the manufacturers protocol with 200 µg protein and 10
µl TEV protease in 1.5 ml TEV buffer (prepared from 20x TEV buffer
(invitrogen) supplemented with 1 mM DTT) and also incubated at RT
(sample 3) or on ice (sample 4). All samples were incubated for 72 h.
Ni-NTA-His-Bind Resin (Novagen) was used to remove the pro-
tease, cleaved His-tag and undigested protein from the samples. 100
µl resin was added to the digestion mix and incubated at 4 °C with
constant agitation for 30 min. The resin was spun down for 30 sec-
onds with 15 000 g and the supernatant containing the processed
protein was removed carefully. The resin was washed 3x with 200 µl
TEV buffer and then incubated with elution buffer B for 5 min at RT.
The supernatant was removed carefully after pelleting the resin via
centrifugation at 15 000 g for 30 seconds.
7.5 dimerizer treatment of ec12 proteins
The processed and re-purified EC12 proteins were pre-incubated with
an excess of Ha-BG or Ha-peg(7)-pl-BG and washed afterwards to
achieve optimal dimerizer binding efficiency. The amount and vol-
umes were adjusted to the yield of the respective processed protein
batch. In detail, 1.4 nmol EC12-GFP-Halo (45 µl, 2.67 µg/µl) were
incubated with 2.5 nmol Ha-BG (0.5 µl, 5 mM) for 15 min at RT. The
proteins were washed 3x with 200 µl PBS using Amicon 0.5, 10 kDa
tubes and finally concentrated to a 50 µM stock solution in 25 µl PBS.
For Ha-peg(7)-pl-BG decorated EC12-GFP-Halo 0.6 nmol processed
protein (60 µl, 9.5 µM) was mixed with 1 nmol of the dimerizer, in-
cubated and washed as described above and finally concentrated to a
10 µM stock solution in 50 µl PBS.
The dimerizer decorated EC12 proteins were kept at 4 °C for maxi-
mum 24 h before using them in live cell experiments.
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B I O C H E M I C A L A N A LY S I S
8.1 sds-page
Cells grown to 80-90 % confluence were washed twice with PBS, put
on ice, submerged with prechilled RIPA lysis buffer supplemented
with 0.5 mM EDTA and 1 % (v/v) Halt Protease and Phosphatase
Inhibitor cocktail (all ThermoFisherScientific) and kept overnight at -
80 °C. The lysate was defrosted on ice and collected with a cell scraper.
Cell debris was pelleted via centrifugation at 4 °C with 14 000 rpm
for 30 min, the supernatant was removed carefully and stored at -20
°C or used directly for SDS-PAGE analysis.
For qualitative analysis of purified proteins from bacterial expres-
sion or processing steps, samples were concentrated using Amicon
0.5 Centrifugal Filter tubes or diluted in their respective buffer to
achieve comparable amounts of protein per samples (maximum 4
µg/sample).
Samples were mixed with self made SDS sample buffer (5:1 v/v)
or 4x NuPAGE LDS Sample Buffer and 10x Sample Reducing Agent
(13:5:2 v/v, ThermoFisherScientific) and denatured for 10 min at 95
°C. The samples and Novex Sharp Pre-stained Protein Standard (Ther-
moFisherScientific) were loaded onto a Novex 4-12 % Bis-Tris PAGE
gel (ThermoFisherScientific) mounted in the XCell SureLock Mini-
Cell SDS-Electrophorese system equipped with a PowerEase 90 W
power supply and filled with MOPS SDS Running buffer (ThermoFish-
erScientific). Electrophoresis was done with constant voltage (200 V
const., max. 120 mA) for 40-90 min according to the molecular weight
of the target protein.
After electrophoresis PAGE gels were used for Western blot (see
section 8.2) or stained with coomassie blue. The later was done by
briefly boiling the gel in comassie blue solution, rinsing 2x with wa-
ter and shaking the gel in comassie destaining solution over night.
Images of Comassie stained gels were taken using a Amersham Im-
ager 600RGB (GE Healthcare) with with white light epi illimination.
8.2 western blot and immunochemiluminescence detec-
tion
Following SDS-PAGE proteins were transferred from the gel onto a
methanol activated nitrocellulose membrane (ThermoFisherScientific)
using the XCell SureLock Mini-Cell equipped with a XCell Blot Mod-
ule mounted according to the manufacturers recommendations. Blot-
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ting was performed as wet blot in NuPAGE Transfer Buffer supple-
mented with 10 % (v/v) methanol with constant voltage (30 V const.,
maximum 220 mA) for 1 h. Successful transfer was validated via
transiently staining the membrane with Ponceau Red solution.
To avoid unspecific antibody binding, the membrane was blocked
with 3 % BSA in TBS-T (w/v) for minimum 1 h at RT. Primary anti-
bodies (see table 4.3.1) were diluted 1:1000 - 1:5000 (v/v) according
to the manufacturers recommendations in TBS-T with 1 % BSA (w/v)
and incubated on the membrane overnight at 4 °C. The antibody so-
lution was recovered and kept at -20 °C for later reuse and the mem-
brane was washed 3x for 10 min with TBS-T at RT. HRP-coupled sec-
ondary antibodies were diluted 1:5000 (v/v) in TBS-T with 1 % BSA
(w/v) and incubated on the membrane for 1 h at RT. Excess secondary
antibodies were removed via 3x washing for 10 min with TBS-T at RT
before incubating the membrane with ECL solution (GE Healthcare).
The chemiluminescent signal was recorded using an Amersham Im-
ager 600RGB in chemiluminescence mode with semiautomated expo-
sure time.
8.3 immunofluorescence staining
Cells cultivated on round glass cover slips (? 12 mm, #1, Menzel)
were washed twice with phenol red-free DMEM without supplements
and fixed by perfusion with 4 % paraformaldehyde (PFA) and incu-
bation for 20 min at RT. Fixed cells were washed twice with PBS
and kept in PBS supplemented with 1 % PenStrep at 4 °C protected
from light or used directly for indirect immunofluorescence staining.
Therefore, fixed cells were permeabilized by incubation with 0.1 %
Triton X-100 in PBS for 5 min at RT, blocked with 1 % BSA in PBS
for 1 h and incubated with the primary antibody in 1 % BSA in PBS
overnight at 4 °C. The next day, cells were washed three times for 10
min with 1 % BSA in PBS before adding the secondary antibody and
optional with a fluorophore coupled phalloidin. After washing three
times for 10 min, samples were mounted in Mowiol. If no Alexa 350
or Alexa 405 conjugated antibody was used, 1 % DAPI was added to
the Mowiol before mounting the cells.
Images were taken with a Leica DM6000B upright fluorescent mi-
croscope equipped with a CCD camera (Leica DFC365 FX) and a 63x
oil objective (HC PL APO, NA 1.4).
8.4 bead aggregation assay
To confirm functionality of recombinant expressed EC12-GFP-Halo
the protein was immobilized on magnetic beads do perform a bead
aggregation assay. 150 µl suspension of Halo ligand functionalized
beads (Magne HaloTag Beads, Promega) were washed twice with 200
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µl PBS and then incubated with 100 µl processed EC12-GFP-Halo (fi-
nal concentration 0.46 µg/µl) for 1 h at RT with 800 rpm shaking.
Fractions of the protein solution were taken before and after incuba-
tion with the beads and analyzed via SDS-PAGE.
The EC12-GFP-Halo loaded beads were diluted in 1000 µl TB buffer
and split in two fraction. One sample was supplemented with 2 mM
Ca2+ by adding 1 µl CaCl2 stock solution (1 M), the other served as
Ca2+ free control. Both samples we incubated for 1 h at RT with
800 rpm shaking then carefully transferred in a chambered coverslip
(Nunc, ThermoFisher Scientific) and analyzed microscopically.
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L I V E C E L L I M A G I N G
9.1 cell lines and culture conditions
A431, BT549, MDA-MB 231, MCF-7 and MDCK.2 cells were pur-
chased from atcc. A431 a-catenin KO cells were a kind gift from
Takuya Kato (Francis Crick Institute, London). A431D and MDCK
E-cadherin KO cells were provided from René-Marc Mège (Univer-
sité Paris Diderot & CNRS, Paris). COS7 cells were a courtesy from
Ulrike Engel (University of Heidelberg, Heidelberg)
All cells were maintained in growth medium consisting of Dul-
becco’s modified Eagle’s medium (DMEM), high glucose supplemen-
ted with GlutaMAX, sodium pyruvate, 10 % fetal bovine serum (FBS)
and 1 % penicillin–streptomycin, at 37 °C with humidified 5 % CO2
atmosphere. Stable transfected cells were maintained in selection
medium (DMEM, high glucose supplemented with GlutaMAX, sodium
pyruvate, 10 % FBS and 750 µg/ml active Geneticin). Medium was
exchanged every two to three days.
Cells were passaged by washing twice with PBS (Ca2+ and Mg2+
free), incubated for 5-10 min with 0.25 % trypsin-EDTA (ThemoFish-
erScientific) and resuspended in full medium in the desired density
in a new flask. For experiments cells were counted with a Neubauer
Haematometer or a Countess II FL Automated Cell Counter (The-
moFisherScientific) according to the manufacturers instructions. The
cells were pelleted, resuspended in an appropriate volume of growth
medium and seeded in the desired vessel. For Western blot analysis
cells were seeded in 6 well plates (2*105 -106 cells per well according
to the cell type). For indirect immunofluorescence staining cells were
seeded on glass cover slips (? 12 mm, #1, Menzel) in a 6 well plate
(4-5 cover slips per well, cell density as for western blot). For live cell
experiments, cells were seeded on glass bottom petri dishes ((#1.5
cover slip, ibid, Martinsried), 8 well chambered cover glass (nunc
Lab-Tek, ThermoFisherScientific) or in µ-channel slides (µ-Slide VI
0.4, ibidi) and incubated over night under standard conditions before
performing the actual experimental procedure.
9.2 transfection methods
9.2.1 Non-liposomal transfection reagent
Cells were seeded in 8 well chambered cover slips (5*104 cells per
well) or µ-channel slides (3*104 cells per channel) and incubated over
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night to reach 60-70 % confluency. The transfection mixture was pre-
pared according to the manufacturers protocol by diluting a total
amount of 200 ng plasmid DNA in 10 µl Opti-MEM (ThermoFisher-
Scientific), adding another 10 µl Opti-MEM supplemented with 0.8 µl
PromoFectin transfection reagent (PromoCell, Heidelberg) and gentle
flipping. The mixture was added drop wise to a well or injected into
a µ-channel. Cells were incubated over night under standard condi-
tions.
9.2.2 Electroporation
Electroporation was performed using the Amaxa Nucleofector I De-
vice (Lonza, Cologne). A431 a-catenin KO and A431D cells were
transfected with Amaxa Cell line Nucleofector Kit T (program X-01;
Lonza), MDCK.2 and MDCK E-Cadherin KO cells were transfected
with Amaxa Cell line Nucleofector Kit L (program A-24; Lonza) fol-
lowing the manufacturers protocol. In brief, 106 cells were resus-
pended in 100 µl nucleofection solution with supplement, 2 µg plas-
mid DNA was added and the mixture was transferred into an electro-
poration cuvette (4 mm slit, provided in the kit). After the pulse, 500
µl prewarmed growth medium was added and the cells were injected
directly into a µ-channel or transferred into a well of a 6 well plate
containing 1 ml growth medium for antibiotic selection.
9.3 generation of stable cell lines
Cells transfected with plasmids carrying a neomycin selection marker
(neoR+) for expression in mammalian cells, were incubated in selec-
tion medium containing geneticin from one day after transfection.
Antibiotic selection was done until all cells of a geneticin sensitive
control sample died (usually 10-14 days). In case of morphological
changes (e.g. less diffraction in phase contrast mode due to increased
cell-cell adhesion) selected cell colonies were carefully detached with
accutase (ThermoFisherScientific) picked with a micropipette, resus-
pended in growth medium and transferred into separated wells of a
12 well plate. The cells were incubated under standard conditions to
form new colonies and the procedure was repeated 3-4 times until all
colonies showed the desired phenotype.
9.4 fluorescence activated cell sorting
In case transfected cells did not change their morphology or high
expression levels were intended, antibiotic selected cells were sorted
via fluorescence activated cell sorting (FACS) using a BD FACSAria III
with 4 lasers (407/488/561/633), 11 colors (3-2-4-2) configuration (BD
Biosciences, Heidelberg; performed in the ZMBH Flow Cytometry &
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FACS Core Facility) or a BD FACS Melody with 3 laser (488/561/640),
8 colors (2-2-4) configuration.
After trypsinization, cells were resuspended in FACS buffer to a
maximum number of 3*106 and sorted into a 6 well plate containing
2 ml growth medium per well or into FCAS tubes containing 1 ml
growth medium. Sorting was performed in purity mode selecting for
high expression of the respective fluorescent marker protein. Cells
sorted into plates were allowed to settle down for 2-3 h before ex-
changing the medium. Cells sorted into FACS tubes were washed
with growth medium and seeded directly for live cell experiments or
transferred into a cell culture flask.
9.5 live cell labeling and imaging
Transiently transfected or stable cells seeded for live cell imaging ex-
periments were kept in imaging medium (FluoroBrite DMEM, high
glucose supplemented with GlutaMAX, sodium pyruvate, 10 % FBS
and 1 % penicillin–streptomycin or 750 µg/ml active geneticin) at 37
°C with humidified 5 % CO2 atmosphere during all live cell imaging
experiments.
Cells were imaged with a Leica DMi8 inverted fluorescent wide-
field microscope equipped with a X-Cite 200DC light source (200
W), a sCMOS camera (Leica DFC9000GT) using either 10x objective
(HC PL FLUOTAR, NA 0.32, PH1) or 63x objective (HC PL APO
CS2, NA 1.40 OIL UV) or a DeltaVision Elite system installed on an
Olympus IX inverted fluorescence wide-field microscope equipped
with a SPECTRA X light engine, a cooled CCD camera (CoolSNAP
HQ/ICX285) and a custom built CO2 and temperature controlled in-
cubator using either a 10x objective (Zeiss 10X/0.30), a 20x objective
(Zeiss 20 X/0.50) or a 60x objective (Olympus 60X/1.40).
For live cell labelling of self-labelling tags the cells were incubated
for 30-60 min with the respective ligand coupled fluorophore (see ta-
ble 9.1) diluted 1:1000 from the respective DMSO stock, washed three
times with growth medium, incubated for 30 min and washed three
times with imaging medium. Actin staining in living cells was done
via incubation with 1 mM SiR-actin (SpiroChrom, Stein am Rhein) for
minimum 1 h. The cells were washed with imaging medium directly
before transferring them to the microscope.
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Table 9.1: ligand coupled fluorophores. Self made * = provided by Wom-
bacher’s Lab
Name Binding tag Fluorophore Cat. No Company
SNAP-Oregon-
SNAP Oregon-Green S9104S NEB
Green
SNAP-
SNAP Atto 488 S9124S NEB
Surface 488
Ha-diAcFl Halo Fluorescein self made *
Ha-TMR Halo
Tetramethyl- self made *
rodhamine
9.6 extracellular e-cadherin complementation
In a µ-channel slide A431D cells stably expressing SNAP-E-cadherin345-
mCherry were incubated with Ha-peg(7)-pl-BG bound EC12-EGFP-
Halo protein (also see chapter 7) diluted in imaging medium in con-
centrations of 1 µM, 500 nM, 50 nM and 5 nM and non-transfected
A431D cells were incubated with 1 µM Ha-peg(7)-pl-BG bound EC12
protein. After 2 h the protein solution was removed and the cells
were washed with imaging medium. After re-administration of the
protein solutions, cells were incubated over night. The next day, the
cells were imaged 1 h after washing with imaging medium.
9.7 characterization of intracellular dimerization and
photocleavage
9.7.1 Dimerization conditions
Dimerizers were diluted in imaging at least 1:1000 from the respec-
tive DMSO stock. Cells were washed with imaging medium be-
fore adding the dimerizer solution. To test the optimal conditions
for intracellular chemically induced dimerization, A431D cells tran-
siently transfected with Halo-GFP-Mito+ mCherry-SNAPf or Halo-
GFP-Mito+mCherry-DHFR via electroporation (see section 9.2.2) were
incubated with the respective dimerizer in different concentrations
with and without washing in a µ-channel slide. For details about
concentrations and incubation times of the various dimerizers please
refer to tables listed in section 10.3.2. Dimerization efficiency was
evaluated according to the sequestration of mCherry protein on the
mitochondria via fluorescence live cell microscopy using the DeltaVi-
sion microscope system.
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For reconstitution of AJs in cells stably expressing Ec-GFP-Halo
and SNAP-mCherry-a(280-906) 200 nM Ha-pl-BG or 40 nM for Ha-
BG were used, respectively.
9.7.2 Photocleavage in the whole field of view
To define minimal light intensities for efficient cleavage of the dimer-
izer, cells A431D cells transiently transfected with Halo-GFP-Mito+
mCherry-SNAPf were incubated with 200 nM Ha-pl-BG for 6 h in
a µ-channel slide. Using the DMi8 microscope system with the 63x
objective, cells that showed efficient sequestration of mCherry pro-
tein at the mitochondria were exposed to repetitive 20 ms pulses of
near UV light (DAPI filter l=350/50, 100 % intensity). Images were
taken between each pulse in green and red fluorescence channel to
follow the signal distribution of the GFP and mCherry proteins. Ex-
posure conditions that lead to an efficient release of mCherry protein
from the mitochondria were tested on cells treated with 40 nM Ha-
BG to validate stability of the protein complexes induced with the
non-cleavable dimerizer and general photo-toxic effects under these
conditions.
Cells stably expressing Ec-GFP-Halo and SNAP-mCherry-a(280-906)
treated with Ha-pl-BG were exposed to 4x20 ms near UV light with
the before mentioned parameters to dissolve AJs.
9.7.3 Photocleavage in defined pattern
Cleaving dimerizer in defined pattern was done using the DMi8 mi-
croscope system equipped with a 405 nm laser (40 mW) in a Leica
Infinity Scanner FS and QSP-T filter cube.
For cleaving with subcellular precision, the 63x objective and ND
100 % was used. Intensities were tested as desired above for photo-
cleavage in the whole field of view by stepwise decreasing the spot
size or increasing laser power, scan speed and the number of itera-
tions. Dissociation of AJs in defined subcellular regions in A431 a-
catenin KO cells stably expressing Ec-GFP-Halo and SNAP-mCherry-
a(280-906) treated with Ha-pl-BG was performed with 10 % laser
power, scan speed 10, spot size 0.68 µm and 20 iterations.
The 10x objective and ND 100 % was used to cleave the dimerizer in
defined subregions of a cellular monolayer. A431 a-catenin KO cells
with Ha-pl-BG reconstituted AJs were scanned with increasing laser
power, scan speed and the number of iterations or decreasing spot
size. Efficient cleavage of the dimerizer was determined indirectly via
morphological changes of the targeted cell, which is increased diffrac-
tion in Phase contrast mode due to dissociation of the AJs. A431 a-
catenin KO cells with Ha-BG reconstituted AJs were used to confirm
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that the morphological changes were not induced by phototoxic or
unspecific cellular stress reactions.
In collective migration and traction force microscopy experiments
50 % laser power, scan speed 10, spot size 1.54 µm and 20 iterations
were used. The parameters were validated for each experimental
setup with changes in the optical path (e.g. cells in glass coverslip
or on hydrogels).
9.8 collective migration analysis
9.8.1 Experimental procedure
One well silicone culture-inserts (ibidi, cut 2 well inlet, growth area
0.22 cm2) were placed in a glass bottom culture dish (#1.5 coverslip,
ibidi). 4 x 104 cells were seeded in 80 µl growth medium and incu-
bated overnight in standard culture conditions. The growth medium
in the inlet was replaced with growth medium containing the dimer-
izer and incubated for 4 - 6 h. The inlet was removed and cells
were carefully washed with phenol red-free DMEM and the dish was
finally filled with imaging medium with or without the dimerizer.
Phase contrast images were taken with the Leica DMi8 microscope
using the 10x objective 2x2 binning in 5 min intervals starting 1 h
after removing the inlet.
9.8.2 Data analysis
Displacement vectors of moving cells between two consecutive phase
contrast images were calculate using a custom-made PIV algorithm.[129–
131] In brief, the images were drift corrected using cell free areas as
reference for image alignment. The signal-to-noise ratio set to 1.3 and
threshold for normalized mean to 2.0. If necessary the two values
were adjusted according to the image quality. An absolute displace-
ment cut off was set that was four times higher as the extrapolated
mean displacement to reduce high noise peaks. The image pairs were
subdivided into 32x32 pixel interrogation windows with 50 % overlap
for displacement comparison. Displacement vectors were calculated
for the whole field with a nodal distance of 16 pixel (equals 20.7 µm
grid space) using cubic splines based interpolation. Displacement
vector fields were displayed in pixel values (setting microns per pixel
value to 1.0).
The correlation length of the lateral velocity displacement vectors
were then calculated using a custom-made MatLab script as described
by Das et al.[123] with modifications for analysis of continuous time
lapse recordings. Displacement vectors were divided by the time dif-
ference between two successive frames to convert them into velocity
vectors. Velocity vectors rij were allocated to the central coordinates
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Table 9.2: Gel mixtures for TFM measurements [µl]
Young´s Modulus [kPa] 0.2 6
PBS 450.25 386.53
Acrylamide 40% 37.5 93.72
Bis-acrylamide 2% 7.5 15
Beads 2 2
APS 10% 2.5 2.5
TEMED 0.25 0.25
(i, j) of each 16x16 pixel window. Each vector consist of a lateral
component (Uij, along the migration front e.g. perpendicular to the
dominant direction of cell migration) and an axial component (Vij,
perpendicular to the migration front). The fluctuations along and
perpendicular to the migration front (uij, vij) were calculated as:
uij = Uij   å
i=1,m
å
j=1,n
Uij/(m n) = Uij  Umean (9.1)
vij = Vij   å
i=1,m
å
j=1,n
Vij/(m n) = Vij  Vmean (9.2)
With Umean and Vmean being the mean velocities along and perpen-
dicular to the migration front. Since axial migration perpendicular
to the migration front is intrinsically highly correlated in the chosen
experimental setup, only the lateral velocity correlation function was
calculated as:
Cr =
hu(r´) u(r´ + r)ir´phu(r´)2i  hu(r´ + r)2i (9.3)
with h. . .i being the average and r being the norm of rij, which is
r =k rij k. The lateral correlation diameter was defined as the point
where the lateral correlation function (3) reaches the lower threshold
of 0.01.
9.9 traction force microscopy
9.9.1 Preparation of gels
Preparation of gels for traction force microscopy (TFM) was done
as described previously [132, 133]. In brief, glass bottom dishes
(#0 coverslips, Cellvis) were incubated for 15 min with 7.14 % 3-
(trimethoxysilyl)propyl methacrylate (Sigma) and 7.14% acetic acid
diluted in ethanol (v/v/v). The surfaces were washed twice with
ethanol and dried carefully.
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Polyacrylamide (PAA) gels containing dark red fluorescent carboxy-
lated polystyrene beads were casted on methacrylate activated sur-
faces. For imaging of cell monolayer migration 0.5 µm beads (Fluo-
resbrite 641, Polysciences) were used, whereas TFM experiments of
small cell clusters were performed on gels containing 0.2 µm beads
(FluoSpheres (660/680), ThermoFisherScientific). In order to achieve
different stiffnesses of the gel mixtures were prepared as shown in ta-
ble 9.2 resulting in 3% acrylamide with 0.03% bis-acrylamide in PBS
for 0.2 kPa gels and 7.5% acrylamide with 0.06% bis-acrylamide in
PBS for 6 kPa gels with 0.05% ammonium persulfate (APS) as radical
starter and a catalytic amount of N,N,N´,N´-tetramethylethylenediamine
(TEMED). 22 µl of the mixture were placed on an activated surface
and covered with an 18 mm round coverslip to generate a flat surface.
The gel was polymerized for 1 h at RT and then submerged with PBS
for 30 min before lifting the coverslip with a scalpel.
The gel surfaces were coated with collagen type I (from rat tail,
Millipore) to facilitate cell adhesion. 75 µl of a 2 µg/µl solution
of the photoreactive cross-linker sulphosuccinimidyl-6-(4´-azido-2´-
nitrophenylamino) hexanoate (Sulfo-SANPAH, ThermoFisherScientific)
in water was added onto the gel and activated by exposure to UV
light (l= 365 nm, 15 W, 3 cm distance). The gel was washed twice
with 10 mM HEPES buffer for 3 min on the orbital shaker, covered
with 500 µl of a collagen type I solution (100 µg/ml in PBS) and incu-
bated over night at 4 °C.
9.9.2 Experimantal procedure
The collagen coated gels were washed vigorously with PBS. One well
silicone culture-inserts that had been submerged with 1 % (w/v) BSA
in PBS for 30 min were placed carefully in the center of a gel. As de-
scribed for collective migration analysis, 4 x 104 cells were seeded in
80 µl growth medium and incubated in standard culture conditions
until cells attached to the surface. The dimerizers were added and
incubated for 6-8 h or overnight to allow the cells to form an intact
monolayer. 1 h prior to imaging, the inlet was removed and the cells
were washed with phenol red free medium before adding the respec-
tive dimerizer dissolved in imaging medium.
The migrating cellular monolayer was imaged in phase contrast
mode and the position of the beads underneath the surface of the gel
was recorded in fluorescent mode using the relative focus control of
the DMi8 microscope equipped with the 10x objective and the 405 nm
laser. Images were taken with 2x2 binning in 5 min intervals for 2-4
h before cleaving the dimerizer in defined regions of the monolayer
as described in section 9.7.3. Image recording continued for another
2-4 h before trypsinizing the cells and taking reference images of the
position of the beads in the relaxed gel.
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9.9.3 Data analysis
Displacement of the beads was calculated using the custom-made PIV
algorithm already presented for collective cell migration analysis (sec-
tion 9.8.2), but comparing each image of the time lapse series with the
reference image. Additionaly to the parameters described in section
9.8.2 the Young´s modulus of the respective gel was entered and the
Poisson´s ratio was set to 0.5. For TFM analysis the actual pixel size
of 1.295 µm per pixel was used to calculate displacement vectors in a
grid space of 20.7 µm. Traction forces were reconstructed from these
vectors via regularized Fourier Transform Traction Cytometry[134]
with a regularization parameter chosen by Generalized Cross Vali-
dation [135] that was kept constant for all frames of one time lapse
recording. For TFM analysis of migrating monolayers padding was
set to 1.0 to circumvent edge problems (i.e. the recorded field of view
was mirrored in all directions along the edge of the image). In case of
small cell clusters a Tukey awas used instead and adjusted to reduce
the influence of cell free areas whithout effecting areas where the gel
was deformed by the cells.
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T O O L D E V E L O P M E N T
10.1 halo and snap tagged target proteins can be dimer-
ized inside living cells
Since the goal was the reconstitution of mechanotransductive protein
complexes, the first aim was to achieve mechanically stable protein-
protein interaction that are interlinked in a covalent-covalent manner.
Motivated by the previous results using Halo and DHFR tagged pro-
teins and data presented by the Wymann lab[55, 56] the first attempt
was to increase the length of the peg linker between the chlorhexane
and benzylguanin moieties. Erhardt et al. could double the dimer-
ization rate of intracellular SNAP and Halo tagged proteins via ex-
tending the linker by one ethylene glycol (EG) and one CH2-CH2
bond[55]. The photocleavable dimerizer presented by Zimmermann
et al. is highly similar to Ha-pl-BG, but has a linker that is three ethy-
lene glycol units longer[56]. Therefore, the photocleavable dimerizer
Ha-peg(7)-pl-BG was synthesized in a 5 step reaction as described in
figure10.1. 20-Azido-3,6,9,12,15,18-hexaoxaicosan-1-ole was coupled
to 6-chloro-1-iodohexane to form compound 5 and the azide group
was hydrolyzed to obtain compound 6. The terminal amino group
of compound 6 was then connected to the terminal carboxyl group
of the O-nitrobenzyl linker in a standard peptide coupling reaction
to yield compound 7. The amino-methyl functionalized benzylgua-
nine was then coupled under basic conditions to the hydroxy group
of compound 7 via the carbamate activated carboxylic acid ester inter-
mediate 8. Analysis via HR-MS, NMR and RP-HPLC confirmed the
composition und purity of compound 9 (Ha-peg(7)-pl-BG ).
Sequencing revealed that the previously used human O6-alkylguanine-
DNA alkyltransferase (hAGT) (previously sold by Covalys as SNAP
tag) carried mutations for improved substrate binding compared to
endogenous hAGT, but was missing mutations for decreased affinity
towards DNA and improved protein stability after substrate bind-
ing [136, 137]. Thus, in a second attempt the hAGT sequence in the
hAGT-mCherry plasmid was replaced with an improved SNAP tag
sequence. The new generated SNAP-mCherry plasmid was cotrans-
fected with a plasmid coding for TOMM20-Halo in COS7 and REF52
cells. The Halo tagged TOMM20 localizes at the outer mitochondrial
membrane whereas the SNAP tagged mCherry is expressed cytosoli-
cally. As shown in figure 10.2 a), after addition of 10 µM Ha-peg(7)-
pl-BG the SNAP-mCherry protein is sequestered at the mitochondria
indicated by significantly increased fluorescent intensity compared
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Figure 10.1: Synthesis of Ha-peg(7)-pl-BG.
The photocleavable dimerizer Ha-peg(7)-pl-BG was assembled in a five
step reaction. Reagents and conditions: a) THF:DMF 7:1, NaH, 0 °C-RT,
overnight. b) MeOH:EtOAc 5:1, Pd/C, H2, RT, 4 h. c) 1. DMF, 4-[4-
(1-Hydroxyethyl)-2-methoxy-5- nitrophenoxy]butyric acid, PyBOP, RT, 2 h;
2. 6, DIPEA, RT, overnight. d) DCM, 4-nitrophenyl chloroformiate, pyri-
dine, RT, 4 h. e) DMF, 6-((4-(Aminomethyl)benzyl)oxy)-9H-purin-2-amine,
triethylamine, RT, overnight.
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a) b)
Figure 10.2: Ha-peg(7)-pl-BG induces the sequestration of SNAP-
mCherry via dimerization with TOMM20-Halo that is re-
versed upon exposure to UV light.
a) In COS7 cells transiently expressing the cytosolic target protein SNAP-
mCherry and the mitochondrial localization doamin TOMM20-Halo addi-
tion of the photocleavable dimerizer Ha-peg(7)-pl-BG induces sequestra-
tion of SNAP-mCherry at the mitochondria. b) Exposure to UV light (1
s, l=390/18 nm) cleaves the dimerizer and releases sequestered SNAP-
mCherry into the cytosol. Inserts are contrast adjusted 3x zoom of the white
outlined area in the main image. Scale bar: 20 µm.
to the cytosolic background. Reversibility of the sequestration was
demonstrated by exposure to UV light figure 10.2 b). Comparisons
of Ha-peg(7)-pl-BG and the shorter Ha-pl-BG in their ability to in-
duce binding of SNAP-mCherry to TOMM20-Halo in cotransfected
cells revealed that the sequestration activity of the shorter dimerizer
was slightly faster and reached similar levels in efficiency. Further-
more, efficient sequestration could be found also for reduced dimer-
izer concentrations of 1 µM for both dimerizer. A quantitative analy-
sis was not applicable because the sequestration rate varied dramat-
ically from cell to cell because of different ratios of expression levels
of SNAP-mCherry and TOMM20-Halo proteins. This was most likely
due to a high variation in the uptake of the two cotransfected plas-
mids.
10.2 the combination of halo, snap and dhfr tagged pro-
teins allows multiplexed dimerization
The next aim was to test the possibility for multiplex sequestration of
target proteins through combination of the SNAP/Halo setup with
the previously established DHFR/Halo setup. Three plasmids coding
for TOMM20-Halo, SNAP-mCherry and EGFP-DHFR, respectively,
were introduced into COS7 and REF52 cells via transient transfec-
tion. Sequentially, addition of 1 µM Ha-peg(7)-pl-BG induced the se-
questration first of SNAP-mCherry at the mitochondria while EGFP-
DHFR remained cytosolic (see figure 10.3 a) and subsequent addition
of 1 µM Ha-pl-TMP also recruited EGFP-DHFR to the mitochondria
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Figure 10.3: SNAP and DHFR tagged proteins are sequestered subse-
quently via dimerization with a Halo tagged localization do-
main and released simultaneously by UV light.
REF52 cells transiently expressing SNAP-mCherry, EGFP-DHFR and
TOMM20-Halo show a) mitochondrial sequestration of SNAP-mCherry, but
not EGFP-DHFR after addition of Ha-peg(7)-pl-BG. b) Only after addition
of Ha-pl-TMP, EGFP-DHFR dimerizes with TOMM20-Halo and is cose-
questered at the mitochondria with SNAP-mCherry. c) Irreadiation with
UV light (1 s, l=390/18 nm) cleaves the dimerizers and simultaniously re-
leases both proteins. Inserts are contrast adjusted 3x zoom of the white
outlined area in the main images. Scale bars: 20 µm.
as shown in figure 10.3 b). Exposure to UV light released both target
proteins coinstantaneously by cleaving the photo linker of Ha-peg(7)-
pl-BG and Ha-pl-TMP. Similar results could also be obtained using
Ha-pl-BG in combination with Ha-pl-TMP. Note that combinations
of the photocleavable dimerizers used in these experiments with the
photostable dimerizers Ha-BG or Ha-TMP in principle would also
allow to release only one of the target proteins after the sequential re-
cruitment to a Halo tagged interaction partner. Therefore, multiplex
dimerization offers a variety of combinatorial possibilities and has a
great potential in studying the effects of protein-protein interactions
or for applications in synthetic biology[51].
10.3 dimerization with bifunctional small molecules
demands for stoichiometric optimization
To reach maximum efficiency for chemically induced dimerization
each target protein would need to bind one dimerizer and one local-
ization domain. Despite the fact that cotransfection of monocistronic
plasmids offers high flexibility in testing different combinations target
proteins as presented in chapter 11, it leads to the problem of stoichio-
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Figure 10.4: Expression from bicistronic vectors enables highly efficient
sequestration of cytosolic target proteins.
DLD1 R2/7 cells expressing Halo-GFP-Mito and mCherry-DHFR after tran-
sient transfection with the bicistronic plasmid Dual ctrl1 show virtually com-
plete sequestration of mCherry-DHFR after administration of Ha-pl-TMP.
The cytossolic localization of mCherry-DHFR after irreadiation with UV
light (1 s, l=390/18 nm) proves that the mitochondrial sequestration was
specifically induced by Ha-pl-TMP treatment. Scale bar: 20 µm.
metric mismatch of dimerization proteins expressed in the cell. If the
cytosolic target protein is expressed in high excess compared to the
localization domain, the amount of sequestered protein might not be
detectable in the high cytosolic background even if 100 % of the local-
ization domains bind a target protein. Apart from that, the number of
dimerizers needs to be carefully adjusted as well. Self-evidently, the
tagged proteins cannot form hetero-dimers if no or too little dimer-
izer is present. But on the other hand, an excess of dimerizer leads to
an increased number of monomeric reacted SNAP and Halo tagged
species, because if both proteins bind one dimerizer each, they cannot
for a hetero-dimer either.
10.3.1 Use of bicistronic vectors optimize expression level ratios
To make sure each of the target proteins is expressed in every trans-
fected cell, ideally the sequences coding for both proteins is intro-
duced via one bicistronic vector. For example, the protein coding re-
gions can be connected via a viral Internal Ribosome Entry Site (IRES).
Depending on the expressing cell type this leads to a 1:1 expression
or an excess of the upstream construct. Ballister et al. [57] presented
a construct were the Halo and GFP tagged localization domain (Halo-
GFP-Mito) is cloned upstream and the DHFR tagged mCherry target
protein (mCherry-DHFR) downstream of the IRES in one plasmid.
DLD1 R2/7 cells were transiently transfected with this plasmid and
incubated with 1 µM Ha-pl-BG. As shown in figure 10.4virtually com-
plete sequestration of DHFR tagged mCherry was achieved.
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10.3.2 High dimerizer doses impair protein complex formation
The bicistronic Halo-GFP-Mito and mCherry-DHFR coding plasmid
(in the following called Dual ctrl1) was used to test optimal concen-
trations and incubation times for the dimerizers Ha-TMP and Ha-pl-
TMP. The molecules were administered to the transiently transfected
A431D cells and the samples were checked after 1 h and after 3 h.
Then the dimerizer were washed out and the samples were checked
after 1 h, after 2 h and after 16 h. Sequestration efficiencies were
rated qualitatively on a scale form “+” (barely detectable) to “+++++”
(virtually complete). The results are presented in table 10.1 and 10.2.
Interestingly the larger molecule Ha-pl-TMP had a much better se-
questration efficiency compared to the photostable Ha-TMP in the
tested concentrations. Ha-pl-TMP shows excellent sequestration ef-
ficiency for all tested concentrations. The slight decrease after 3 h
compared to 1 h for high concentrations indicates an oversaturation
of dimerizer i.e. formation of monomeric reacted Halo and DHFR
tagged species. This interpretation is further supported by the fact
the sequestration efficiency reached the maximum level again after
washing out the excess dimerizer allowing new expressed proteins to
bind the monoreacted species. For early timepoints Ha-TMP shows
a much weaker and slower sequestration rate. This could be either
to a lower cell permeability or an impaired binding of the two inter-
action partners. In case of low permeability, higher concentrations
should lead to better results, but for the highest concentration tested
here (20 µM Ha-TMP) no sequestration could be detected before re-
moving excess dimerizer. Instead, the sequestration rate increased
moderate with longer incubation, but continued rising even after the
dimerizer was washed out reaching maximal level for 0.2 µM con-
centration. For 20 µM Ha-TMP a good sequestration rate was found
only 16 h after washing. Therefore, it was concluded that Ha-TMP
has a good cell permeability and that high concentrations led to a
complete oversaturation. The slow turn on could be explained with
an impaired binding of two proteins, which might be because of ster-
ical hindrance due to the short linker between the Halo ligand and
the TMP moiety. To test also the optimal incubation conditions for
Ha-BG and Ha-pl-BG the DHFR tag in Dual ctrl1 was replaced with
a SNAP tag. According to the procedure desired for Dual ctrl1 the
resulting plasmid Dual ctrl2 was introduced into A431D cells and in-
cubated with Ha-pl-BG and checked after 1 h and 3 h. After washing
the samples were checked after 2 h and 16 h. The results are shown
in table 10.3. Optimal sequestration was found with 1 µM Ha-pl-BG
after 3 h incubation and 2 h after washing. Similar to Ha-pl-TMP high
concentrations led to lower efficiency after 3 h compared to 1 h incu-
bation but slowly recovered after washing. Low concentrations gave
good results after longer incubation and after washing. Therefore, it
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Table 10.1: Testing optimal concentration and incubation time for Ha-pl-
TMP.
Time Ha-pl-TMP concentration
point 0 nM 8 nM 40 nM 0.2 µM 1 µM 5 µM
After 1 h - +++++ +++++ +++++ +++++ +++++
addition 3 h - +++++ +++++ +++++ ++++ +++
After 1 h - +++++ +++++ +++++ +++++ ++++
washing
2h - +++++ +++++ +++++ +++++ +++++
16 h - +++++ +++++ +++++ +++++ +++++
Table 10.2: Testing optimal concentration and incubation time for Ha-
TMP.
Time Ha-TMP concentration
point 0 nM 40 nM 0.2 µM 1 µM 5 µM 20 µM
After 1 h - - + + - -
addition 3 h - + +++ +++ ++ -
After 1 h - +++ +++++ ++++ ++++ -
washing
2 h - ++++ +++++ +++ +++ -
16 h - ++++ +++++ ++++ ++++ +++
was tested if lower concentrations could lead to efficient dimerization
after longer incubations. Dual ctrl2 expressing cells were constantly
incubated with Ha-pl-BG or Ha-BG and checked after 1 h, 3 h, 5 h
and 8 h. To test how long the complexes are stable, the cells were
washed after 24 h and checked again the next day. Results shown
in tables10.4 and 10.5 confirm that even nanomolar concentrations of
Ha-pl-BG and Ha-BG con induce efficient dimerization without sat-
uration effects. Furthermore the formed complexes are stable for at
least 24 h after removing the dimerizer solution. Ha-peg(7)-pl-BG
was not considered for detailed testings of incubation conditions, be-
cause Ha-pl-BG showed sufficient dimerization efficiency.
In summery, the combination of expression from bicistronic vec-
tors and longer incubation with nanomolar dimerizer concentrations
led to reproducible formation of protein complexes that are stable
for up to 48 h.The covalent-non-covalent binding dimerizers Ha-pl-
TMP and Ha-TMP led to faster and more efficient dimerization over
a broad range of concentrations, whereby Ha-TMP might work effi-
ciently even in lower doses then the ones tested. But also the covalent-
covalent binding Ha-pl-BG and Ha-BG showed significant formation
protein hetero-dimers that should be stable stable even under high
tensile forces. In respect of the planned experiments, this gives flex-
ibility to study the processes of cell adhesion and migration even in
long time lapse experiments.
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Table 10.3: Testing optimal concentration and incubation time for Ha-pl-
BG.
Time Ha-pl-BG concentration
point 0 nM 40 nM 0.2 µM 1 µM 5 µM 20 µM
After 1 h - - + ++++ +++ ++
addition 3 h - + +++ +++++ ++++ +
After 2 h - +++ ++++ +++++ ++++ +
washing 16 h - +++ +++ ++++ ++++ ++
Table 10.4: Testing long term incubation and Ha-pl-BG induced complex
stability.
Time Ha-pl-BG concentration
point 0 nM 1.6 nM 8 nM 40 nM 200 nM 1 µM
1 h - - - + + ++
After 3 h - - - + +++ +++
5 h - - + ++ +++ +++
addition 8 h - - + ++ +++ +++
24 h - - + ++ +++ ++++
48 h - - + ++ ++++ +++++
Table 10.5: Testing long term incubation and Ha-BG induced complex sta-
bility.
Time Ha-BG concentration
point 0nM 0.32 nM 1.6 nM 8 nM 40 nM 200 nM
1 h - - - - - +
After 3 h - - + ++ +++ +++
5 h - - + ++ ++++ ++++
addition 8 h - - ++ +++ ++++ ++++
24 h - - ++ ++++ +++++ +++++
32 h - - ++ ++++ ++++ ++++
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P R O T E I N S
Having established the method of protein sequestration via photo-
cleavable dimerizers, the next aim was to test potential target proteins.
Therefore, three different concepts of how to apply the dimerizer tool
were investigated. The first concept was based on retention of target
proteins. The was idea to prevent proteins from reaching their place
of activity by trapping them in a cellular compartment where they
have no function. A big advantage of this concept is, that the proteins
only need to be fused with self-labelling tag and are fully functional.
This conforms to a functional knock down without perturbations of
the expression levels or protein structure. Thus, it is applicable for
a broad range of target proteins even without detailed knowledge
about the structure of their binding sites for interacting proteins. Fur-
thermore, when proteins that are active e.g. at the plasma membrane,
are sequestered at the outer mitochondrial membrane, their turn on
after release would be limited only by diffusion through the cytosol.
This should allow to study even processes with super high turn on
kinetics.
In contrast, the second concept was built on recruitment of tar-
get proteins. Known binding sites of interacting proteins could be
replaced with the self labelling tags. This would put the protein-
protein interaction under control of the presence of a dimerizer. Ad-
vantageous of this approach would be a very low background activ-
ity, since the proteins should not be able to interact without dimer-
izer. Additionally, protein complexes induced by the photocleavable
dimerizer could be dissolved with ultra high spatiotemporal resolu-
tion, therefore giving the possibility to study fast turn off effects.
The third concept was the dimerizer induced complementation of
split proteins. Proteins that are interlinking other proteins in a multi-
protein complex via different domains that are structurally indepen-
dent from each other (i.e. domain A is folding correctly without do-
main B and vice versa), could be expressed as two separate constructs.
If each is carrying a self labelling tag at the position of the missing
domain, dimerization of the two domains should also reconstitute the
interlinking function of the protein. The advantage compared to the
second concept would be that only one protein needs to be geneti-
cally modified to control the formation of the targeted multi-protein
complex.
Different target proteins were tested for their potential as a switch
for cell adhesion following the three concepts “retention”, “recruit-
ment” and “complementation”. Each target protein was fused with a
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self-labelling tag and a fluorescent protein to to follow its cellular lo-
calization and translocation in live cell experiments. Although it had
been shown that bicistronic vectors can improve the expression ratios
of two dimerizer targeted proteins, cotransfection of monocistronic
vectors was the method of choice, because it offers a higher flexibility
to test various combinations of potential target proteins. The most
promising combinations were then to be cloned into a bicistronic vec-
tor for further experiments.
11.1 retention of focal adhesion proteins
The FA complex proteins vinculin and paxillin were chosen as targets
for the retention approach. Terminal fluorescent fusion proteins are
well established and do not effect their functionality [111, 112, 138,
139]. Since proteins are constantly exchanged with a cytosolic pool
even in mature FAs[106, 138, 140], it should be possible to sequester
the full amount of expressed protein over time. The final goal was
to retain vinculin and paxillin within the same cell and release them
separately or together as a stimulus to increase cell-matrix adhesion.
Therefore, vinculin was fused N-terminally with DHFR tag while pax-
illin was equipped with N-terminal SNAP tag. To follow the seques-
tration and reintegration into FAs after release EGFP and mCherry
were inserted with the tag, respectively. In a first step, each protein
was transiently expressed together with a Halo tagged TOMM20 in
COS7 and REF52 cells. The mitochondria in COS7 cells are particu-
larly large, which is favorable for sequestration. REF52 cells however
form large and well defined FA structures, which should be easier
to detect after releasing the proteins. Using the fluorescently labeled
TOMM20-mCherry-Halo was very helpful for evaluating if the vin-
culin accumulations found after dimerizer treatment were still in FA
structures or sequestered on the mitochondria by overlaying the two
fluorescence signals (see figure 11.1 a). The mCherry in TOMM20-
mCherry-Halo was exchanged with EGFP to achieve an easier dis-
crimination for paxillin localization as well (figure 11.1 b).
Both target proteins could successfully be sequestered at the mi-
tochondria after addition of the respective dimerizer. But from the
overlay it was also visible that a significant amount remained in the
cytosol, of which some fraction did integrate in FA structures as in-
dicated by the clusters that do not overlap with the mitochondrial
signal.
An attempt to improve sequestration efficiency was to replace the
DHFR tag with a modified mutant that is destabilizing the protein
it is fused with when it is not bound to TMP[141]. The aim of this
DD tag was to have the level of vinculin low before the dimerizer is
added and stabilize only those proteins that are bound to a dimer-
izer. When releasing the sequestered DD tagged vinculin by cleaving
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Figure 11.1: Efficiency of vinculin and paxillin retention via sequestration
at the mitochondria is not high enough to prevent incorpora-
tion in FAs.
a) Sketch of the Ha-pl-TMP induced protein dimer of TOMM20-mCherry-
Halo and DHFR-EGFP-vinculin. b) REF52 cells transiently expressing
DHFR-EGFP-vinculin and TOMM20-mCherry-Halo show vinculin accumu-
lation at the mitochondria and in FAs after incubation with Ha-pl-TMP.
Vinculin sequestered at the mitochondria appears in yellow in the over-
lay of mCherry (mitochondria) and the GFP (vinculin) signal, while clus-
ters in FAs appear in green. c) Sketch of the Ha-pl-BG mediated dimer
of TOMM20-EGFP-Halo and SNAP-mCherry-paxillin fusion proteins. d)
REF52 cells transiently expressing SNAP-mCherry-paxillin and TOMM20-
EGFP-Halo show accumulations of paxillin at the mitochondria and in FAs
after incubation with Ha-pl-BG. Mitochondrial located paxillin appears in
yellow in the overlay of mCherry (paxillin) and the GFP (mitochondria) sig-
nal, while clusters in FAs appear in red. Inserts are contrast adjusted 3x
zoom of the white outlined area in the main images. Scale bars: 10 µm.
Sketches not to scale.
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the dimerizer the TMP moiety should stay bound to the DD tag and
the released proteins should stay stabilized. As shown in supple-
mentary figure A.1, the DD tag is binding Ha-pl-TMP and can be
translocated to the mitochondria, but apparently the destabilizing ef-
fect is not strong enough to reduce the level of tagged vinculin to the
desired level.
Furthermore it was tried to remove the fraction of tagged pro-
teins integrated in FAs. Cells coexpressing DHFR-EGFP-vinculin and
TOMM20-mCherry-Halo were treated with accutase. This enzyme
mix is detaching cells by digesting matrix proteins like collagen, but
preserves most of the proteins on the cell surface, allowing a fast reat-
tachment of the cells as soon it is removed. By detaching the cell
from the surface, FAs should be dissolved and all vinculin should be
cytosolic. In presence of the dimerizer the cytosolic pool should be
sequestered before they can reintegrate in FAs. When seeding cells
detached with accutase in presence of Ha-pl-TMP, no DHFR-EGFP-
vinculin was found at the mitochondria, but integrated in FAs.
At this stage of the project it was shown that functional vinculin
and paxillin can be sequestered at the mitochondria in living cells.
However, to achieve a functional knock down a very high efficiency
in sequestration would be necessary, which could not be achieved
under the tested parameters. As discussed before, the expression
ratio of target to localization domain is a critical parameter for an ef-
ficient sequestration. Although the two plasmids were cotransfected
in ratios 1:2 (target:TOMM20) the amount of target protein appeared
to be always much higher then what could be sequestered on the
mitochondria. Expressing target and localization domain from a bi-
cistronic vector could help to overcome this problem. But to achieve
a functional change in cell-matrix adhesion this system should be ap-
plied in cells that do not express an endogenous pool of the respective
target protein (KO cells). Such cells were currently not at hand.
11.2 recruitment of adherens junction proteins
For the recruitment concept adherens junctions were chosen as target
structures. The linear connection between E-cadherin and F-actin via
the CCC complex offers good potential and multiple variabilities in
replacing protein-protein binding domains. Since the final goal was
to control cell-cell adhesion via dimerizer induced formation of AJs, a
cell line had to be chosen, that is deficient of AJs but can form stable
cell-cell contacts if the missing components are introduced. Therefore,
the expression levels of AJ components were analyzed for a variety of
cell lines (see Figure 11.2). REF52 cells are rat fibroblasts and express
only very low levels of all tested adhesion components. They served
as models for mesenchymal cells that show no features of an epithe-
lial phenotype. BT549, MDA-MB 231 and MCF-7 cells are epithelial
11.2 recruitment of adherens junction proteins 85
E-cadherin
N-cadherin
α-catenin
β-catenin
β-actin
125 kDa
83 kDa
130 kDa
160 kDa
58 kDa
102 kDa
92 kDa
43 kDa
REF52 BT549 MDA-MB 231 MCF-7 A431
Figure 11.2: Expression levels of adherens junctions components are de-
pendent on the cell type.
The expression levels of all AJ components are reduced in REF52 fibroblasts.
Expression patterns of E-cadherin and N-cadherin are varying between the
epithelial cell lines BT549, MDA-MB 231, MCF-7 and A431 wild type cells
(A431) depending on their respective degree of cancer progression, while a-
and b-catenin levels are not effected. b-actin serves as loading control.
breast cancer cells that are widely used as models for different stages
of EMT. While MCF-7 cells do express high levels of E-cadherin and
show an epithelial like phenotype, BT549 cells switched completely
to N-cadherin expression and are phenotypically mesenchymal as
they grow as single cells (see supplementary figureA.2). MDA-MB
231 cells reflect an intermediate stage of EMT, since they do not ex-
press E-cadherin nor N-cadherin and show a mesenchymal pheno-
type without strong cell-cell connections (also supplementary figure
A.2). A431 cells are epidermoid carcinoma cells with a strong epithe-
lial phenotype that is also reflected in high levels of E-cadherin and
no N-cadherin expression. All four epithelial cells show similar ex-
pression rates of a- and b-catenin. Furthermore, E-Cadherin deficient
mutants of A431 (A431D) and gene edited A431 a-catenin knock out
cells were used to test the dimerizer induced recruitment of AJ pro-
teins. For a detailed description of the A431 mutants, please refer to
section 12.1. A431 wild type (WT) and knock out (KO) cells were diffi-
cult to transfect and thus cotransfection of two monocistronic vectors
for testing target proteins was not possible. Therefore, the cloned fu-
sion proteins were tested in REF52, MDA-MB 231 and MCF-7 cells for
stability and functionality via expression after transient transfection
and the most promising candidates will be tested in A431 KO cells
for their ability to rescue the morphology of the wild type phenotype.
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Figure 11.3: E-cadherin-Halo mutants localize in the plasma membrane
and can be stained with Halo ligand conjugated fluorophores.
a) Full length E-cadherin-EGFP-Halo, b) the b-catenin binding site (Db-
ctnBS) depleted mutant E-cadherin-Db-ctnBS-EGFP-Halo and c)+d) mutants
deficient of all protein binding site of the cytosolic domain E-cadherin-
Dcyto-mCherry-Halo and E-cadherin-Dcyto-EGFP-Halo are found to local-
ize in the plama membrane upon expression in MDA-MB 231 cells and can
be fluorescently labelled at their Halo tag via treatment with a)+b)+d) 5 µM
Halo-TMR or c) 1 µM Halo-Fl. Sketches above the fluorescence images illus-
trate the respective fusion protein constructs. Scale bar is 20 µm. Sketches
not to scale.
The first step was to test if the c-terminal intracellular domain
of E-cadherin (aa578-728), which includes the b-catenin binding site
(aa677-706), can be replaced with a Halo tag. Two variants were
tested, replacing only the b-catenin binding site (Db-ctnBS, truncation
at aa694-706) or the full cytosolic tail (truncation at aa583-706). For
analysis in live cell fluorescence microscopy EGFP or mCherry were
inserted with the Halo tag. A full length E-cadherin with N-terminal
EGFP and Halo tag served as positive control. To confirm function-
ality of the Halo tag the cells were stained with the cell permeable
fluorophores Halo-TMR or Halo-Fl. As shown in figure 11.3 all Halo
tagged E-cadherin mutants could be expressed and stained success-
fully. They are predominantly located in the plasma membrane and
vesicular clusters inside the cells as expected for transmembrane pro-
teins. The signal is higher at cell-cell contact areas of two transfected
cells due to an overlap of plasma membranes form both cells. In-
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Figure 11.4: SNAP-mCherry-b-catenin is found in the cytoplasma and nu-
cleus and can be labeled with fluorophore coupled SNAP lig-
ands.
a) Illustration of the labeling of a SNAP-mCherry-b-catenin fusion pro-
tein with the fluorescent SNAP tag substrate BG-OregonGreen. b) SNAP-
mCherry-b-catenin expressed in MDA-MB 231 shows high nuclear accumu-
lation. Incubation with 5 µM BG-OregonGreen leads to efficient labeling of
the SNAP tag and accumulation of the synthetic fluorophore, but not SNAP-
mCherry-b-catenin in vesicular structures (green spots in the overlay). Scale
bar 10 µm. Sketch not to scale.
terestingly, the E-cadherins without cytosolic domain (figure 11.3 c)
and d)) seem to be more stable then the full length (figure 11.3 a)) or
the Db-ctnBS mutant (figure 11.3 b)). Nevertheless, if fluorescently
tagged b-catenin was expressed together with full length E-cadherin-
EGFP-Halo both proteins accumulated in cell-cell contact areas of co-
transfected cells thereby indicating a functional interaction (see sup-
plementary figure A.3 a)).
In a second step, the catenins were evaluated for their potential as
target proteins. b-catenin was N-terminally fused with a SNAP and
mCherry tag, expressed in MDA-MB 231 cells (figure 11.4) and MCF-
7 cells (supplementary figure A.3) and stained with the SNAP ligand
BG-OregonGreen. In MDA-MB 231 cells the protein was found in
the cytosol and nucleus, whereas in MCF-7 cells it showed a strong
association with the plasma membrane. This reflects the behavior of
endogenous b-catenin in the absence or presence of functional AJs
(see also figure 12.2). Coexpression with E-cadherin-EGFP as shown
in supplementary figure A.3 resulted in co-accumulation of both pro-
teins, proofing that tagging of both, E-cadherin and b-catenin does
not interfere with their natural ability to bind to each other.
Remarkably, only low expression rates of the b-catenin construct
could be achieved. Higher loads of plasmid and transfection agents
led to increased cell death when transfecting the SNAP-mCherry-b-
catenin plasmid, while control transfections with e.g. SNAP-mCherry
showed high transfection rates. Thus, high expression of exogenous
b-catenin seemed to be cytotoxic in these cells.
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Figure 11.5: SNAP-mCherry-b-catenin colocalizes with E-cadherin-Db-
ctnBS-EGFP-Halo only after incubation with Ha-pl-BG.
a) Coexpressed in REF52 cells the membrane localized E-cadherin-Db-ctnBS-
EGFP-Halo and the cytosolic SNAP-mCherry-b-catenin show no colocal-
ization. b) After addition of the Ha-pl-BG SNAP-mCherry-b-catenin is re-
cruited to clusters of E-cadherin-Db-ctnBS-EGFP-Halo. A Ha-pl-BG induced
dimers is illustrated on top. c) Exposure to UV light cleaves the dimerizer
and reverses colocalization of E-cadherin-Db-ctnBS-EGFP-Halo and SNAP-
mCherry-b-catenin.
The white frames indicate areas shown as zoom on the right next to the
images. Scale bars: 10 µm; 5 µm for the zoomed images. Sketches not to
scale.
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Finally, E-cadherin-Db-ctnBS-EGFP-Halo and SNAP-mCherry-b-catenin
were coexpressed in REF52 cells and treated with Ha-pl-BG dimer-
izer (figure 11.5). Without the dimerizer (figure 11.5 a)) the b-catenin
binding deficient E-cadherin was membrane localized and showed
increased signal in cell-cell contact areas due to overlapping plasma
membrane structures, but could not form defined clusters. The b-
catenin on the other side was found in high levels in the cytosol
and nucleus, but not enriched at the plasma membrane. However,
after incubation with 5 µM Ha-pl-BG (figure 11.5 b) b-catenin colo-
calized with E-cadherin rich structures at the interface of cotrans-
fected cells. The well defined colocalization could be dissolved via
UV light exposure (1 s, l=390/18 nm), proofing that the recruitment
of SNAP-mCherry-b-catenin to E-cadherin-Db-ctnBS-EGFP-Halo was
specifically induced by the photocleavable dimerizer. Thus, the inter-
action of E-Cadherin and b-catenin was chemically reconstituted and
could be abrogated with light.
Since REF52 cells do express only very low levels of a-catenin, func-
tional AJ complexes could not form. The coexpression of E-cadherin-
Db-ctnBS-EGFP-Halo and SNAP-mCherry-b-catenin in MDA-MB 231
cells was not possible, because of cytotoxicity as discussed earlier in
this section. This could be explained with the relatively low level
of endogenous b-catenin found REF52 in comparison to cells MDA-
MB 231 cells. Therefore, the level of recombinant expressed b-catenin
alone did not reach a critical level REF52 cells, while the combination
of high endogenous expression combined with exogenous expression
is killing MDA-MB 231 cells.
a-catenin, the third component of the minimal AJ complex was
tested as a target for chemically induced protein complex formation.
To overcome the problems of b-catenin overexpression encountered
in the previous setup, the aim was to recruit a-catenin directly to E-
cadherin. As discussed in section2.2.1, fusion proteins of E-cadherin
and a-catenin had been shown to maintain the connection to the
actomyosin network although they do not contain b-catenin bind-
ing sites.[96, 142] Such a chimeric construct could be obtained from
the Troyanovsky lab. E-cadherin-Dcyto-GFP-a-catenin(280-906) (short
EcGFP-a(280-906)) contained an E-cadherin that was truncated from
aa596 and an a-catenin lacking the first 279 aa connected via GFP. That
means the E-Cadherin is missing the cytosolic domain including the
binding sites for b-catenin and p120-catenin and a-catenin is missing
the N-terminal domain, that is responsible for binding to b-catenin
and homodimerization. To put the formation of this E-cadherin-a-
catenin complex under control of a dimerizer a Halo tag with a stop
codon, an IRES sequence and a SNAP-mCherry tag were inserted be-
tween GFP and a-catenin. The resulting plasmid was a bicistronic vec-
tor for co-expression of Ec-GFP-Halo and SNAP-mCherry-a(280-906)
that could be tested directly in A431 knock out cells. When A431D
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Figure 11.6: Dimerizer induces the formation of E-cadherin-a-catenin com-
plexes, that cluster along cell-cell contact areas and dissipate
after illumination with UV light.
a) The sketch shows the expected protein complex that forms via Ha-pl-
BG mediated binding between E-cadherin-Dcyto-EGFP-Halo and SNAP-
mCherry-a(280-906). Indeed, A431D cells expressing the tailless E-cadherin-
Dcyto-EGFP-Halo and SNAP-mCherry-a(280-906) from a bicistronic vector
show strong colocalization of the two fusion proteins at the cell-cell contact
areas after incubation with Ha-pl-BG. b) The Ha-pl-BG mediated dimers
are decomposed upon UV light illumination. SNAP-mCherry-a(280-906) is
released into the cytosol and E-cadherin-Dcyto-EGFP-Halo forms transient
irregular clusters while the cells are drifting apart from each other.
Scale bar 10 µm. Sketches not to scale.
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cells transfected with this plasmid were incubated with Ha-pl-BG, not
only colocalization of Ec-GFP-Halo and SNAP-mCherry-a(280-906)
was induced , but the E-cadherin-a-catenin complex formed linear
cluster along the cell-cell contact areas (figure 11.6 a). When cleaving
the dimerizer with UV light (figure 11.6 b)), the a-catenin construct
was immediately released form the linear clusters and the cells de-
tached forming elongated tethers between them. These tethers were
particularly visible because of the high content of the E-cadherin con-
struct. Furthermore, the small cluster of cells seemed to fall apart
according to the position of the nuclei, which is supporting the im-
pression that the linear clusters were holding the cells together.
In summary, the recruitment of AJ proteins is a promising way
to control cell-cell adhesion. To confirm that the dimerizer induced
protein complexes do resemble functional adherens junctions further
analysis had to be done (please refer to chapter 12), but at this stage,
recruitment of a-catenin to tailless E-cadherin showed the best per-
formance and was therefore the focus of further experiments. The
recruitment of b-catenin was impaired by several problems. First of
all, high expression of SNAP-mCherry-b-catenin was not possible in
MDA-MB 231 cells presumably to cytotoxic effects. This could be
avoided either by putting SNAP-mCherry-b-catenin expression un-
der the control of a weaker or inducible promotor or making stable
cell lines of cells selected for an tolerated expression level. Further-
more, the E-cadherin-Db-ctnBS-EGFP-Halo fusion protein was less
stable than the tailless E-cadherin constructs. This might be due to
the fact that tailless E-cadherin is also missing structures that are tar-
geted to induce internalization or degradation like two cut sites for
proteases and the two phosphorylation sites in the p120-catenin bind-
ing site[89] (see section ??). In principle, b-catenin recrution could
be facilitated with tailless E-cadherin as well, which would also offer
the possibility to induce a sequential recruitment of b-catenin and a-
catenin by multiplexed dimerization as demonstrated in section 10.2.
A big advantage of the recruitment concept in comparison to the
retention approach is that the complex formation efficiency does not
have to be 100 %. A cytosolic pool of unbound target protein should
be rater buffering high doses of dimerizer then having negative ef-
fects as long the amount of formed clusters is sufficient to induce a
physiological effect.
11.3 complementation of split e-cadherin
Instead of recruiting binding partners to a protein that is deficient of
the endogenous binding domain, it should also be possible to recruit
the separately expressed binding domain and thereby reconstitute the
full functionality of the protein. E-cadherin offers two interesting tar-
get sites for this complementation approach. On the one hand, the
92 definition and evaluation of target proteins
E-cadherin-Δcyto-mCherry-Halo DHFR-EGFP-cytotail overlay
1 
µM
 H
a-
pl
-T
M
P
U
V
 li
gh
t λ
 =
 3
90
 n
m
EC 1-5 TM Halo
Δcyto
mCherry DHFR EGFP cytotail
Ha-pl-TMP
E-cadherin-Δcyto-mCherry-Halo DHFR-EGFP-cytotail overlay
a)
b)
Figure 11.7: Intracellular reconstitution of split E-cadherin via chemically
induced dimerization leads to accumulation at cell-cell con-
tact areas that can be dissolved via UV illumination.
a) Tailless E-cadherin-Dcyto-mCherry-Halo and DHFR-EGFP-cytotail are
connected via Ha-pl-TMP to form a protein dimer, that combines the extra-
and intracellular binding sites of E-cadherin. In REF52 cells this leads to
coaccumulation of the reconstituted E-cadherin at cell-cell contact areas in-
dicated via colocalization (yellow in overlay) of the tailless E-cadherin (red)
and the cytosolic domain (green). b) Exposure to UV light (l= 390 nm)
cleaves the dimerizer and releases the cytosolic domain from its membrane
localization. Scale bars 10 µm. Sketches not to scale.
extracellular domains, that have been shown to be essential for epithe-
lial adhesion (see section ??) and can serve as adhesive ligands even
as recombinantly expressed fragments immobilized on surfaces[143–
145]. On the other hand, the intracellular cytosolic domain that me-
diates the connection to the acto-myosin network via catenins (see
section 2.2.1) and can induce physiological changes if expressed sep-
arately in epithelial cells [146–148].
The intracellular reconstitution of split E-cadherin is technically
similar to the recruitment of binding proteins as described in the pre-
vious section 11.2. The cytosolic domain of E-cadherin (aa578-728)
was fused C-terminally to a DHFR-EGFP construct and expressed in
REF52 cells together with E-cadherin-Dcyto-mCherry-Halo. Treated
with Ha-pl-TMP the GFP tagged cytosolic domain was enriched at
cell-cell interface colocalizing with the mCherry tagged tailless E-
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Figure 11.8: SNAP-E-cadherin345-mCherry is located in the plasma mem-
brane presenting the SNAP tag to the extracellular space.
MCF-7 cells expressing a) SNAP-E-cadherin345-mCherry or b) SNAP-
mCherry were treated with either with BG-OregonGreen (upper row of
fluorescent images) or BG-Surface488 (lower row) for fluorescent labeling
(green) of the SNAP tag. While the cell permeable BG-OregonGreen labels
both proteins, the non-permeable BG-Surface488 in bound only be extracel-
lularely presented SNAP tag of the E-cadherin construct. Scale bars are 10
µm. Sketches not to scale.
cadherin (figure 11.7). Similar to the recruitment of a-catenin(280-906)
to tailless E-cadherin (figure 11.6) the dimerizer induced complexes
accumulated in linear structures along the contact area. After cleav-
ing the dimerizer the cytosolic domain was released immediately and
the accumulation of tailless E-cadherin became less defined, however
no tethers did form nor did the cells change their position relative to
each other. As discussed for the case of b-catenin recruitment, REF52
cells do express only very little amounts of b-catenin and a-catenin.
Therefore, the reconstitution of split E-cadherin might have failed to
induce the formation of AJs in these cells because it could not be
connected to the actomyosin network.
For reconstitution of the extracellular domain the sub-domain 1
and 2 (EC12) were replaced by SNAP tag and expressed in mam-
malian cells, while an EC12-Halo fusion protein was recombinantly
expressed in bacteria. For analysis in live cell experiments, the mam-
malian construct was fused with an intracellular mCherry tag (SNAP-
E-cadherin345-mCherry). The SNAP tag was inserted in exchange of
the EC12 domain (aa1-221) only, i.e. preserving the signal peptide
for localization into the ER lumen and the pro-domain for proteolytic
processing of the N-terminus to achieve extracellular presentation of
SNAP-E-cadherin345-mCherry. Functionality and extracellular local-
ization were tested by expressing SNAP-E-cadherin345-mCherry in
MCF-7 cells and staining it with the cell permeable BG-OregonGreen
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and the non-permeable BG-Surface488 dyes (figure 11.8). SNAP-mCherry
expressing cells served as a control for the non-permeability of BG-
Surface488. While SNAP-E-cadherin345-mCherry was stained with
both dyes, the cytosolic SNAP-mCherry could be stained with BG-
OregonGreen only. Thus, the SNAP tag of the cadherin construct
must be presented on the extracellular side of the plasma membrane.
Note that the high amount of SNAP-E-cadherin345-mCherry in in-
tracellular clusters could be explained with the inability to form ex-
tracellular trans-dimers that stabilize the membrane localization of
E-cadherin. The construct is expected to be highly internalized as
long it is deficient of the EC12 domain, but should stabilize as soon
the extracellular domain is reconstituted.
The EC12 domain was fused C-terminally with a Halo tag (EC12-
Halo) for expression in E. coli. In a second version an EGFP opti-
mized for bacterial expression systems [149] was inserted between the
EC12 and Halo domain (EC12-EGFP-Halo). While EC12-EGFP-Halo
should serve as an easily detectable probe to establish the method,
EC12-Halo was intended to be used in actual live cell experiments.
The proteins carried an N-terminal His tag for purification from the
bacterial expression culture via immobilized metal ion affinity chro-
matography (IMAC). Because the correct processing of the N-terminus
is crucial for trans-dimer formation between extracellular domains of
E-cadherin[95] the His tag was followed by a TEV protease recogni-
tion site (HisTEV, amino acid sequence ENLYFQ’X with ’ being the ac-
tual cut site and X the P1’ residue). According to Ritterson et al.[128]
the P1’ position was changed from serine (S) or glycine (G) in the orig-
inal recognition site to aspartic acid (D) to obtain the right N-terminal
sequence of EC12 after proteolytic processing (see figure 11.9a). Since
the TEV protease used for this purpose also carried a His tag, the mix-
ture could be easily purified via IMAC yielding only processed EC12
protein in the flow through. For the EC12-EGFP-Halo construct the
processing quality was validated via Western blot analysis (figure 11.9
b). Fractions from the purified but unprocessed protein (1), from the
proteolytic reaction (2), the re-purified, processed protein (3) and the
immobilized fraction (4) were detected with an antibody against GFP
(showing processed and unprocessed EC12-EGFP-Halo) and an anti-
body against the His tag (showing unprocessed protein and the TEV
protease). Comparing lane 1 and 2 of the His tag stained membrane,
it is obvious that His tag was efficiently removed from EC12 protein.
The weak band in lane 3 on the His tag stained membrane was most
likely due to unspecific binding of the anti-His tag antibody to the
EC12 construct, because unprocessed protein was immobilized on
the IMAC column in the re-purification. Indeed, lane 4 showed the
pooled and concentrated eluate from the re-purification, which con-
tains the TEV protease and unprocessed EC12 protein. Furthermore,
direct comparison of lane 3 and 4 on the His tag stained membrane re-
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Figure 11.9: Proteolytic processing of EC12 proteins from bacterial expres-
sion generates the endogenous N-terminal sequence.
a) EC12-EGFP-Halo is expressed in bacterial cultures with a N-terminal His
tag, that needs to be removed via proteolytic cleavage with TEV protease. b)
Evaluation of N-terminal processing via immunochemical staining for GFP
and His tag in Western blot analysis: purified HisTEV-EC12-EGFP-Halo
(86.5 kDa, lane 1) is treated with a His tagged TEV protease (30 kDa) in a
proteolysis reaction mix that remeoves the His tag (lane 2). When passed
through an IMAC column only the processed EC12-EGFP-Halo (84.8 kDa)
can be detected in the flow through (lane 3), while the TEV protease and
unprocessed HisTEV-EC12-EGFP-Halo are retained at the column and can
be eluted subsequently (lane 4). anti-GFP staining shows the amount of
EC12 protein recoverd after each step, anti-His tag staining validates the
presence of His tag in the respective bands. Please note, the anti-His tag
antibody showes little cross-reactivity with processed EC12-EGFP-Halo. c)
Coomassie stained SDS-PAGE gel showing the amount of EC12-EGFP-Halo
before (lane 1) and after (lane 2) incubation with Halo tag binding mag-
netic beads. d) The EC12-EGFP-Halo binding to the beads can be visual-
ized via fluorescence microscopy. M: N-terminal methionin resudue that
results from an ATG start codon, His tag: poly-histidin tag for protein pu-
rification via IMAC, IMAC: immobilized metal ion affinity chromatography,
TEV: recognition site for proteolytic cleavage with TEV protease, L: protein
ladder. Scale bar 100 µm. Sketches not to scale.
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vealed a small shift between the hight of the band further supporting
the opinion that lane 3 contained only processed EC12-EGFP-Halo
(84.8 kDa) whereas the heavier unprocessed protein (86.5 kDa) was
found in lane 4. To conclude, EC12-EGFP-Halo was successfully pro-
cessed and re-purified.
Next, the functionality of EC12-EGFP-Halo was tested in vitro. The
processed protein was efficiently immobilized on Halo ligand coated
magnetic beads (figure 11.9 c+d) thereby proofing the functionality
of the Halo tag. A bead aggregation assay was performed with the
EC12-EGFP-Halo decorated beads as described in Zhang et al. [150] to
proof the formation of EC12 trans dimers under high calcium condi-
tions, but no differences on bead aggregation could be detected with
or without calcium. Most likely, the beads used in this assay were
to heavy to be held together by EC12 fragments, because it had been
shown previously, that at least EC1-3 are necessary to achieve a signif-
icant formation of aggregated beads, while only the full extracellular
domain EC1-5 can fulfill the full adhesive potential [143].
Since in the presented setup, EC12 will be combined with EC345
on the cell surface via the dimerizer, it was assumed that the recon-
stituted extracellular domain should acquire a significant adhesive
strength further supported via lateral clustering. Since the dimerizer
did not need to be highly cell permeable, the larger Ha-peg(7)-pl-BG
dimerizer was used in this case. Processed EC12 protein was coupled
with Ha-peg(7)-pl-BG, washed to remove unbound dimerizer and
administered to A431D cells stably expressing SNAP-E-cadherin345-
mCherry (see figure 11.10) in different concentrations. After 2 h
the cells incubated with 1 µM or 500 nM dimerizer coupled EC12
protein showed a significant accumulation of the EGFP labeled pro-
tein on the cell surface and in intracellular clusters strongly colocal-
izing with the mCherry signal from SNAP-E-cadherin345-mCherry.
The specificity of dimerizer mediated binding between EC12-EGFP-
Halo and SNAP-E-cadherin345-mCherry was further supported by
the finding, that enrichment of EC12-EGFP-Halo did not happen on
untransfected A431D cells. Although in the transfected cells the sig-
nals were higher at cell-cell contact areas due to the overlap of mem-
branes, no specific clustering could be observed. To check if the ex-
pected E-cadherin clusters need longer time to form, incubation with
dimerizer bound EC12 protein was continued over night. After 24
h, even the 50 nM protein solution lead to a significant staining of
SNAP-E-cadherin345-mCherry expressing cells. However, no specific
clustering of E-cadherin could be detected for the different samples.
Instead, the mCherry positive intracellular aggregates did increase
dramatically, indicating that no functional E-cadherin could be for-
med.
Despite the challenges encountered in the presented experiments,
extracellular complementation of E-cadherin has some conceptional
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advantages compared to the intracellular complementation approach.
First of all, only one fusion protein has to be expressed in the cells,
omitting the problem of coexpression in suitable ratios. Second, the
purified extracellular domains can be preincubated with an excess
of dimerizer to ensure high binding efficiencies. Unbound dimerizer
can then be washed out to avoid single reacted protein species as
discussed in section 10.3. Third, since the dimerization happens in
the extracellular space, cell permeabilization is not a limiting step and
the cells can be supplied with new protein repeatedly without the risk
of oversaturation. Finally, additional modifications can be introduced
easily in the EC12 fragment in biochemical in vitro reactions.
The encountered problems could be explained by various scenarios.
On the one hand, the aggregation of SNAP-E-cadherin345-mCherry is
much higher then observed in the cytosolically truncated E-cadherin
mutants presented in section 11.2. The extracellular truncation may
lead to increased endocytosis, because this E-cadherin version can-
not be stabilized at the cell membrane via trans-interaction with E-
cadherins from neighboring cells. This could be evaluated by mea-
suring the diffusion rate within the membrane in comparison to a
full length E-Cadherin in a FRAP experiment. An adaptation form
classical FRAP measurements as demonstrated by Hong et al. [151],
the internalization rate could be measured using a photoconvertable
fluorescent protein like Dendra2. In case high internalization rates
are an issue, stabilizing mutation could be introduced in the jux-
tamembrane region as was shown by Hong et al. for C-terminally
truncated E-cadherins. Notably, the three point mutations K584R,
L587V and L588A were included in the EcGFP-a(280-906) and thus
also in the Ec-GFP-Halo construct derived from this plasmid. The E-
cadherin-Dcyto-mCherry-Halo plasmid used for intracellular recon-
stitution of E-cadherin on the other hand was truncated before these
critical residues at position V583.
Regarding the EC12 construct, mass spectrometry measurements
could confirm the correct processing of the N-terminus and the effi-
ciency of binding the Ha-peg(7)-pl-BG dimerizer in addition to the in
vitro characterization performed here. Western blot analysis of cell
lysate could be done to proof the binding efficiency of EC12-EGFP-
Halo and SNAP-E-cadherin345-mCherry after the experiments pre-
sented in figure 11.10. Another critical point is the sterical confirma-
tion of the reconstituted complex. Reconnection of EC12 and EC345 is
maintained via EGFP-Halo and the SNAP tag domain, each of them
being larger than a single EC domain. The large protein sequence
inserted in the extracellular domain might interfere with lateral clus-
tering and the ability to stiffen under high Ca2+ conditions, since
the Ca2+are complexed in the hinge region between the EC domains,
which is disrupted between EC2 and 3 in the presented setup. In has
been reported, that replacing e.g. the EC 3 and 4 domain with pro-
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tein domains of similar size and shape leads to homophilic binding
efficiencies as low as for EC12[143]. Therefore, the split for extra-
cellular complementation of E-cadherin should be made in another
position. Insertions of multiple protein domains has been reported to
be possible e.g. between the EC5 and the transmembrane region of
E-cadherin [152]. As discussed in section ?? the full extracellular do-
main EC1-5 recombinantly expressed by mammalian cells, is known
to have strong adhesive potential. Although the yield from mam-
malian expression cultures is known to be much lower then from bac-
terial expression systems, a big advantage would be that mammalian
cells do process the N-terminus of the protein endogenously mak-
ing the proteolytic treatment presented for EC12 fragments obsolete.
The EC1-5-SNAP proteins presented by Fichtner et al. [144] could be
combined with an E-cadherin in which the full extracellular domain
had been replaced by a Halo tag. Concerning that EC1-5 proteins
are widely used for surface functionalizations to maintain cell adhe-
sion via cadherins, this approach has good potential to reconstitute
functional E-cadherins.
Nevertheless, regarding the good results achieved with the recruit-
ment of catenins and the intracellular complementation of E-cadherin
and for the temporal restrictions of this project, the extracellular com-
plementation strategy was set on hold.
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Figure 11.10: Complementation of extracellular E-cadherin domains has
no effect on E-cadherin accumulation at cell-cell interfaces.
a) EC12-EGFP-Halo can be dimerized via Ha-peg(7)-pl-BG with SNAP-E-
cadherin345-mCherry to reconstitute the extracellular domain of E-cadherin.
b) N-terminally processed and dimerizer conjugated EC12-EGFP-Halo is
binding to SNAP-E-cadherin345-mCherry expressed on the surface of stable
transfected A431D cells depending on the protein concentration. After 2 h
and 24 h incubation the reconstituted E-cadherins do not cluster at cell-
cell surfaces, but form aggregates within the cells. c) Untransfected A431D
cells do not bind dimerizer conjugated EC12-EGFP-Halo on the cell surface,
but also internalize the protein. Images are diplayed with higher contrast
correction then in b) to visualize the intracellular aggregates, that occur to a
much lower extend then in SNAP-E-cadherin345-mCherry expressing cells.
Scale bars: 40 µm. Sketches not to scale.
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12.1 characterization of a431 mutant cells
Direct comparison of a knock out mutant with their respective wild
type equivalent is a widely used approach to test the functionality of
recombinantly expressed proteins. Ideally, the recombinant expres-
sion of a protein that was depleted in the cell should recover the wild
type phenotype. This concept is known as rescue transfection. Re-
garding the promising results that were achieved via dimerization
of Ec-GFP-Halo and SNAP-mCherry-a(280-906) expressed from a bi-
cistronic vector (hereafter referred to as Dual1), the cells were charac-
terized more detailed. The dimerizer induced complex resembles the
chimeric fusion construct Ec-GFP-a(280-906), and should share func-
tional features of both, E-cadherin and a-catenin. Therefore, an A431
a-catenin knock out cell line (A431 a-catenin KO cells) was included
in these experiments in addition to the E-cadherin deficient A431D
cells. Since it was planned to use the cells in collective migration ex-
periments where a homogeneous expression level throughout the cell
population would be favorable, all analysis were made from stable
transfected cell lines. In addition to Dual1 transfected KO cells, cell
lines transfected with the chimeric Ec-GFP-a(280-906) fusion protein
or a fluorescently tagged full length version of the KO protein, that is
E-cadherin-GFP in A431D and mEmerald-a-catenin in A431 a-catenin
KO cells were used as controls for rescue of the wild type phenotype.
Although the transfected plasmids carried a resistance marker for an-
tibiotic selection, cells tended to reduce the expression levels of re-
combinant proteins. Therefore, the cells were freshly sorted for high
expression levels before each collective migration experiment.
12.1.1 Expression levels of adherens junction proteins in stable cell lines
The expression levels of endogenous and recombinant E-cadherin
and a-catenin was investigated via Western blot analysis. As shown
in figure 12.1, A431D did not express E-cadherin whereas endoge-
nous E-cadherin was found in wild type A431 cells (A431 WT) with
a molecular weight of ca. 120 kDa according to the protein standard
used in this experiment. The discrepancy to the value of 80 kDa cal-
culated for the processed E-cadherin from the amino acid sequence
is because the majority of cellular E-cadherin is unprocessed and car-
ries the pro-domain resulting in 97 kDa molecular weight calculated
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Figure 12.1: Western blot analysis of A431 mutants for expression of E-
cadherin and a-catenin constructs.
a) Illustration of the different E-cadherin and a-catenin constructs expres-
sed in A431 mutants in comparison to the endogenous proteins. Dual1 cells
express Ec-GFP-Halo and SNAP-mCherry-a(280-906). b) Immunochemical
detection of E-cadherin (left) and a-catenin constructs (right) expressed in
stable transfected A431D cells in comparison to A431 WT ynd untrans-
fected A431D cells. Numbers on the right site of the blot correspond to
the constructs illustrated in a) and indicate the hight expected according to
the molecular weigth. a-catenin constructs Ec-GFP-a(280-906) and SNAP-
mCherry-a(280-906) (expressed by Dual1 cells) are expressed in addition to
endogenous a-catenin. The extra band of low molecular weigt detected in
a-catenin stainings of Dual1 cells could not be assigned. b-actin serves as
loading control. Original images of the blots are presented in supplemen-
tary figure A.4 a). c) Stable transfected A431 a-catenin KO cells analyzed
in the same setup as described in b). Endogenous E-cadherin is expressed
in A431 a-catenin KO cells in very low amounts. Also for A431 a-catenin
KO Dual1 cells an unassignable band was found in the a-catenin detection.
Lanes in the images shown in c) were rearranged for better comparability
with results from b). Cut sites are indicated in dashed lines. Original images
of the blots are presented in supplementary figure A.5. endog.: endogenous,
transf.: transfected. Sketches not to scale.
12.1 characterization of a431 mutant cells 103
for the amino acid sequence. The additional difference arises from
heavy glycolisation as reviewed in eg. van Roy et al.[89]. Small dis-
crepancies also arise for the fusion constructs E-cadherin-GFP (124
kDa), Ec-GFP-a(280-906) (180 kDa) and Ec-GFP-Halo (145 kDa) indi-
cating successful glycosilation (all molecular weights calculated from
the amino acid sequence including the pro domain). Note, that the
expression levels of the three recombinant E-cadherins differ signif-
icantly for A431D cell lines due to problems with stable expression
levels. Endogenous a-catenin (102 kDa) was expressed in all A431D
cell lines and A431 WT. The expression level in A431D cells was sig-
nificantly lower than in A431 WT cells, but could be fully recovered
in A431D cells expressing E-cdherin-GFP. Since the antibody used for
a-catenin detection recognized the C-terminus of a-catenin, the 145
kDa band of Ec-GFP-a(280-906) is visible in addition to the endoge-
nous a-catenin of Ec-GFP-a(280-906) transfected A431D cells. For
A431D cells transfected with Dual1, additionally to the endogenous
a-catenin and the recombinant SNAP-mCherry-a(280-906) (119 kDa)
a third band of ca. 85 kDa was detected that could not be specified
further. The level of endogenous a-catenin in A431D cells transfected
with Ec-GFP-a(280-906) or Dual1 was comparable to A431D rather
then A431 WT cells, indicating that endogenous a-catenin is not af-
fected in these cells.
For A431 a-catenin KO cells the expression level of endogenous E-
cadherin was highly reduced in comparison to A431 WT cells. While
in Dual1 transfected cells the endogenous E-cadherin was barely de-
tectable over the strong signal from recombinant Ec-GFP-Halo, cells
expressing Ec-GFP-a(280-906) on the other hand showed levels com-
parable to A431 WT for endogenous E-cadherin in addition to the
heavier chimeric fusion protein. This could be interpreted as a sign
for a rescue in phenotype. For mEmerald-a-catenin transfected A431
a-catenin KO cells however, the detected amount of endogenous E-
cadherin was much lower then for Ec-GFP-a(280-906) transfected cells.
If this reflects the true expression level or is due to a technical prob-
lem in the revelation of the membrane would need to be evaluated in
a repetition of this experiment.
The absence of endogenous a-catenin was confirmed for A431 a-
catenin KO cells, whereas the recombinant mEmerald-a-catenin (128
kDa), Ec-GFP-a(280-906) and SNAP-mCherry-a(280-906) were expres-
sed in high amounts compared to the level of endogenous a-catenin
in A431 WT.
12.1.2 Cellular localization of adherens junction proteins in rescue trans-
fected cell lines
The cellular localization of adherens junction proteins was analyzed
via fluorescent immunohistochemical staining of paraformaldehyde
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Figure 12.2: Cellular localization of adherens junctions components in
A431 wild type and knock out cells.
Fluorescent immunohistochemical staining for E-cadherin, b-catenin or a-
catenin, respectively and costaining for F-actin in A431 WT, A431D and
A431 a-catenin KO cells illustrates the localization of the CCC complex com-
ponents inside the cells. For more detailed desrciption please refer to the
main text. Scale bar 10 µm. Sketches not to scale.
fixated cells. Fluorescently tagged recombinant proteins were de-
tected by the fluorescent signal of their tag. E-cadherin fusion con-
structs were additionally detected with an anti-E-cadherin antibody
to confirm the coherence between the GFP signal and E-cadherin de-
tection and to potentially detect additional pools of endogenous E-
cadherin that did not colocalize with the recombinant protein. In
A431 WT cells E-cadherin, b-catenin and a-catenin accumulated at
the plasma membrane at cell-cell interfaces forming functional AJs as
indicated by the co-accumulation of F-actin. By contrast, in A431D
cells b-catenin and a-catenin were found predominantly in the nu-
cleus, while staining for E-cadherin resulted in a low undefined sig-
nal in the perinuclear region and actin was mainly organized in stress
fibers stretching between focal adhesions. In A431 a-catenin KO cells
E-cadherin was found to be accumulated in small vesicles in the per-
inuclear region. b-catenin showed an undefined localization varying
from cell to cell with a slight tendency for the plasma membrane or
the nucleus. Despite the absence of a-catenin confirmed via western
blot analysis (see figure 12.1) immunofluorescence detection with the
antibody against the N-terminus of a-catenin showed nuclear local-
ization for A431 a-catenin KO cells. Since this was not the case for
the transfected A431 a-catenin KO cells, this is considered to be an
experimental artifact.
E-Cadherin-GFP expressed in A431D cells (figure 12.3 a) localized
mainly in the plasma membrane and accumulated in cell-cell contacts
together with b-catenin, a-catenin and F-actin in forming AJs. Expres-
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Figure 12.3: Cellular localization of adherens junctions components in res-
cue transfected A431D cells.
Fluorescent immunohistochemical staining for E-cadherin, b-catenin or a-
catenin, respectively and costaining for F-actin together with fluorescent
signal from the GFP tag illustrates the localization of the CCC complex
components with a) E-cadherin-GFP and b) Ec-GFP-a(280-906) inside sta-
ble transfected A431D cells. For more details please refer to the main text.
Scale bar 10 µm. Sketches not to scale.
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Figure 12.4: Cellular localization of adherens junctions components in res-
cue transfected A431 a-catenin KO cells.
Fluorescent immunohistochemical staining for E-cadherin, b-catenin or a-
catenin, respectively and costaining for F-actin together with fluorescent
signal from the GFP tag illustrates the localization of the AJ components
with a) mEmerald-a-catenin and b) Ec-GFP-a(280-906) inside stable trans-
fected A431 a-catenin KO cells. For more details please refer to the main
text. Scale bar 10 µm. Sketches not to scale.
sion of Ec-GFP-a(280-906) (figure 12.3 b)also led to clusters of the E-
cadherin fusion construct at cell-cell contacts and co-accumulation of
F-actin, but b-catenin and a-catenin were not recruited to these clus-
ters. Instead they showed an undefined localization with a tendency
for nuclear localization.
Expression of mEmerald-a-catenin in A431 a-catenin KO cells (fig-
ure 12.4 a) rescued the colocalization of E-cadherin, b-catenin and
a-catenin together with F-actin accumulation at cell-cell contact sites
in AJ complexes. Interestingly, expression of Ec-GFP-a(280-906) (fig-
ure 12.4 a) did not only lead to clustering of the chimeric fusion
construct and F-actin colocalization, but also induced b-catenin co-
accumulation at cell-cell contacts.
In summary, the immunostainings confirmed the expected arrange-
ment of E-cadherin, b-catenin, a-catenin and F-actin in functional AJs
in A431D cells transfected with E-cadherin-GFP and A431 a-catenin
KO cells transfected with mEmerald-a-catenin. Expression of Ec-GFP-
a(280-906) induced cell-cell contact formation and F-actin reorganiza-
tion, but was missing b-catenin recrution in A431D cells. Although
Ec-GFP-a(280-906) did not contain a b-catenin binding site the colocal-
ization of b-catenin in A431 a-catenin KO cells could be possibly ex-
plained by an indirect recruitment via lateral cadherin clustering. The
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Ec-GFP-a(280-906) get stabilized at the plasma membrane via extra-
cellular trans dimerization with E-cadherin from opposing cells and
on the other hand via binding to the actomyosin network as shown
by enrichment of F-actin at these clusters. Via lateral clustering the E-
cadherin domain of Ec-GFP-a(280-906) can also recruit endogenous
E-cadherin, which in turn binds b-catenin even without direct con-
nection to the actomyosin network. Therefore, b-catenin recruitment
is dependent on endogenous E-cadherin, which in turn explains why
b-catenin is not affected in A431D cells.
12.1.3 A431D and A431 a-catenin KO cells respond differently to dimer-
izer induced adherens junctions
Ha-pl-BG and Ha-BG are covalently bound by Halo tag and SNAP
tag. Therefore, the formation of the dimeric complex between Ec-
GFP-Halo and SNAP-mCherry-a(280-906) (short: E-cadherin-a-catenin
complex) could be analyzed via western blot of protein samples elec-
trophoretically separated in a polyacrylamide gel under denaturing
conditions. A431D cells expressing Dual 1 were incubated for 9
h with the photocleavable Ha-pl-BG dimerizer or the photostable
Ha-BG dimerizer and lysed directly or after exposure to UV light
(l= 365 nm) from a table top UV lamp. E-cadherin and a-catenin
were detected via immunoblotting using an antibody against the un-
modified extracellular domain of E-cadherin and C-terminal domain
of a-catenin. As shown in figure12.5 without the dimerizer SNAP-
mCherry-a(280-906) was found in a single band with a molecular
weight (MW) of 119 kDa. When incubated with either Ha-pl-BG or
Ha-BG (both: MW ca. 1 kDa), an additional band was detected. The
hight of the band fit to the expected MW of 265 kDa for the covalent-
covalent dimerized Ec-GFP-Halo (MW 145 kDa) and SNAP-mCherry-
a(280-906). This heavy band was not present when Ha-pl-BG cells
had been exposed to UV light, but was found in similar intensity in
lysate from cells treated with Ha-BG with or without UV exposure.
The same pattern was also found when detecting E-cadherin on the
membrane, but the relative amount of E-cadherin that contributed to
the dimer was much lower than for a-catenin.
The data proofed, that the heavier band was indeed the E-cadherin-
a-catenin complex and that this complex could be specifically disinte-
grated with UV light if Ha-pl-BG was used to induce dimerization. In
the reported case, the dimerizer were applied in concentrations found
to be optimal in the mitochondrial sequestration experiments pre-
sented in section10.3.2. Because Ec-GFP-Halo and SNAP-mCherry-
a(280-906) are connected via an IRES sequence on the vector, the E-
cadherin construct is tendentially expressed in a higher level than the
a-catenin fusion protein. Since also less then 50 % of SNAP-mCherry-
a(280-906) were bound in the complex, it should be possible to im-
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Figure 12.5: Western blot analysis of dimerizer treated and UV exposed
A431D Dual1 cells.
a) Illustration of Ec-GFP-Halo and SNAP-mCherry-a(280-906) and the
dimeric complexes that form in A431D Dual1 cells via treatment with photo-
cleavable Ha-pl-BG (3) or non-cleavable Ha-BG (4). b) Immunochemical de-
tection of E-cadherin (left) and a-catenin constructs (right) expressed in sta-
ble transfected A431D cells show additionally heavy bands for the dimeric
Ec-GFP-Halo-SNAP-mCherry-a(280-906) complex. Dimers formed via Ha-
pl-BG are dissociated upon UV light (l=365 nm) exposure, while Ha-BG
induced dimers stay intact. Sketches not to scale.
prove that ratio by longer incubation time or optimized dimerizer
concentrations.
To check the effects on cellular localization of AJ components after
E-cadherin-a-catenin dimer formation and light induced dissociation
of the complex, cells were treated as described above but fixed with
PFA and analyzed via immunohistochemical fluorescent staining (fig-
ure 12.6). Dual1 transfected A431D cells showed high amounts of
recombinant E-cadherin in the plasma membrane, but did resemble
the E-cadherin knock out phenotype considering nuclear localization
of b-catenin and stress fibre organization of F-actin. Recombinant
SNAP-mCherry-a(280-906) was mainly found in the perinuclear re-
gion as detected by mCherry fluorescence. After incubation with the
photocleavable dimerizer Ha-pl-BG, SNAP-mCherry-a(280-906) was
recruited to colocalize with Ec-GFP-Halo at the plasma membrane.
Accumulation of dimerizer induced E-cadherin-a-catenin complexes
at cell-cell contacts were associated with an enrichment of F-actin.
Therefore, it can be assumed that the E-cadherin-a-catenin complexes
are functionally connected to the actomyosin network. When Ha-
pl-BG treated cells were exposed to UV light, they switched back
to the knock out phenotype with perinuclear SNAP-mCherry-a(280-
906) and Ec-GFP-Halo being found in the plasma membrane. Dual1
expressing A431D cells treated with the non-cleavable dimerizer Ha-
BG instead did not react to the UV exposure, but kept the F-actin
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Figure 12.6: Light controlled dissociation of dimerizer induced E-
cadherin-a-catenin complexes in A431D cells do not affect b-
catenin localization.
a) Illustration of dimer formation and dissociation between Ec-GFP-Halo
and SNAP-mCherry-a(280-906) in A431D Dual1 cells via treatment with
photocleavable Ha-pl-BG or non-cleavable Ha-BG and UV light irradiation
(indicated by the flash). b) Immunohistochemical stainings for b-catenin
and F-actin recorded together with fluorescent signals from GFP (fused to
E-cadherin) and mCherry (fused to a-catenin) show the rearrangement of
AJ components within the cell before (first row), after incubation with Ha-
pl-BG (second row) and after additional treatment with UV light (third row,
l=365 nm). The fourth row shows UV exposed cells that had been treated
with Ha-BG. b-catenin localization is not effected by the formation or disso-
ciation of E-cadherin-a-catenin complexes. Scale bar 10 µm. Sketches not to
scale.
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Figure 12.7: Dynamic formation of dimerizer induced E-cadherin-a-
catenin complexes in A431D Dual1 cells can be reversed by
UV light.
a) Fluorescent timelapse recordings of A431D Dual1 cells show the forma-
tion of E-cadherin-a-catenin complexes after addition of Ha-pl-BG via colo-
calization of Ec-GFP-Halo and SNAP-mCherry-a(280-906) that is efficiently
reversed after exposure to UV light (l=350/50 nm). b) A line plot of the
fluorescence intensity values for E-cadherin (GFP) and a-catenin (mCherry)
along the white dashed line between the arrow heads in the fluorescence
images shown in a). Scale bar 20 µm.
linked E-cadherin-a-catenin complexes. b-catenin localization was
not affected during the formation and dissociation of E-cadherin-a-
catenin complexes in A431D cells. Using live cell fluorescence mi-
croscopy (figure 12.7) it was possible to follow the recruitment of
SNAP-mCherry-a(280-906) to Ec-GFP-Halo over time. Note that the
cells were forming extensive overlappings with each other that were
visible due to the GFP labeled membranes. Addition of Ha-pl-BG in-
duced a translocation of SNAP-mCherry-a(280-906) from the cytosol
to the plasma membrane via dimerization with Ec-GFP-Halo. After
ca. 4 h the colocalization reached its maximum and stayed stable
for several hours. Despite forming structures with high density of
the E-cadherin and a-catenin constructs, reflected by high intensities
of GFP and mCherry fluorescence, respectively, the dimerized com-
plex was also detected in the overlapping extrusions. UV light (l=350
nm) did cleave the dimerizer and released SNAP-mCherry-a(280-906)
from the plasma membrane back into the cytosol. The peaks of Ec-
GFP-Halo localization became broader which indicated less rigid or-
ganization of the cell-cell contact area. Directly after the light pulse
some fractions of the a-catenin construct remained at the regions with
previously high concentration of the E-cadherin-a-catenin complexes.
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Figure 12.8: Western blot analysis of dimerizer treated and UV exposed
A431a-catenin KO Dual1 cells.
a) Illustration of Ec-GFP-Halo and SNAP-mCherry-a(280-906) and the
dimeric complexes that form in A431a-catenin KO Dual1 cells via treatment
with photocleavable Ha-pl-BG (3) or non-cleavable Ha-BG (4). b) Immuno-
chemical detection of E-cadherin (left) and a-catenin constructs (right) ex-
pressed in stable transfected A431D cells show additionally heavy bands
for the dimeric Ec-GFP-Halo-SNAP-mCherry-a(280-906) complex. Dimers
formed via Ha-pl-BG are dissociated upon UV light (l=365 nm) exposure,
while Ha-BG induced dimers stay intact. Sketches not to scale.
However, these remainings dissolved within 30 min and while also
the Ec-GFP-Halo localization became more dispersed.
When testing the effects of dimerizer treatment and subsequent
UV exposure in Dual1 expressing A431a-catenin KO cells, western
blot analysis showed the same pattern of E-cadherin-a-catenin dimer
formation that was reversible for Ha-pl-BG but not for Ha-BG treated
cells (see figure12.8).
In immunostainings Dual1 transfected A431a-catenin KO cells looked
similar to their A431D counterpart, regarding the localization of E-
cadherin, SNAP-mCherry-a(280-906) and F-actin, but additionally to
the nuclear localization b-catenin showed colocalization with clusters
of the recombinant Ec-GFP-Halo at the plasma membrane (see fig-
ure 12.9). Although in close proximity to each other, cells were not
connected to each other. Treatment with Ha-pl-BG led to the for-
mation of E-cadherin-a-catenin dimers that colocalize with b-catenin.
These complexes showed a strong accumulation in linear structures
at cell-cell contact areas and association with F-actin forming closely
connected cell clusters. Exposure to UV light induced decomposi-
tion of the tightly bound cell clusters leaving only tethered connec-
tions between retracted cells. This was clearly related to a disruption
of the E-cadherin-a-catenin complexes as SNAP-mCherry-a(280-906)
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Figure 12.9: Dimerizer treated A431 a-catenin KO Dual1 cells form
straight cell-cell contacts containing b-catenin and disinte-
grate under formation of tether like structures after exposure
to UV light.
a) Illustration of dimer formation and dissociation between Ec-GFP-Halo
and SNAP-mCherry-a(280-906) in A431 a-catenin KO Dual1 cells via treat-
ment with photocleavable Ha-pl-BG or non-cleavable Ha-BG and UV light
irradiation (indicated by the flash). b) Immunohistochemical stainings for
b-catenin and F-actin recorded together with fluorescent signals from GFP
(fused to E-cadherin) and mCherry (fused to a-catenin) show the rearrange-
ment of AJ components within the cell before (first row), after incubation
with Ha-pl-BG (second row) and after additional treatment with UV light
(third row, l=365 nm). The fourth row shows UV exposed cells that had
been treated with Ha-BG as negative controls for dimerizer cleavage. b-
catenin localization follows the formation and dissociation of E-cadherin-a-
catenin complexes. Scale bar 10 µm. Sketches not to scale.
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Figure 12.10: Dimerizer induced E-cadherin-a-catenin complexes in A431
a-catenin KO Dual1 cells mature into defined linear com-
plexes that are dissolved immediately after light induced dis-
sociation.
a) Fluorescent timelapse recordings of A431 a-catenin KO Dual1 cells af-
ter addition of Ha-pl-BG show the formation of E-cadherin-a-catenin com-
plexes via colocalization of Ec-GFP-Halo and SNAP-mCherry-a(280-906).
The dimerizer induced AJs mature into linear structures between cells that
are immediately gone after exposure to UV light (l=350/50 nm). E-cadherin
rich membrane tethers remain transiently after dissociation of the AJs. The
line plots below show fluorescence intensity values for E-cadherin (GFP)
and a-catenin (mCherry) along the white dashed line between the arrow
heads in the fluorescence images shown above. b) Same setup as in a) but
cells are incubated with the non-cleavable dimerizer Ha-BG. AJs are stable
for several hours after the same exposure to UV light as used in a). Scale
bars 20 µm.
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and b-catenin relocalized from the plasma membrane to the perinu-
clear region and the nucleus. E-cadherin stayed mainly at the plasma
membrane e.g. in the elongated tether structures, but was also found
inside the cells in vesicular structures. Although F-actin was also
fond in the tethered connections between cells, its localization did
not correlate with accumulations of Ec-GFP-Halo or SNAP-mCherry-
a(280-906). If Ha-BG was used to induce E-cadherin-a-catenin dimer
formation, the same UV intensity could not destroy the dimers and
the cell clusters stayed closely connected with linearly arranged cell-
cell contacts.
Following the process in living cells (figure 12.10), shows that Dual1
transfected A431 a-catenin KO cells did not form overlapping mem-
brane extrusions as found in A431D cells. Instead, Ec-GFP-Halo
formed transient aggregates in the plasma membrane, but SNAP-
mCherry-a(280-906) did not colocalize with these clusters in absence
of the dimerizer. However, as reported for A431D cells, when the
dimerizer was added SNAP-mCherry-a(280-906) was recruited to the
plasma membrane, thereby stabilizing the Ec-GFP-Halo aggregates.
The E-cadherin-a-catenin dimers accumulated at cell-cell interfaces
and expanded the contact areas increasingly into defined linear ar-
rangements. Similar to the results presented for fixed samples, the
cells treated with Ha-pl-BG (figure 12.10a) retracted from each other
under formation of elongated membrane tethers when cleaving the
dimerizer with a short pulse of UV light. SNAP-mCherry-a(280-906)
was immediately released to the cytosol and did not translocate back
to the membrane during the time course of this experiment. Most of
the membrane tethers disassembled briefly after the light pulse, but
some were maintained for several hours. Ec-GFP-Halo was accumu-
lated in these tethers but also formed temporary aggregates in the
plasma membrane and was intensively internalized. In contrast, Ha-
BG treated cells (figure12.10b) were not affected by the same UV light
exposure.
Another difference between Dual1 expressing A431D cells and A431
a-catenin KO cells was discovered during the live cell experiments.
When imaged with phase contrast microscopy, without dimerizer
both KO cell lines form highly diffractive monolayers i.e. they they
appear with a bright halo ring around their cell body (see figure
12.11). While A431D cells did not change their appearance during
incubation with the dimerizer, A431 a-catenin KO cells lost the halo
effect. This means the monolayer became less diffractive which could
be explained by a more homogeneously flattened cell layer in contrast
to a cobblestone like arrangement without dimerizer. The appearance
of the cells after incubation with the dimerizer widely resembles the
morphology of A431 WT cells. Furthermore, cleaving the dimerizer
indeed reversed the morphologic changes completely (please refer to
section 12.2.2). This means that the formation of dimerizer induced
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Figure 12.11: Dimerizer induced E-cadherin-a-catenin complex formation
initializes strong morphologic changes in confluent A431 a-
catenin KO Dual1 cell layers, but not between A431D Dual1
cells.
Phase contrast time lapse recordings of confluent monolayers of A431D
Dual1 and A431 a-catenin KO Dual1 cells after addition of Ha-pl-BG. A431
a-catenin KO Dual1 cells show a strong reduction of diffracted light (bright
“halo” around rounded cells), but A431D Dual1 cells stay morphologically
unchanged during the formation of E-cadherin-a-catenin complex. Scale bar
100 µm.
E-cadherin-a-catenin complexes could rescue A431 a-catenin KO, but
not A431D cells in terms of monolayer morphology. To summarize,
dimerization of Ec-GFP-Halo and SNAP-mCherry-a(280-906) could
be proven to occur in both Dual1 transfected cell lines and depended
on the administration of the small molecules Ha-pl-BG or Ha-BG. If
the dimers were formed using Ha-pl-BG they could be dissociated
via exposure to UV light, while the Ha-BG formed dimers were sta-
ble under UV light exposure. In A431 a-catenin KO cells formation of
the E-cadherin-a-catenin dimers led to recruitment of b-catenin to the
cell-cell contact sites, while b-catenin was not affected in A431D cells.
As discussed in section 12.1.2 for the fusion construct Ec-GFP-a(280-
906), b-catenin might be indirectly recruited via lateral clustering of
actomyosin connected E-cadherin-a-catenin dimers with endogenous
E-cadherin. In A431 a-catenin KO cells treatment with dimerizer in-
duced a morphological switch towards the phenotype of A431 WT
cells, while A431D cells did not change their morphology. The dimer-
izer mediated complexes in A431 a-catenin KO cells were considered
to be functional AJs as they built a connection between neighboring
cells via E-cadherin, b-catenin and a-catenin connected with the acto-
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myosin network. Since the protein complexes that formed in A431D
cells after dimerizer administration did not contain b-catenin and
could not rescue the A431 WT phenotype, they were not considered
to be functional AJs and will be called AJ like complexes hereafter.
While in A431 a-catenin KO cells cleaving Ha-pl-BG directly led to
a full relocation of SNAP-mCherry-a(280-906) to the cytosol and an
immediate retraction of the cells from each other under formation of
extended membrane tethers, in A431D cells a significant amount of
SNAP-mCherry-a(280-906) transiently remained at the cell-cell con-
tact sites. Furthermore, A431D cells did not retract from each other
and did not form membrane tethers upon light induced dissociation
of the AJ like structures. A possible explanation for this difference
could be that the AJ like structures in A431D cells are connected to
the actomyosin network as shown in the immunofluorescence stain-
ings, but the connection is under much lower tension than in A431
a-catenin KO cells. When releasing the a-catenin construct that is
interacting with a network under low tension, a-catenin might be re-
tained at the actin rich cell outline, while in cases of high tension, the
actomyosin network contracts immediately and thereby withdraws
a-catenin from the plasma membrane. A higher stress load on dimer-
izer mediated AJs in A431 a-catenin KO cells would also explain the
immediate retraction of cells after light induced dissociation of AJs.
The tether structures that form during this retraction are unlikely to
arise from clusters of incompletely dissociated AJs, since no accu-
mulation of SNAP-mCherry-a(280-906) were found in the immunos-
tainings and the western blot analysis of samples treated with the
same light intensity showed the complete disruption of the dimers.
Possibly, the reconstituted AJs triggered the formation of other cell-
cell contact structures like desmosomes or tight junctions. When the
AJs were dissociated, these structures would stay intact and would
have to maintain the stress load that what was built up between the
cells without support from the AJs and would therefore stretch the
membrane on tubular structures to transiently maintain the cell-cell
connections, while the cell body is retracting. To proof this concept
immunostainings for desmosomal or tight junction markers should
be done.
The intracellular vesicular structure containing Ec-GFP-Halo found
in A431 a-catenin KO cells indicate an increased internalization of E-
cadherins after light induced dissociation of the AJ complexes. Since
these E-cadherin loaded vesicles did not occur after exposure to UV
light in cells incubated with Ha-BG, they are unlikely to arise from
a an unspecific stress reaction to the UV light. They might rather be
explained by an increased uptake of E-cadherin that is destabilized
in its plasma membrane localization due to missing connection to the
actomyosin network as discussed in 2.2.1or reviewed in Delva et al.
[153].
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12.2 light induced dissociation of adherens junctions
with high spatial precision
Having shown the formation of dimerizer induced AJs in A431 a-
catenin KO cells and the possibility to dissociate them with light, the
next aim was to test the applicability and flexibility of this tool to ma-
nipulate epithelial cells at different length and time scales. Using light
as a trigger offers the ability to dissociate dimerizer mediated AJs not
only at defined timepoints as demonstrated in the previous section,
but should also allows to target defined regions within an epithelial
monolayer or when using higher magnification also subcellular re-
gions of cell-cell contacts. To do so a 405 nm laser in a laser scanner
unit was mounted on the microscope. Using a 405 nm laser instead
of wide field near UV light exposure had multiple advantages. De-
spite the low light doses necessary to cleave the Ha-pl-BG dimerizer,
using visible light instead of near UV light reduced potential DNA
damage caused by irradiation with high energetic wave lengths. Fur-
thermore, the spot size of the laser could be set to sub-micrometer
size to achieve high spatial precision and the scanner unit allowed to
target subregions with various shape and size in the field of view.
12.2.1 Adherens junctions can be dissociated with subcellular precision
As shown in figure 12.12 A431 a-catenin KO Dual1 cells were treated
with Ha-pl-BG and formed defined AJ outlining the cell-cell contact
areas. For dissociation of AJs in subcellular regions, AJs at the in-
terface of two adjacent cells (area outlined in white dashes) were
targeted with the 405 nm laser. By measuring the fluorescence in-
tensity profiles (figure 12.12b+c) across the targeted AJs (line 1) in
comparison with non-targeted AJs (line 2) showed that before cleav-
ing Ha-pl-BG the a-catenin construct (red) colocalized with the E-
cadherin construct (timepoint -01:00 min). Directly after laser irradia-
tion (timepoint 00:00 min), the a-catenin peak disappeared at the tar-
geted AJ, and AJ dissociation led to detachment of the cells from each
other (timepoint 05:00 min). Cell-cell attachment and colocalization
of E-cadherin and a-catenin at the non-targeted AJs were not affected.
Kymograph analysis (figure 12.12 b) showed that the E-cadherin in-
tensity stayed stable until the cells start to detach from each other
ca. 60 seconds after irradiation. This indicated that even without
connection to the actomyosin network E-cadherin at least transiently
remained clustered, but could not build enough adhesive strength to
maintain the connection between the cells. Herewith it was proven
that dimerizer mediated adherens junctions could be dissociated with
subcellular precision. The frame rate in these experiments was on a
scale of seconds, but could be reduced to subsecond resolution if nec-
essary.
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Figure 12.12: Dimerizer mediated adherens junctions can be dissociated
with subcellular precision using a 405 nm laser.
a) Detaching of cells at targeted AJs is followed in a fluorescence time lapse
recording. Irradiation of AJs of two adjacent Ha-pl-BG treated A431 a-
catenin KO Dual1 cells with a 405 nm laser (area outlined in white dashes)
directly before timepoint 00:00 min dissociates targeted AJ between two ad-
jacent cells without affecting untargeted AJs. b) Kymograph of the targeted
AJ along line 1 (white dashed line between arrowheads in a)) for E-cadherin
(GFP fluorescence) and a-catenin (mCherry fluorescence) signal shows the
immediate dispersal of a-catenin after laser irradiation (black and white
dashed line), while E-cadherin dissociates only after 60 seconds. Note that
the kymograph is displayed corrected for different frame rates used in this
recording. The frame rate was adopted dynamically to the occuring process
to reduce bleaching effects. c) Line plots for E-cadherin (GFP) and a-catenin
(mCherry) intensities of the cross sections of targeted (line 1) or untargeted
(line 2) AJs indicated by white dashed lines between arrowheads in a). Scale
bar 10 µm.
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Figure 12.13: Dimerizer mediated compaction of adherent monolayer can
be reversed in confined areas.
Highly diffractive round cells laying loosely attached on top of an overcon-
fluent surface attached layer of A431 a-catenin KO Dual1 cells. Incubation
with Ha-pl-BG induces the formation of dimerizer mediated AJs within 4 h
that leads to a less diffractive morphology. During this process the round
cells integrate into the cell layer and increase the compaction of surface at-
tached cells. A 405 nm laser is used to cleave the dimerizer in the area
marked by the white dashed outline between two frames of the phase con-
trast time lapse recording (one frame every 5 min). Dissociation of dimerizer
mediated AJs causes the compacted cell layer to disseminate by cells detach-
ing from the surface only in the targeted area. Scale bar 200 µm.
12.2.2 Dimerizer induced compaction of epithelial monolayers and disinte-
gration in defined patterns
A431 a-catenin KO cells did not stop to proliferate when reaching
full confluence, although when undergoing cytokinesis the dividing
cells could not reintegrate into the monolayer. Instead, the newly
formed cells stayed loosely attached in a spherical shape on top of
the adherent cell layer. As shown in figure 12.13 (00:00 h) the round
cells were highly diffractive and appeared as bright spheres in phase
contrast images. After addition of Ha-pl-BG, the cells started to form
AJs and the round cells integrated into the monolayer. This com-
paction was characterized by reduced scattering of light around the
cell body in the phase contrast images (04:00 h). The 405 nm laser
was used to cleave the dimerizer and thereby trigger AJs dissociation
in the area marked by the dashed outline in figure12.13 (04:05 h). In
the targeted area the compacted cell layer immediately disseminated
and pushed out cells that had been integrated during the compaction,
whereas the monolayer in the non-targeted area maintained the com-
pacted, low diffractive morphology. Note that from the time lapse
recording it could be seen that the few highly diffractive cells in the
non-targeted are either cells that were in the process of cytokinesis
and reintegrated into the cell layer after cell fission or were not re-
120 characterization and evaluation of dimerizer induced cell adhesion
sponding to the dimerizer treatment over the full time course of the
experiment. The later were mainly cells that did not express sufficient
levels of Ec-GFP-Halo or SNAP-mCherry-a(280-906) as could be seen
in fluorescent imaging (data not shown).
These experiments showed that the induction of dimerizer medi-
ated AJs is not only passively changing the appearance of a adherent
cell layer, but the monolayer underwent an active compaction by rein-
tegrating previously expelled cells. Furthermore, the process could
be reversed completely by cleaving the dimerizer that maintained the
AJs.
12.3 collective cell migration and contraction
To proof whether the dimerizer mediated AJs were functional in terms
of force transmission, the cells were analyzed for their collective be-
havior. If the AJs were mechanically connecting cells they should not
only influence their direct neighbors but be able to transmit the ex-
erted forces across the surrounding cells as described in section 2.2.1.
Thereby, they should be able to coordinate the direction of their move-
ment and pulling forces over distances of several cell diameters (see
section 2.3 and ??).
12.3.1 Dimerizer mediated cell adhesion increases coordination in the mi-
grating cell layer
Despite being a well established model to study adherens junctions
A431 cells (and therefrom derived KO cells) are known to have very
low migratory activity without external stimuli[154]. However it was
possible to stimulate cell migration in a modified wound healing as-
say. Cells were cultured in a confined area to form a confluent cell
monolayer. When the confinement was removed, the cells migrated
into the open space (see figure 12.14). Unlike in a standard wound
healing assay, where two opposing cell fronts are investigated for the
time they need to close the gap between them, only a single front
of migrating cells was studied. The migration was analyzed by cal-
culating the correlation length in a velocity field that was derived
from consecutive phase contrast images via particle image velocime-
try (PIV). Since the cells were prone to migrate into the open space
(defined as axial direction) due to the experimental setup, only the
lateral components of the velocity vectors were considered for the cal-
culation of the correlation length. Therefore, the lateral correlation
length or correlation diameter is a measure of how far cells could
align their motions[123, 124]. As shown in figure 12.14 the lateral
correlation diameter calculated for Ha-pl-BG treated Dual1 express-
ing A431 a-catenin KO cells was 258.0 +/- 4.9 µm while for the same
cells without the dimerizer it was 165.5 +/- 1.4 µm. Thus, the lat-
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Figure 12.14: Cells with dimerizer induced adherens junctions show
higher degree of collectivity.
a) Time lapse phase contrast recordings of a migration front of A431 a-
catenin KO Dual1 cells with Ha-pl-BG and a negative control control layer
of the cells without dimerizer in a rupture free wound healing assay 2 h
after removal of the confinement. b) PIV analysis of collective cell migra-
tion of two consecutive frames (Dt: 5 min) show higher turbulances in the
velocity vector field calculated for the monolayer of cells without dimerizer.
c) Analysis of the lateral component of the velocity vectors shows a sig-
nificantly higher correlation diameter for Ha-pl-BG treated cells (258.0 +/-
4.9 µm) then for the negative control without dimerizer (165.5 +/- 1.4 µm).
****p<0.0001 Scale bar 200 µm.
eral correlation diameter was significantly higher (p<0.0001) for cells
with dimerizer mediated AJs. In a second approach presented in
figure 12.15Ha-pl-BG treated cells were irradiated with the 405 nm
laser in the middle of the experimental time course, to test if the
higher correlation diameter was directly dependent on the presence
of AJs. When analyzing the collective migration behavior for cells
in the targeted area a significantly different (p<0.0001) average cor-
relation diameter that was calculated with 184.1 +/- 5.5 µm before
and 136.1 +/- 2.7 µm after light induced dissociation of the AJs. The
experiments showed a dimerizer dependent increase of collectivity
in the migrating cell layer and that the collectivity could be immedi-
ately reduced by disrupting the AJs. This indicated that the cells are
mechanically linked via the dimerizer mediated AJs. The differences
for the correlation diameters of Ha-pl-BG treated cells between the
two experiments could have been caused by various interdependent
parameters. Although the cells were always freshly sorted before and
seeded in the same number for each experiment, differences in the
cell number and resulting cell density within the confined monolayer
could have occurred from variations in the sorting performance due
to recurrent technical problems and therefrom resulting reductions
in cell viability and incubation times. Nevertheless, the relative shifts
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Figure 12.15: Light induced dissociation of adherence junctions shortens
the coordination of cell motions.
a) Time lapse phase contrast recordings of a migration front of A431 a-
catenin KO Dual1 cells preincubated with Ha-pl-BG in a rupture free wound
healing assay before and after 405 nm laser irradiation of the area marked
with dashed yellow outline. b) The correlation diameter of the lateral com-
ponent of the velocity vectors is significantly higher before laser irradiation
for the cells in the targeted area (before (Ha-pl-BG): 184.1 +/- 5.5 µm; after
(405 nm laser): 136.1 +/- 2.7 µm) directly after light induced dissociation of
dimerizer mediated AJs. PIV analysis was done from timelapse recordings
(Dt: 5 min) 2 h before and after laser irradiation. ****p<0.0001 Scale bar 200
µm.
in the correlation diameter between cells with or without dimerizer
mediated AJs is consistent throughout the different experiments.
12.3.2 Light induced dissociation of adherence junctions discontinues col-
lective contractility
Since the coordinated migration suggested a mechanical coupling be-
tween cells with dimerizer mediated AJs the next aim was to investi-
gate if this was also reflected by the forces exerted on the underlying
substrate. Therefore, the wound healing assay was combined with
traction force microscopy measurements as shown in figure 12.16.
The cells were grown in the confinement on a collagen coated PAA
gel with a Young’s modulus of 200 Pa. When the cells with recon-
stituted AJs were released from the confinement traction forces were
highest along the migration front and increased over one hour be-
fore reaching a steady state. Traction forces at the migration front
exert stresses of 7-10 Pa on the gel, while the stresses measured un-
der the cell monolayer were much lower (maximum 4 Pa). When
cleaving the dimerizer, large numbers of cells were immediately ex-
truded from the cell layer and the tractions at the migration front
gradually decreased and spread throughout the cell layer in irregular
patterns. After 1-2 h the traction forces at the migration front became
as low and disorganized as under the migrating cell layer. Therefore,
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Figure 12.16: High traction forces at the migration edge dissolve after light
induced dissociation of adherence junctions.
Combination of the rupture free wound healing assay and traction force
microscopy (TFM) reveals high traction forces at the migration front of a
confluent layer of Ha-pl-BG treated A431 a-catenin KO Dual1 cells. The cell
layer becomes highly diffractive immediately after irradiation of the whole
field of view with a 405 nm laser and the traction forces at the migration
front decrease gradually. Scale bar 200 µm.
it could be shown that dimerizer mediated AJs maintained a mechan-
ical connection between the cells in the monolayer, that allowed them
to couple contractile forces. By pulling collectively, the cells could
exert much higher forces at the migration front before the dissoci-
ation of their AJs. If the gradual decrease of traction forces at the
migration front is solely caused by the disruption of AJs or pushing
forces of the extruded cells also contribute to this process could not be
conclusively clarified. However, it was observed, that cells that were
extruded directly after dissociation of AJs reattached to the surface
while the migrating cell layer spread out.
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C O N C L U S I O N
In this work I developed the first optochemical tool to control the
formation of mechanically active adhesion protein complexes inside
living cells. The method is based on chemically induced dimerization
of proteins or protein domains via photocleavable dimerizers. It is
bioorthogonal, because it does not interfere with signaling pathways
or proteins others then the ones targeted. The dimerizers I applied
are bifunctional small molecules that combine the ligands of two self-
labelling tags via a photocleavable linker and therefore can mediate
the binding between these protein tags in a light reversible manner.
These self-labelling tags can be fused to any protein of interest. The
modularity of this dimerizer binding cassette offered me an easy way
to test multiple combinations of target proteins and finally led to the
herein presented method to control the activity of intracellular pro-
teins with unprecedented spatiotemporal precision.
I synthesized a Halo and SNAP tag binding dimerizer and used
this to achieve covalent-covalent binding between the targeted pro-
teins to ensure mechanical stability of the dimerizer induced protein
complexes. Furthermore, I solved the stoichiometric problem of the
tripartite binding complex. I controlled the expression levels of target
proteins via bicistronic expression vectors and optimized the condi-
tions for dimerizer administration to avoid the formation of monore-
acted species. Additionally, I showed the possibility to combine the
Halo and SNAP tag binding dimerizer with Halo and DHFR tag bind-
ing dimerizer for multiplexed dimerization and light induced release
in a mitochondrial sequestration setup. By combining photocleavable
and photostable dimerizers this system offers a great combinatorial
flexibility and thus has great potential for applications in synthetic bi-
ology to create e.g. signaling circuits by sequential binding of effector
proteins.
I tested three different concepts, retention, recruitment and com-
plementation to apply the dimerizers in the context of adhesion com-
plex formation. I induced sequestration of the FA proteins vinculin
and paxillin at the outer mitochondrial membrane. Although further
optimizations will be necessary, I could show that it is possible to
retain these proteins from integration into FAs by translocation to
a cellular compartment where they are functionally inactivated but
structurally intact and can be released by cleaving the dimerizer with
light. The recruitment concept I applied to control the binding be-
tween AJ proteins. I replaced the binding sites of E-cadherin for their
intracellular adaptor proteins (e.g. b-catenin and p120-catenin) with
a Halo tag and proofed that these proteins are expressed and local-
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ized in the plasma membrane, but cannot form stable AJs or bind b-
catenin. However, when coexpressed with SNAP tagged a-catenin or
b-catenin the protein-protein interaction could be restored via chem-
ically induced dimerization. I could obtain similar results for the in-
tracellular complementation of E-cadherin by recruiting the cytosolic
domain to a tailless E-cadherin. The complementation of the extra-
cellular domain of E-cadherin however was technically challenging. I
proofed the extracellular presentation and ligand binding capabilities
of an E-cadherin where the EC12 domain was replaced with a SNAP
tag in living cells. Furthermore, I established a protocol for bacterial
expression and proteolytic N-terminal processing of a Halo tagged
EC12 domain that could be successfully bound to the extracellularly
truncated E-cadherin.
I characterized the different effects of the formation of AJs after
chemically induced E-cadherin-a-catenin dimerization in E-cadherin
deficient A431D cells and A431 a-catenin KO cells in comparison to
A431 wt cells. Thereby I found that the reconstitution of AJs could re-
store the tightly packed wt phenotype in A431 a-catenin KO cells, but
not in A431D cells. I could relate this to the fact that the chemically in-
duced E-cadherin-a-catenin dimers as well as the control E-cadherin-
a-catenin fusion protein failed to recruit b-catenin to the E-cadherin-
a-catenin dimers in A431D cells. By uncoupling b-catenin recrution
from direct binding to a-catenin, I could show that b-catenin is essen-
tial for the formation of AJs but unlike vinculin or a-catenin it does
not need to be under tension to be fully activated.
For A431 a-catenin KO cells however, I could show that the dimer-
izer mediated AJs contained also b-catenin and induced a morpholog-
ical transition from KO to wt phenotype. Using low doses of a blue
light 405 nm laser to cut the dimerizer, I could dissociate the recon-
stituted AJs with subcellular precision and trace the detachment of
cells. On a monolayer scale, laser scanning could be used to dissem-
inate tightly packed dimerizer treated cells in defined patterns and
follow the rearrangements of the monolayer. Moreover, in a collective
monolayer migration experiment, I could increase the correlation of
cell motion via dimerizer induced AJ formation and cancel the cor-
relation via cleaving the dimerizer with light. Finally, I could proof
that the dimerizer induced AJs also facilitate collective contraction as
in TFM measurements they did build up strong traction forces at the
migration front that vanished after light induced dissociation of the
AJs.
The use of photocleavable dimerizers to control the formation of
adherens junction complexes offers two binary switches: a systemic
“ON switch” via addition of the dimerizer to induce reconstitution
of AJ and a spatiotemporally precise “OFF switch” by cutting the
dimerizer with 405 nm or near UV light to disseminate the AJ com-
plex. The possibility of patterned deactivation and combination with
conclusion 129
specialized imaging techniques like TFM makes it a powerful tool to
study the mechanobiology of AJs and its contribution to collective mi-
gration and stress propagation in epithelial cell layers. I am confident
that this will help to understand the mechanical aspects of dynamic
regulation of AJs and their biological effects in the context of EMT as
it is essential for embryonal development, wound healing or cancer
metastasis.
E-cadherin
β-catenin
α-catenin
Ec-GFP-Halo SNAP-mCherry-
α(208-906)
+ Ha-pl-BG
+ light pulse
N-domain
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Figure 13.1: Summary sketch.
Light induced dissociation of dimerizer mediated adherens junction com-
plexes allows to abort actomyosin coupled cell-cell adhesions with high spa-
tiotemporal precision on subcellular, single cell or tissue lenght scale.
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O U T L O O K
14.1 e-cadherin-a-catenin dimers initiate formation of
desmosomes in a431 a-catenin ko cells
One of the open questions about the presented tool of light induced
dissociation of AJs in A431 a-catenin KO cells is the origin of the
tether structures that arise directly after cleaving the dimerizer. The
hypothesys was that the reconstitution of AJs enables cell-cell con-
tacts, that are further manifested by the formation of other cell ad-
hesion structures like desmosomes, tight junctions and gap junctions.
Cleaving the dimerizer however, affects AJ dissociation only, while
other adhesion complexes stay intact.
Indeed, immunofluorescent staining of A431 a-catenin KO Dual1
cells for the desmosomal marker desmoplakin (see section2.2) showed
that without dimerizer the cells are not able to connect their inter-
mediate filaments (figure 14.1 a) while in presence of the dimerizer
intracellular cables of cytokeratin are linked via desmosomal plaques
(figure 14.1 b). After exposure to UV light, cytokeratine was found to
stretch through the tethered structures that form after light induced
dissociation of AJs and the desmosomal plaques were situated right
in the middle of the tethers.
Apparently, the tethers arise from the desmosomal connections of
cytokeratin, that are at least transiently resistent to the ripping apart
of cells. Whether also other adhesive structures contribute to the
formation of these tethers is under current investigation.
The observation that desmosomes are involved in the dimerizer in-
duced transition from KO to WT phenotype in A431 a-catenin KO
cells could also explain why A431D cells fail to undergo this transi-
tion. Lewis et al. reported that A431D cells fail to form desmosomes
after E-cadherin rescue transfection due to low level of plakoglobin[85].
While plakoglobine alone is not sufficient either, double transfection
with E-cadherin and plakoglobin on the other side does regain the
ability to reorganize desmosomal structure in their experiments. There-
fore, it should be possible to induce the switch from KO to wt pheno-
type in A431D Dual1 cells that are cotransfected with plakoglobin.
14.2 intracellular e-cadherin complementation - appli-
cation and physiological relevance
As demonstrated in this work, dimerizer induced E-cadherin-a-catenin
complexes are able to restore mechanical connection in a-catenin KO
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Figure 14.1: Desmosomes transiently persist adherens junction dissocia-
tion.
cells. The design of the construc made it possible to show that AJs
can be functionally restored without incorporating b-catenin in the
mechanically stressed protein complex. However, this is not reflect-
ing the physiological situation and might lack important mechanisms
that regulate AJ dynamics. As presented in section 11.3 it was also
possible to recruit the cytosolic domain of E-cadherin to a tailless
E-cadherin in REF52 fibroblasts. As discussed, fibroblast are an inad-
equat model for the reconstitution of AJs via E-cadherin complemen-
tation, because they express only very little amounts of b-catenin and
a-catenin. Meanwhile, a MDCK E-cadherin KO cell line was gener-
ated in the Ladoux-Mège lab that is still forming AJs via cadherin-6,
but these AJs are weaker in terms of stresses that can be build up
between the cells [118].
A bicistronic vector that combines a Halo tagged tailless E-cadherin
(E-cadherin-D-cyto-Halo) and the DHFR-EGFP tagged cytosolic E-
cadherin domain (DHFR-EGFP-cytotail) was transfected into the MDCK
E-cadherin KO cells. While DHFR-EGFP-cytotail is strictly cytosolic
on the absence of dimerizer (data not shown) it is efficiently recruited
to the plasma membrane presumably via binding to E-cadherin-D-
cyto-Halo upon addition of Ha-pl-TMP (figure 14.2). The effects of
E-cadherin complementation on cell adhesion strength, collective mi-
gration behaviour and contraction of MDCK monolayers is currently
under investigation in collaboration with the Ladoux-Mège lab.
It should be mentioned that the DHFR-EGFP-cytotail construc used
here contains the full cytosolic domain and should therefore enable
interaction with all endogenous binding partners (e.g p120-catenin
and b-catenein) and full regulation via phosphorylation [89]. Further-
more, the release of this domain via photocleaving the Ha-pl-TMP
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a) b) MDCK E-cadherin KO 
Figure 14.2: The DHFR tagged cytosolic domain of E-cadherin is recruited
to a Halo tagged tailless E-cadherin via the dimerizer Ha-pl-
TMP.
a) Sketch illustrating the intracellular complementation setup. b) DHFR-
GFP-cytotail is recruited to E-cadherin-D-cyto-Halo after addition of Ha-pl-
TMP. Scale bar 10 µm. Sketches not to scale.
dimerizer reflects the cleaving of endogenous E-cadherin between the
aa577 and aa588 by g-secretase[155] . The fragment is associated with
Alzheimer´s disease[155] and might be involved in pathways regulat-
ing proliferation and apoptosis[88, 148][88, 148], but the excact mech-
anisms are still elusive. By offering high spatiotemporal control for
the release of this fragment dimerizer mediated complementation of
E-cadherin will be a powerfull tool to invastigate on these pathways.
14.3 neural crest cells on the move - an applications
for spatiotemporal control of adherens junction
Neural crest cells are specifc group of cells that arise transiently dur-
ing embyonal development in all vertebrates and give rise to various
tissues and organs like the skull bone and cartilage, neurons and
glia cells in the peripheral nervous system and the aortic outflow
tract of the heart[103, 156]. They originate from the neuroepithelium
that forms the neural tube and accumulate at the boarder to the ec-
toderm (figure 14.3 a). During a process called delamination they
undergo EMT, which makes them more motile and allows them to
spread across the embryo before differentiating into the desired cell
type [76] (figure 14.3 b,c). As a hallmark of EMT they downregulate
E-cadherin and upregulate N-cadherin and integrin b, which allows
them to become migratory and crawl in between the sourrounding
tissue.
The group of Roberto Mayor established a model system of neu-
ral crest explants from Xenopus embryos to analyze the migration
behavior during this process[157, 158]. They could show that the
E- to N-cadherin switch control a behaviour that is known as “con-
tact inhibition of locomotion” (CIL). During CIL forces are redis-
tributed from cell-cell to cell-matrix contacts and E-cadherin represses
CIL[156, 157].
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Figure 14.3: Neural crest cells are undergoing EMT to spread in the devel-
oping embryo before differentiating into various tissues.
Figure originally from Szabó et al.[156].
Currently it is tested if the dimerizer mediated reconstitution of
adherens junctions can help to control the onset of migration of ex-
planted neural crest cells and thereby help to understand this funda-
mental process.
14.4 talin complementation - a tool to control focal
adhesion complex formation
To extend the dimerizer mediated control of cell adhesion from cell-
cell adhesion to cell-matrix adhesion complexes the complementation
of split protein approach is currently tested for talin (see also section
2.2.3). The group of Carsten Grashoff generated a mouse fibroblast
cell line that is deficient of both isoforms talin-1 and talin-2, which
led to strongly impaired cell-matrix adhesion (figure 14.4a). Transfec-
tion with a C-terminally tagged talin-1 or a talin-1 with a FRET based
tension sensor (TS) could restore the typical fibroblast spreading be-
haviour and formation of defined FA complexes (see figure 14.4b).
The incorporation of the TS module between the head and the rod
domain (figure 14.4c) did not perturb the function of talin, which
makes it an ideal position for incorporation of a dimerizer binding
cassette. It is planned to replace the TS module with the EGFP-Halo-
IRES-SNAP-mCherry sequence from the Dual1 construct, which will
create a split talin where the head domain carries the EGFP-Halo tag
and the rod doamin is fused to the SNAP-mCherry tag coexpressed
from a bicistronic vector due to the IRES sequence. If coexpressed in
the talin double deficient cells, the dimerization of TalinHead-EGFP-
Halo and SNAP-mCherry-TalinRod can be induced with Ha-pl-BG
and reversed with light, analogue to the Dual1 construct presented in
this thesis. Cloning of the split talin is currently in progress.
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Figure 14.4: Talin as a target for dimerizer controlled cell-matrix adhesion.
a) Cell adhesion and spreading is impaired in double knock out cells for
talin1 and talin 2, but b, c) can be rescue transfected with C-terminally YFP
tagged talin1(Tln1Y) or tension sensor talin Talin1TS. d) The tension sensor
module will be replaced by a dimerizer binding cassette, which generates a
split talin protein, that can be reconstituted with Ha-pl-TMP dimerizer.
Figure adapted from [107]. Scale bars: 20 µm. Sketches not to scale.
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Figure A.1: Mitochondrial retention of DD-EGFP-Vcl.
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MCF-7MDA-MB 231BT549
A431A431DA431 α-catenin KO
Figure A.2: Phenotypic variations of epithelial cancer cell lines.
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mCherry-β-catenin E-cadherin-EGFP-Halo overlay
SNAP-mCherry-β-catenin E-cadherin-EGFP overlay
SNAP-mCherry-β-catenin BG-OregonGreen overlay
Halo-TMR E-cadherin-EGFP-Halo overlay
Figure A.3: Labelling and localization of SNAP-mCherry-b-catenin and E-
cadherin-EGFP-Halo in living cells.
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Figure A.4: Complete Western blots for A431D cell lines.
supplementary figures 143
Du
al 
1
A4
31
 w
t
A4
31
 α-
ca
t K
O
Du
al 
1 +
 H
a-p
l-B
G 
+ U
V 
Du
al 
1 +
 H
a-p
l-B
G
Du
al 
1 +
 H
a-B
G 
+ U
V 
Du
al 
1 +
 H
a-B
G
Ec
-G
FP
-α
(20
8-9
06
)
Ec
-G
FP
-α
(20
8-9
06
) +
 U
V 
mE
me
ral
d-α
-ca
t
Tranf. A431α-cat KO
Du
al 
1
kDa
A4
31
 w
t
A4
31
 α-
ca
t K
O
Du
al 
1 +
 H
a-p
l-B
G 
+ U
V 
Du
al 
1 +
 H
a-p
l-B
G
Du
al 
1 +
 H
a-B
G 
+ U
V 
Du
al 
1 +
 H
a-B
G
Ec
-G
FP
-α
(20
8-9
06
)
Ec
-G
FP
-α
(20
8-9
06
) +
 U
V 
mE
me
ral
d-α
-ca
t
Tranf. A431α-cat KO
160
110
50
40
80
60
30
260
160
110
50
40
80
60
30
260160
110
50
40
80
60
30
260
160
110
50
40
80
60
30
260
E-cadherin
β-actin
α-catenin
β-actin
kDa kDa kDa
A431 α-catenin KO 
Figure A.5: Complete Western blots for A431 a-catenin KO cell lines.
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b.1 primer lists
b.1.1 List of cloning primers
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
1 SNAP_N-term-
Fw
ATG GAC AAA GAC TGC GAA ATG 53.6 21
2 SLIC-rev-
primer
CTC GCC CTT GCT CAC CAT ACT
TCC TCC TCC TCC ACT TCC TCC
TCC TCC ATT AAC CTC GAG TTT
AAA CG
71.2 68
3 SNAP-N-term-
Rev
CAT TTC GCA GTC TTT GTC CAT 53.6 21
4 mCherry-Fw ATG GTG AGC AAG GGC GAG 57.9 18
37 GFP-mCherry-
ex_Nterm
Fw
GTG AGC AAG GGC GAG GAG 58.5 18
38 GFP-mCherry-
ex_Nterm
Rev
CTC CTC GCC CTT GCT CAC 58.5 18
39 GFP-mCherry-
ex_Cterm
Fw
CGG CAT GGA CGA GCT GTA CAA
G
60.3 22
40 GFP-mCherry-
ex_Cterm
Rev
CTT GTA CAG CTC GTC CAT GCC
G
60.3 22
51 GA_bCatenin-
Cterm-Rev
CTT TGT TAG CAG CCG GAT CAG
CTT TTA CAG GTC AGT ATC AAA
CCA GGC CAG C
69.4 52
52 Flexi_3’-Fw GCT GAT CCG GCT GCT AAC AAA
GC
60.9 23
53 GA_paxillinC-
term
Rev
CTT TGT TAG CAG CCG GAT CAG
CGA GCC TAG CAG AAG AGC TTG
AGG
69.8 45
145
146 dna oligos and plasmids
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
56 eDHFR-Cterm-
FW_neu
GCT ATT GCT TTG AGA TTC TGG
AGC GGC GGG CGG ATC C
69.9 37
57 eDHFR-Nterm-
Rev_neu
ATC TAC CGC TAA CGC CGC AAT
CAG ACT GAT CAT CTC G
66.3 37
67 GA_hECad-
EGFP-Fw
ATG TAC GGA GGC GGC GAG GAC
GAC CCG CGG GTG AGC AAG GGC
GAG GAG CTG TTC ACC
77 57
68 GA_hECad-
EGFP-Halo-Rev
TTA GGT GAC ACT ATA GAA TAG
GGC CCT CTA GAA TTC TAT TAA
CCG GAA ATC TCC
65.2 54
69 GA_hECad-
EGFP-Rev
AAC AGC TCC TCG CCC TTG CTC
ACC CGC GGG TCG TCC TCG CCG
CCT CC
77.9 47
70 GA-hECad-
EGFP-Halo-Fw
ATT TCC GGT TAA TAG AAT TCT
AGA GGG CCC TAT TCT ATA GTG
TCA CCT AAA TGC
65 54
77 E-Cad-
[bCat]_Fw
GGA GGA GGA GGA AGT GTG AGC
AAG GGC GAG GAG CTG TTC ACC
G
72.2 43
78 E-Cad-
[bCat]_Rev
ACT TCC TCC TCC TCC GGA GCT
CAG ACT AGC AGC TTC GGA ACC
G
71.4 43
85 GA_hECad-
cytosol-Fw
GCA TGG ACG AGC TGT ACA AGG
GAG GAG GAG GAA GTA AAG AGC
CCT TAC TGC CCC CAG AGG
72.6 60
86 GA-hECad-
cytosol-Rev
GCT GAT TAT GAT CTA GAG TCG
CGG CCT TAG TCG TCC TCG CCG
CCT CCG TAC ATG TCA GC
72 59
87 GA-hECad-
[cyt]-Rev
TTG CTC ACA CTT CCT CCT CCT
CCG ACC ACC GCT CTC CTC CGA
AGA AAC AGC
72.6 51
88 CMV_GA_Fw CCA TTG ACG CAA ATG GGC GGT
AGG CGT GTA CGG TGG
70.4 36
89 CMV_GA_Rev CCA CCG TAC ACG CCT ACC GCC
CAT TTG CGT CAA TGG
70.4 36
109 ECad12-
Halo_Fw
ACA CTA TAG AAT AAG GAG CGA
TAT GCA CCA CCA CCA CCA CCA
CGA AAA CC
68.5 50
B.1 primer lists 147
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
110 ECad12-Halo-
Rev
AAA GCC AGT ACC GAT TTC GGA
TCT GTC GTT CAG ACC GCC ACC
AGG AGC
71,4 48
111 ECad12-EGFP-
Halo
Fwd
AAT GAC AAC GCT CCT GGT GGC
GGT TCT TCT GTG AGC AAG GGC
GAG G
72.6 46
113 prohECad_vector
Fw
GAA TTC TAG AGG GCC CTA TTC
TAT AGT GTC ACC TAA ATG CTA
GAG CTC GC
66.1 50
114 prohECad_vector
Rev
TCT CTT CTG TCT TCT GAG GCC
AGG AGA GGA GTT GGG AAA TGT
GAG C
68.9 46
115 SNAP-hECad3
Fw
TGG CCT CAG AAG ACA GAA GAG
AGA CAA AGA CTG CGA AAT GAA
GC
67.2 44
116 SNAP-hECad3
Rev
CC TTG TAC GTG GTG GGA TTA
TTA ACC TCG AGT TTA AAC GC
64.2 40
117 hECad3 Fw ATC CGC GTT TAA ACT CGA GGT
TAA TAA TCC CAC CAC GTA CAA
GGG TCA GG
68.4 50
118 hECad3 Rev CCT TGC TCA CCA TAC TTC CTC
CTC CTC CGT CGT CCT CGC CGC
CTC CG
73.8 47
119 hECad-
mCherry
Fw
CGG AGG CGG CGA GGA CGA CGG
AGG AGG AGG AAG TAT GGT GAG
CAA GG
73.8 47
120 hECad-
mCherry
Rev
TGA CAC TAT AGA ATA GGG CCC
TCT AGA ATT CTT ACT TGT ACA
GCT CGT CCA TGC C
67.4 55
121 ECad12-
EGFP_Rev
TCG CCC TTG CTC ACA GAA GAA
CCG CCA CCA GGA GCG TTG TCA
TTA ATA TCC
70.8 51
122 ECad12-EGFP-
Halo
Rev2
CCA GTA CCG ATT TCG GAT CCC
TCG ATC CCC TTG TAC AGC TCG
69.1 42
138 GA_Halo-IRES-
Fw
GGA GAT TTC CGG TTA ATA GAA
TTC TAG ACA ATT GCT TAA GGA
TCC GCC CCT CTC C
67.3 55
139 GA_Halo-IRES-
Rev
GGA GAG GGG CGG ATC CTT AAG
CAA TTG TCT AGA ATT CTA TTA
ACC GGA AAT CTC C
67.3 55
148 dna oligos and plasmids
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
140 GA_IRES-
SNAP-Fw
GGT TTT CCT TTG AAA AAC ACG
ATG ATA ATA TGG ACA AAG ACT
GCG AAA TGA AGC GCA CC
67.6 59
141 GA_IRES-
SNAP-Rev
GGT GCG CTT CAT TTC GCA GTC
TTT GTC CAT ATT ATC ATC GTG
TTT TTC AAA GGA AAA CC
67.6 59
142 GA_mCh-
a(280)-Rev
GTC AAA GTT ATT GAG TGC ATA
CCG CGG TGC AGA ATT CGA AGC
TTG AGC TCG
68.9 51
157 GA_IRES-
DHFR_fw
GGT TTT CCT TTG AAA AAC ACG
ATG ATA ATA TGA TCA GTC TGA
TTG CGG CGT TAG CG
66.8 56
158 GA_IRES-
DHFR_rev
CGC TAA CGC CGC AAT CAG ACT
GAT CAT ATT ATC ATC GTG TTT
TTC AAA GGA AAA CC
66.8 56
159 GA_exSNAP
wDHFR_rev
TTC CTC CTC CTC CAT TAA CCT
CGA GTT TCC GCC GCT CCA GAA
TCT CAA AGC
70.4 51
161 GA_mCh-
SNAP_rev
AGG CGG CCG CCT CGA GCG CTT
AAT TAA CCT CGA GTT TAA ACG
CGG ATC C
72.2 49
163 GA_mCh-
SNAP_fw2
ATG GAC GAG CTG TAT AAG GCC
GGC CAC ATG GAC AAA GAC TGC
GAA ATG AAG C
70.8 52
180 ECad[cyto]-
Halo_Fw
CCA GAG GAT GAC ACC CGG GCT
AGC GAT AAC GAT GGA TCC GAA
ATC GGT ACT GG
71 53
181 cytoECad_
XbaI_Rev
TGA CAC TAT AGA ATA GGG CCC
TCT AGA GTC GCG GCC TTA GTC
GTC CTC G
69,7 49
b.1.2 List of sequencing primers
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
29 EGFP-C-
term_Fw
CAA CGA GAA GCG CGA TCA CAT
GG
60.6 23
30 EGFP-N-
term_Rev
CTG AAC TTG TGG CCG TTT ACG
TCG
60.3 24
B.1 primer lists 149
Int. Ref.
No.
Name Sequence Tm [°
C]
Length
[bp]
31 SNAPf-
mCherry-C-
term_Fw
TGA AAG AGT GGC TGC TGG 55.2 18
32 SNAPf-
mCherry-N-
term_Rev
TGT TCG CAC CCA GAC AGT TCC 59.8 21
41 mCherry-C-
term
Fw
TGG ACA TCA CCT CCC ACA ACG 59.4 21
42 mCherry-N-
term
Rev
CAC CCT TGG TCA CCT TCA GCT
TGG
62 24
58 Bcat-Rev GAA GGG TCC CAG CAG TAC AAC
GAG C
63.2 25
59 Pax_Rev TGC GTG TCT GCT GTT GGG TGG
AG
63.9 23
123 Halo_Nterm_Rev TCT GGA GCA ATG CAG CGA TGG 60.3 21
136 h_aCat(295)-Fw CCT TGA GCT TCA GCG AGG AG 57.8 20
137 h_aCat(310)-
Rev
CAC TAA TGA TGC TTT CCA GAC
G
53.8 22
143 CMV-for CGC AAA TGG GCG GTA GGC GTG 63.9 21
144 BGH-rev TAG AAG GCA CAG TCG AGG 53.6 18
151 aCat_Cterm_fw GCA GAC AGT GAA GGC ATC CTA
CG
59.7 23
152 T7 TAA TAC GAC TCA CTA TAG G 44.5 19
153 T7term TGC TAG TTA TTG CTC AGC GG 55.2 20
162 IRES_fw CAA ACA ACG TCT GTA GCG ACC 56.3 21
150 dna oligos and plasmids
b.2 plasmid list
Int. Ref. No Name
pDO13 SNAPf-mCherry
pDO25 TOMM20-EGFP-Halo
pDO30 DD-EGFP-Vcl
pDO31 SNAPf-mCherry-paxillin
pDO32 SNAPf-mCherry-betaCatenin
pDO33 hE-Cadherin-EGFP-Halo
pDO34 hE-Cadherin-b-EGFP-Halo
pDO35 hE-Cadherin[cyto]-EGFP-Halo
pDO36 hE-Cadherin[cyto]-mCherry-Halo
pDO37 eDHFR-EGFP-cytoECad
pDO38 eDHFR-mEmerald-a1-Catenin-C18
pDO56 EcGFP-Halo_IRES_SNAP-mCherry-a(280-906)
pDO60 Halo-GFP-Mito+mCherry-SNAPf
pDO61 EcGFP-Halo_IRES_DHFR-mCherry-a(280-906)
pDO68 E-cadherin-D-cyto-Halo_IRES_DHFR-EGFP-cytotail
pNB01 ECad12-Halo
pNB02 ECad12-GFP-Halo
pNB03 SNAP-ECad345-mCherry
pFC20A HaloTag T7 SP6 FlexiVector
b.3 synthetic ds-dna
DHFR degron sequence ordere das gBlocks Gene Fragment from IDT
ATG ATC AGT CTG ATT GCG GCG TTA GCG GTA GAT TAC GTT ATC GGC ATG
GAA AAC GCC ATG CCG TGG AAC CTG CCT GCC GAT CTC GCC TGG TTT AAA
CGC AAC ACC TTA AAT AAA CCC GTG ATT ATG GGC CGC CAT ACC TGG GAA
TCA ATC GGT CGT CCG TTG CCA GGA CGC AAA AAT ATT ATC CTC AGC AGT
CAA CCG AGT ACG GAC GAT CGC GTA ACG TGG GTG AAG TCG GTG GAT GAA
GCC ATC GCG GCG TGT GGT GAC GTA CCA GAA ATC ATG GTG ATT GGC GGC
GGT CGC GTT ATT GAA CAG TTC TTG CC AAA AGC GCA AAA ACT GTA TCT
GAC GCA TAT CGA CGC AGA AGT GGA AGG CGA CAC CCA TTT CCC GGA TTA
CGA GCC GGA TGA CTG GGA ATC GGT ATT CAG CGA ATT CCA CGA TGC TGA
TGC GCA GAA CTC TCA CAG CTA TTG CTT TGA GAT TCT GGA GCG GCG A
b.4 cloning tables
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dh
er
in
-
[ß
-C
at
]
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
88
C
M
V
-G
A
-
Fw
C
C
A
T
T
G
A
C
G
C
A
A
A
T
G
G
G
C
G
G
T
A
G
G
C
G
T
G
T
A
C
G
G
T
G
G
78
E-
C
ad
-
[b
C
at
]-
R
ev
A
C
T
T
C
C
T
C
C
T
C
C
T
C
C
G
G
A
G
C
T
C
A
G
A
C
T
A
G
C
A
G
C
T
T
C
G
G
A
A
C
C
G
EG
FP
-
H
al
o2
TO
M
M
20
-E
G
FP
-
H
al
o
(p
D
O
25
)
77
E-
C
ad
-
[b
C
at
]-
Fw
G
G
A
G
G
A
G
G
A
G
G
A
A
G
T
G
T
G
A
G
C
A
A
G
G
G
C
G
A
G
G
A
G
C
T
G
T
T
C
A
C
C
G
68
G
A
-h
EC
ad
-
EG
FP
-H
al
o-
R
ev
T
T
A
G
G
T
G
A
C
A
C
T
A
T
A
G
A
A
T
A
G
G
G
C
C
C
T
C
T
A
G
A
A
T
T
C
T
A
T
T
A
A
C
C
G
G
A
A
A
T
C
T
C
C
158 dna oligos and plasmids
pD
O
35
E-
ca
dh
er
in
-D
cy
to
-E
G
FP
-H
al
o
Fw
Pr
im
er
Re
v
Pr
im
er
lin
ea
riz
ed
Ba
ck
bo
ne
Te
m
pl
at
e
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
70
G
A
-h
EC
ad
-
EG
FP
-H
al
o-
Fw
A
T
T
T
C
C
G
G
T
T
A
A
T
A
G
A
A
T
T
C
T
A
G
A
G
G
G
C
C
C
T
A
T
T
C
T
A
T
A
G
T
G
T
C
A
C
C
T
A
A
A
T
G
C
89
C
M
V
-G
A
-
R
ev
C
C
A
C
C
G
T
A
C
A
C
G
C
C
T
A
C
C
G
C
C
C
A
T
T
T
G
C
G
T
C
A
A
T
G
G
In
se
rts
Te
m
pl
at
e
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
E- ca
dh
er
in
-
D
cy
to
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
88
C
M
V
-G
A
-
Fw
C
C
A
T
T
G
A
C
G
C
A
A
A
T
G
G
G
C
G
G
T
A
G
G
C
G
T
G
T
A
C
G
G
T
G
G
87
G
A
-h
EC
ad
-
[c
yt
]-
R
ev
T
T
G
C
T
C
A
C
A
C
T
T
C
C
T
C
C
T
C
C
T
C
C
G
A
C
C
A
C
C
G
C
T
C
T
C
C
T
C
C
G
A
A
G
A
A
A
C
A
G
C
EG
FP
-
H
al
o2
TO
M
M
20
-E
G
FP
-
H
al
o
(p
D
O
25
)
77
E-
C
ad
-
[b
C
at
]-
Fw
G
G
A
G
G
A
G
G
A
G
G
A
A
G
T
G
T
G
A
G
C
A
A
G
G
G
C
G
A
G
G
A
G
C
T
G
T
T
C
A
C
C
G
68
G
A
-h
EC
ad
-
EG
FP
-H
al
o-
R
ev
T
T
A
G
G
T
G
A
C
A
C
T
A
T
A
G
A
A
T
A
G
G
G
C
C
C
T
C
T
A
G
A
A
T
T
C
T
A
T
T
A
A
C
C
G
G
A
A
A
T
C
T
C
C
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pD
O
36
E-
ca
dh
er
in
-D
cy
to
-m
C
he
rr
y-
H
al
o
Fw
Pr
im
er
Re
v
Pr
im
er
lin
ea
riz
ed
Ba
ck
bo
ne
Te
m
pl
at
e
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
70
G
A
-h
EC
ad
-
EG
FP
-H
al
o-
Fw
A
T
T
T
C
C
G
G
T
T
A
A
T
A
G
A
A
T
T
C
T
A
G
A
G
G
G
C
C
C
T
A
T
T
C
T
A
T
A
G
T
G
T
C
A
C
C
T
A
A
A
T
G
C
89
C
M
V
-G
A
-
R
ev
C
C
A
C
C
G
T
A
C
A
C
G
C
C
T
A
C
C
G
C
C
C
A
T
T
T
G
C
G
T
C
A
A
T
G
G
In
se
rts
Te
m
pl
at
e
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
E- ca
dh
er
in
-
D
cy
to
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
88
C
M
V
-G
A
-
Fw
C
C
A
T
T
G
A
C
G
C
A
A
A
T
G
G
G
C
G
G
T
A
G
G
C
G
T
G
T
A
C
G
G
T
G
G
38
G
FP
-
m
C
he
rr
y-
ex
-
N
te
rm
R
ev
C
T
C
C
T
C
G
C
C
C
T
T
G
C
T
C
A
C
m
C
he
rr
y
SN
A
Pf
-m
C
he
rr
y
(p
D
O
13
)
37
G
FP
-
m
C
he
rr
y-
ex
-
N
te
rm
Fw
G
T
G
A
G
C
A
A
G
G
G
C
G
A
G
G
A
G
40
G
FP
-
m
C
he
rr
y-
ex
-
C
te
rm
R
ev
C
T
T
G
T
A
C
A
G
C
T
C
G
T
C
C
A
T
G
C
C
G
H
al
o
E-
ca
dh
er
in
-
D
cy
to
-E
G
FP
-
H
al
o
(p
D
O
35
)
39
G
FP
-
m
C
he
rr
y-
ex
-
C
te
rm
Fw
C
G
G
C
A
T
G
G
A
C
G
A
G
C
T
G
T
A
C
A
A
G
68
G
A
-h
EC
ad
-
EG
FP
-H
al
o-
R
ev
T
T
A
G
G
T
G
A
C
A
C
T
A
T
A
G
A
A
T
A
G
G
G
C
C
C
T
C
T
A
G
A
A
T
T
C
T
A
T
T
A
A
C
C
G
G
A
A
A
T
C
T
C
C
160 dna oligos and plasmids
pD
O
37
D
H
FR
-E
G
FP
-c
yt
ot
ai
l
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
D
H
FR
-E
G
FP
(p
D
O
28
)
Bs
rG
I
T
/
G
T
A
C
A
N
ot
I
G
C
/
G
G
C
C
G
C
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
cy
to
ta
il
E-
ca
dh
er
in
-G
FP
(p
D
O
48
)
85
G
A
-h
EC
ad
-
cy
to
so
l-
Fw
G
C
A
T
G
G
A
C
G
A
G
C
T
G
T
A
C
A
A
G
G
G
A
G
G
A
G
G
A
G
G
A
A
G
T
A
A
A
G
A
G
C
C
C
T
T
A
C
T
G
C
C
C
C
C
A
G
A
G
G
86
G
A
-h
EC
ad
-
cy
to
so
l-
R
ev
G
C
T
G
A
T
T
A
T
G
A
T
C
T
A
G
A
G
T
C
G
C
G
G
C
C
T
T
A
G
T
C
G
T
C
C
T
C
G
C
C
G
C
C
T
C
C
G
T
A
C
A
T
G
T
C
A
G
C
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pD
O
38
D
H
FR
-m
Em
er
al
d-
a
-c
at
en
in
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
m
Em
er
al
d-
a
-
ca
te
ni
n
(p
D
O
23
)
Bm
tI
G
C
T
A
G
/
C
A
ge
I
A
/
C
C
G
G
T
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
D
H
FR
D
H
FR
-E
G
FP
(p
D
O
28
)
88
C
M
V
-G
A
-
Fw
C
C
A
T
T
G
A
C
G
C
A
A
A
T
G
G
G
C
G
G
T
A
G
G
C
G
T
G
T
A
C
G
G
T
G
G
38
G
FP
-
m
C
he
rr
y-
ex
-
N
te
rm
R
ev
C
T
C
C
T
C
G
C
C
C
T
T
G
C
T
C
A
C
162 dna oligos and plasmids
pD
O
56
Ec
-G
FP
-H
al
o-
IR
ES
-S
N
A
P-
m
C
he
rr
y-
a
(2
80
-9
06
)
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
Ec
G
FP
-a
(2
80
-9
06
)
(p
D
O
52
)
Br
sG
I
T
/
G
T
A
C
A
Sa
cI
I
C
C
G
C
/
G
G
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
H
al
o2
E-
ca
dh
er
in
-
EG
FP
-H
al
o
(p
D
O
33
)
39
G
FP
-
m
C
he
rr
y-
ex
-
C
te
rm
Fw
C
G
G
C
A
T
G
G
A
C
G
A
G
C
T
G
T
A
C
A
A
G
13
9
G
A
-H
al
o-
IR
ES
-R
ev
G
G
A
G
A
G
G
G
G
C
G
G
A
T
C
C
T
T
A
A
G
C
A
A
T
T
G
T
C
T
A
G
A
A
T
T
C
T
A
T
T
A
A
C
C
G
G
A
A
A
T
C
T
C
C
IR
ES
H
al
o-
G
FP
-
M
it
o+
m
C
he
rr
y-
D
H
FR
(p
D
O
47
)
13
8
G
A
-H
al
o-
IR
ES
-F
w
G
G
A
G
A
T
T
T
C
C
G
G
T
T
A
A
T
A
G
A
A
T
T
C
T
A
G
A
C
A
A
T
T
G
C
T
T
A
A
G
G
A
T
C
C
G
C
C
C
C
T
C
T
C
C
14
1
G
A
-I
R
ES
-
SN
A
P-
R
ev
G
G
T
G
C
G
C
T
T
C
A
T
T
T
C
G
C
A
G
T
C
T
T
T
G
T
C
C
A
T
A
T
T
A
T
C
A
T
C
G
T
G
T
T
T
T
T
C
A
A
A
G
G
A
A
A
A
C
C
SN
A
P-
m
C
he
rr
y
SN
A
P-
m
C
he
rr
y-
b
-c
at
en
in
(p
D
O
32
)
14
0
G
A
-I
R
ES
-
SN
A
P-
Fw
G
G
T
T
T
T
C
C
T
T
T
G
A
A
A
A
A
C
A
C
G
A
T
G
A
T
A
A
T
A
T
G
G
A
C
A
A
A
G
A
C
T
G
C
G
A
A
A
T
G
A
A
G
C
G
C
A
C
C
14
2
G
A
-m
C
h-
a(
28
0)
-R
ev
G
T
C
A
A
A
G
T
T
A
T
T
G
A
G
T
G
C
A
T
A
C
C
G
C
G
G
T
G
C
A
G
A
A
T
T
C
G
A
A
G
C
T
T
G
A
G
C
T
C
G
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pD
O
60
H
al
o-
G
FP
-M
it
o+
m
C
he
rr
y-
SN
A
Pf
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
H
al
o-
G
FP
-
M
it
o+
m
C
he
rr
y-
D
H
FR
(p
D
O
47
)
Fs
eI
G
G
C
C
G
G
/
C
C
Pa
cI
T
T
A
A
T
/
T
A
A
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
SN
A
P2
SN
A
Pf
-m
C
he
rr
y
(p
D
O
13
)
16
3
G
A
-m
C
h-
SN
A
P-
fw
2
A
T
G
G
A
C
G
A
G
C
T
G
T
A
T
A
A
G
G
C
C
G
G
C
C
A
C
A
T
G
G
A
C
A
A
A
G
A
C
T
G
C
G
A
A
A
T
G
A
A
G
C
16
1
G
A
-m
C
h-
SN
A
P-
re
v
A
G
G
C
G
G
C
C
G
C
C
T
C
G
A
G
C
G
C
T
T
A
A
T
T
A
A
C
C
T
C
G
A
G
T
T
T
A
A
A
C
G
C
G
G
A
T
C
C
164 dna oligos and plasmids
pD
O
61
Ec
G
FP
-H
al
o-
IR
ES
-D
H
FR
-m
C
he
rr
y-
a
(2
80
-9
06
)
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
Ec
G
FP
-H
al
o-
IR
ES
-S
N
A
P-
m
C
he
rr
y-
a
(2
80
-
90
6)
(p
D
O
56
)
A
flI
I
C
/
T
T
A
A
G
Pm
eI
G
T
T
T
/
A
A
A
C
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
D
H
FR
-
EG
FP
-
cy
to
ta
il
eD
H
FR
-E
G
FP
(p
D
O
28
)
15
7
G
A
-I
R
ES
-
D
H
FR
-f
w
G
G
T
T
T
T
C
C
T
T
T
G
A
A
A
A
A
C
A
C
G
A
T
G
A
T
A
A
T
A
T
G
A
T
C
A
G
T
C
T
G
A
T
T
G
C
G
G
C
G
T
T
A
G
C
G
15
9
G
A
-
ex
SN
A
Pw
D
H
FR
-
re
v
T
T
C
C
T
C
C
T
C
C
T
C
C
A
T
T
A
A
C
C
T
C
G
A
G
T
T
T
C
C
G
C
C
G
C
T
C
C
A
G
A
A
T
C
T
C
A
A
A
G
C
IR
ES
2
H
al
o-
G
FP
-
M
it
o+
m
C
he
rr
y-
D
H
FR
(p
D
O
47
)
13
8
G
A
-H
al
o-
IR
ES
-F
w
G
G
A
G
A
T
T
T
C
C
G
G
T
T
A
A
T
A
G
A
A
T
T
C
T
A
G
A
C
A
A
T
T
G
C
T
T
A
A
G
G
A
T
C
C
G
C
C
C
C
T
C
T
C
C
15
8
G
A
-I
R
ES
-
D
H
FR
-r
ev
C
G
C
T
A
A
C
G
C
C
G
C
A
A
T
C
A
G
A
C
T
G
A
T
C
A
T
A
T
T
A
T
C
A
T
C
G
T
G
T
T
T
T
T
C
A
A
A
G
G
A
A
A
A
C
C
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pD
O
68
E-
ca
dh
er
in
-D
-c
yt
o-
H
al
o_
IR
ES
_D
H
FR
-E
G
FP
-c
yt
ot
ai
l
5’
cu
t
3’
cu
t
lin
ea
ri
ze
d
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
N
am
e
Se
qu
en
ce
#
N
am
e
Se
qu
en
ce
Ec
G
FP
-a
(2
80
-9
06
)
(p
D
O
68
)
Bm
tI
G
C
T
A
G
/
C
Xb
aI
T
/
C
T
A
G
A
Fw
Pr
im
er
R
ev
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
Se
qu
en
ce
#
N
am
e
Se
qu
en
ce
H
al
o-
IR
ES
Ec
G
FP
-
H
al
o_
IR
ES
_D
H
FR
-
m
C
he
rr
y-
a
28
0-
90
6
(p
D
O
61
)
18
0
EC
ad
[c
yt
o]
-
H
al
o_
Fw
C
C
A
G
A
G
G
A
T
G
A
C
A
C
C
C
G
G
G
C
T
A
G
C
G
A
T
A
A
C
G
A
T
G
G
A
T
C
C
G
A
A
A
T
C
G
G
T
A
C
T
G
G
15
8
G
A
_I
R
ES
-
D
H
FR
_r
ev
C
G
C
T
A
A
C
G
C
C
G
C
A
A
T
C
A
G
A
C
T
G
A
T
C
A
T
A
T
T
A
T
C
A
T
C
G
T
G
T
T
T
T
T
C
A
A
A
G
G
A
A
A
A
C
C
D
H
FR
-
EG
FP
-
cy
to
ta
il
eD
H
FR
-E
G
FP
-
cy
to
EC
ad
(p
D
O
37
)
15
7
G
A
-I
R
ES
-
D
H
FR
-f
w
G
G
T
T
T
T
C
C
T
T
T
G
A
A
A
A
A
C
A
C
G
A
T
G
A
T
A
A
T
A
T
G
A
T
C
A
G
T
C
T
G
A
T
T
G
C
G
G
C
G
T
T
A
G
C
G
18
1
cy
to
EC
ad
_
X
ba
I_
R
ev
T
G
A
C
A
C
T
A
T
A
G
A
A
T
A
G
G
G
C
C
C
T
C
T
A
G
A
G
T
C
G
C
G
G
C
C
T
T
A
G
T
C
G
T
C
C
T
C
G
166 dna oligos and plasmids
pN
B
01
EC
12
-H
al
o
5’
cu
t
3’
cu
t
lin
ea
riz
ed
Ba
ck
bo
ne
So
ur
ce
Pl
as
m
id
#
Na
m
e
Se
qu
en
ce
#
Na
m
e
Se
qu
en
ce
pF
C
20
A
H
al
oT
ag
T7
SP
6
Fl
ex
iV
ec
to
r
Ba
m
H
I
G
/
G
A
T
C
C
A
si
SI
G
C
G
A
T
/
C
G
C
Fw
Pr
im
er
Re
v
Pr
im
er
In
se
rt
s
Te
m
pl
at
e
#
N
am
e
S
e
q
u
e
n
c
e
#
N
am
e
S
e
q
u
e
n
c
e
EC
ad
12
EC
ad
12
-A
vi
(p
D
O
40
)
10
9
EC
ad
12
-
H
al
o-
Fw
A
C
A
C
T
A
T
A
G
A
A
T
A
A
G
G
A
G
C
G
A
T
A
T
G
C
A
C
C
A
C
C
A
C
C
A
C
C
A
C
C
A
C
G
A
A
A
A
C
C
11
0
EC
ad
12
-
H
al
o-
R
ev
A
A
A
G
C
C
A
G
T
A
C
C
G
A
T
T
T
C
G
G
A
T
C
T
G
T
C
G
T
T
C
A
G
A
C
C
G
C
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